data_1yva_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yva _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.687 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 97.2 m -89.14 133.48 34.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.408 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 41.4 m -137.69 93.49 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 109.985 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 29.0 m -105.45 161.75 21.83 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.393 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.6 Cg_endo -70.08 -10.2 27.75 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.173 1.617 . . . . 0.0 111.605 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 172.57 -169.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.257 . . . . 0.0 111.005 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 11' ' ' SER . 11.2 mm -65.76 -33.4 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.106 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.7 t -53.7 -66.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.818 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -60.32 -58.6 7.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.888 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -40.54 -37.06 0.65 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.533 -0.729 . . . . 0.0 110.318 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 6.2 t -76.12 -36.22 58.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' CB ' ' OG1' ' A' ' 30' ' ' THR . 68.7 m-20 -69.13 -63.01 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.583 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 0.7 OUTLIER -47.41 -34.62 7.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 13.3 m-20 -78.14 -14.3 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -96.66 -19.57 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.442 -0.786 . . . . 0.0 110.034 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -91.28 -23.69 20.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.412 -0.805 . . . . 0.0 110.868 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 26.4 tpt180 -88.95 -8.21 54.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.499 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.601 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.1 mt -60.8 -45.17 96.8 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.488 -0.757 . . . . 0.0 110.75 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.1 Cg_endo -73.65 -76.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.635 1.334 . . . . 0.0 110.895 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.11 25.91 0.11 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.502 HG22 ' HD2' ' A' ' 22' ' ' PRO . 4.1 m -91.34 141.33 26.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.134 -1.215 . . . . 0.0 110.261 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.91 122.96 8.08 Favored 'Trans proline' 0 C--N 1.285 -2.773 0 O-C-N 124.557 1.819 . . . . 0.0 108.5 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 1.8 pt-20 -34.74 -28.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.052 0.453 . . . . 0.0 110.986 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.26 -47.47 85.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.09 -1.006 . . . . 0.0 109.524 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -20.34 60.44 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.316 -0.865 . . . . 0.0 109.837 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -86.95 -24.94 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -100.17 -3.52 31.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.305 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -97.18 -29.02 13.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -90.04 -33.57 16.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.507 ' OG1' ' CB ' ' A' ' 12' ' ' ASN . 1.2 t -93.19 -19.74 21.15 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.353 -0.842 . . . . 0.0 110.354 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 108.87 -42.16 2.03 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.405 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' O ' ' O ' ' A' ' 27' ' ' ALA . 43.1 t -43.79 166.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.31 . . . . 0.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.411 HD12 ' HG3' ' A' ' 41' ' ' PRO . 1.4 pt -145.59 146.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.458 HG21 ' N ' ' A' ' 35' ' ' ILE . 2.9 mp -108.21 156.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.418 -0.801 . . . . 0.0 109.562 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.502 HG22 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -142.03 145.2 35.06 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.145 -0.972 . . . . 0.0 110.282 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.35 62.01 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.11 1.584 . . . . 0.0 110.518 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.91 -139.36 2.78 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -148.21 12.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.976 . . . . 0.0 110.481 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 106.33 13.52 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.251 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 76.0 m -74.83 164.46 61.23 Favored Pre-proline 0 C--N 1.291 -1.956 0 O-C-N 121.859 -0.526 . . . . 0.0 109.66 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 47.0 Cg_endo -74.06 -165.44 0.26 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.944 1.497 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.69 -25.22 10.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.508 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 2.4 m-20 -85.62 -23.47 27.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -1.183 . . . . 0.0 109.666 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.508 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 2.8 m-85 -121.59 35.72 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.367 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.25 29.22 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.444 -0.785 . . . . 0.0 110.87 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.846 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.755 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.495 HG21 ' CD1' ' A' ' 13' ' ' PHE . 4.3 m -87.97 157.84 18.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -155.45 111.14 3.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 111.093 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -113.69 150.2 42.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.63 30.86 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.75 1.395 . . . . 0.0 112.046 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.532 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 7.5 t -178.21 155.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 110.928 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 13.4 mt -65.53 -25.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.499 -0.751 . . . . 0.0 109.792 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 4.1 t -80.78 -54.03 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.803 . . . . 0.0 109.884 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.52 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -53.81 -48.13 70.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 109.495 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -68.51 -27.12 65.84 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.1 t -74.62 -45.23 46.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.152 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.9 m-20 -52.17 -48.67 64.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.464 -0.773 . . . . 0.0 108.967 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.495 ' CD1' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -52.96 -41.39 64.49 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.534 0.683 . . . . 0.0 109.629 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -75.04 -11.98 60.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.64 -23.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.587 -0.695 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' HG22 ' A' ' 21' ' ' THR . 2.0 t -89.92 -17.11 28.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.64 0.99 55.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.899 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.572 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -55.41 -44.61 99.73 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.483 -0.76 . . . . 0.0 110.957 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.7 Cg_endo -76.62 -22.88 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.678 1.357 . . . . 0.0 110.852 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.58 15.2 2.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.585 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.3 m -65.3 145.16 99.11 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.975 -1.309 . . . . 0.0 110.293 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 42.3 Cg_endo -74.95 119.07 5.5 Favored 'Trans proline' 0 C--N 1.287 -2.685 0 O-C-N 124.613 1.849 . . . . 0.0 108.696 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 6.3 pt-20 -35.54 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.246 0.546 . . . . 0.0 110.528 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.18 -40.46 81.55 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.119 -0.988 . . . . 0.0 109.572 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -33.54 43.61 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 36.2 m -83.45 -17.88 40.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 111.155 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -100.85 -11.68 19.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 109.68 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.6 m -93.64 -25.47 17.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.85 -29.35 13.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.246 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -95.71 -16.59 21.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.439 -0.788 . . . . 0.0 110.36 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 110.95 -42.16 2.04 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.761 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 27' ' ' ALA . 73.0 m -40.5 149.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.165 -1.197 . . . . 0.0 110.438 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 33' ' ' ILE . 18.2 pt -129.77 148.38 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.417 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' CD1' ' HG3' ' A' ' 23' ' ' GLU . 3.3 mp -113.29 151.34 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -145.79 162.69 34.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.03 -3.82 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.83 1.437 . . . . 0.0 110.838 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.19 -142.65 12.54 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.94 7.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.469 -1.018 . . . . 0.0 111.233 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' CYS . 1.4 t -130.23 -2.63 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.798 -1.189 . . . . 0.0 111.101 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.582 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 9.0 p 37.64 -163.25 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 122.064 -0.398 . . . . 0.0 110.391 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.582 ' CD ' ' HB2' ' A' ' 40' ' ' CYS . 54.9 Cg_endo -79.24 176.98 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 122.84 0.916 . . . . 0.0 111.253 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.05 -2.34 66.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.41 -28.08 14.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 5.3 m-85 -114.36 23.69 12.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.31 -0.869 . . . . 0.0 109.544 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . -84.99 30.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.532 ' HB3' ' N ' ' A' ' 6' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.852 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.779 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.6 m -111.37 154.07 25.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -144.93 86.58 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.455 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 33.7 m -109.74 132.56 21.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' C ' ' OG ' ' A' ' 6' ' ' SER . 50.3 Cg_endo -76.18 47.57 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.862 1.454 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 179.47 121.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.084 -1.01 . . . . 0.0 109.903 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.6 mm -45.59 -32.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.007 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.0 t -79.3 -50.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.847 . . . . 0.0 109.951 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.421 ' CB ' ' OG ' ' A' ' 6' ' ' SER . . . -46.25 -31.1 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.901 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.546 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.35 -42.52 36.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.44 -0.787 . . . . 0.0 109.653 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.546 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -63.95 -53.85 43.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.388 -0.82 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.437 ' HB2' ' CG2' ' A' ' 30' ' ' THR . 36.2 m-20 -50.54 -50.54 53.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 1.1 t80 -51.06 -37.67 46.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -76.57 -15.18 59.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -23.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.641 -0.662 . . . . 0.0 109.739 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.485 ' SG ' HG23 ' A' ' 21' ' ' THR . 1.5 t -89.05 -18.71 26.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.403 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -90.51 -5.67 55.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.603 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -64.51 -42.24 64.32 Favored Pre-proline 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 111.003 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 44.9 Cg_endo -74.15 -26.63 12.53 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.456 1.24 . . . . 0.0 110.604 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.65 10.96 1.98 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.236 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.549 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 8.6 m -70.39 143.99 91.31 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.019 -1.283 . . . . 0.0 110.352 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -74.94 120.03 5.91 Favored 'Trans proline' 0 C--N 1.285 -2.811 0 O-C-N 124.627 1.856 . . . . 0.0 108.989 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 24' ' ' ALA . 1.7 pp20? -32.74 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.957 0.408 . . . . 0.0 111.413 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.48 -40.67 95.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 0.0 109.396 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -73.66 -37.39 65.31 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.48 ' O ' ' OG1' ' A' ' 30' ' ' THR . 23.8 m -75.28 -19.84 59.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' HD13 ' A' ' 34' ' ' ILE . . . -95.7 -6.64 39.41 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.076 0.941 . . . . 0.0 109.524 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -29.21 19.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.29 -35.23 17.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.676 -0.64 . . . . 0.0 109.489 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 26' ' ' CYS 0.261 16.8 p -80.35 -23.62 40.42 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.396 -0.815 . . . . 0.0 110.284 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 23.45 47.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -116.85 175.1 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -1.029 . . . . 0.0 109.937 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 pp -132.95 148.0 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.539 HD13 ' CB ' ' A' ' 27' ' ' ALA . 3.3 mp -105.68 161.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.247 -0.908 . . . . 0.0 110.114 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.507 ' CG1' HG23 ' A' ' 1' ' ' THR . 48.6 pt -148.72 163.39 26.11 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 110.436 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.7 Cg_endo -70.12 -38.03 7.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.014 1.534 . . . . 0.0 110.198 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.54 130.77 1.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.472 ' O ' HG21 ' A' ' 39' ' ' THR . . . -174.2 17.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.603 -0.94 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 66.86 4.29 3.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 110.89 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.516 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER 56.14 142.61 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.778 -0.576 . . . . 0.0 110.867 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' CG ' ' CD2' ' A' ' 44' ' ' TYR . 45.9 Cg_endo -74.6 173.68 13.92 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.631 1.332 . . . . 0.0 110.054 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.23 -4.11 88.79 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.425 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 37.3 m-20 -102.0 -26.11 13.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -1.201 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 4.8 m-85 -118.12 21.14 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.8 30.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.455 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.998 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.778 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 t -113.27 169.4 8.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.473 ' O ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -157.54 102.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.133 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.85 159.34 41.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.136 -0.978 . . . . 0.0 110.49 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 49.4 Cg_endo -77.83 6.51 4.5 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.178 1.62 . . . . 0.0 111.246 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 5' ' ' PRO . 8.7 m -170.56 168.35 7.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.086 . . . . 0.0 110.815 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 7' ' ' ILE . 4.0 mm -68.76 -30.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.513 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 9' ' ' ALA . 10.4 t -80.89 -48.46 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -44.18 -36.71 2.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.184 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.523 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -78.0 -39.28 42.75 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.407 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.523 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 4.4 p -55.62 -48.05 75.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.587 -0.696 . . . . 0.0 110.216 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 7.7 p30 -69.93 -33.29 71.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.0 OUTLIER -59.75 -41.33 90.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 108.741 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -79.54 -30.38 41.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.516 0.674 . . . . 0.0 109.422 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 1.0 OUTLIER -64.97 -32.82 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.533 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.47 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -80.83 -27.83 36.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.503 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 21' ' ' THR . 2.0 ttt180 -94.3 6.39 48.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.299 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -74.16 -41.95 5.38 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.587 -0.695 . . . . 0.0 110.958 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -74.8 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.479 1.252 . . . . 0.0 110.941 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.19 24.84 0.2 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.533 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 7.6 m -94.95 141.42 23.25 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 120.995 -1.297 . . . . 0.0 110.255 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -73.7 119.74 6.07 Favored 'Trans proline' 0 C--N 1.285 -2.797 0 O-C-N 124.648 1.867 . . . . 0.0 108.793 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -35.13 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.225 0.536 . . . . 0.0 110.849 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.85 -45.58 93.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.848 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -70.85 -36.09 72.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 110.51 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.2 m -74.44 -23.46 58.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.689 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -96.0 -12.57 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.997 . . . . 0.0 109.761 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.1 m -95.13 -21.64 18.38 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -99.58 -20.46 16.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.512 ' OG1' ' OD1' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -111.55 -7.28 14.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.56 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 104.18 -34.48 5.75 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.686 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -46.15 174.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.027 -1.278 . . . . 0.0 110.42 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 32' ' ' CYS . 28.3 pt -158.32 145.74 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 4.8 mp -106.41 140.48 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 110.138 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 2.2 pp -160.98 134.1 4.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 110.186 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.98 70.81 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.918 1.483 . . . . 0.0 110.448 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . 168.87 138.27 2.44 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.48 15.35 5.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -81.9 10.29 6.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.524 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -40.57 163.53 0.09 OUTLIER Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.874 -0.516 . . . . 0.0 110.264 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 42.7 Cg_endo -69.8 169.28 19.34 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.068 1.562 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.69 61.83 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 43.4 p-10 -112.0 -19.86 12.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.03 -1.276 . . . . 0.0 109.519 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 16.2 m-85 -123.27 17.94 9.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.614 -0.678 . . . . 0.0 109.444 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.4 32.55 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.489 -0.757 . . . . 0.0 110.338 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 17.7 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.337 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.84 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.56 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 94.2 m -127.58 160.71 30.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.5 m -148.05 156.98 43.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.528 ' HB3' ' CB ' ' A' ' 9' ' ' ALA . 85.9 m -147.53 130.52 7.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 6' ' ' SER . 49.6 Cg_endo -77.74 25.26 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.977 1.514 . . . . 0.0 112.79 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER 174.25 164.95 0.21 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.254 -1.528 . . . . 0.0 111.059 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' SER . 56.4 mt -65.46 -30.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.508 -0.745 . . . . 0.0 109.328 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 64.8 t -66.74 -50.79 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.925 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 4' ' ' CYS . . . -55.24 -66.15 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -51.75 -22.52 3.63 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.531 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 2.1 t -80.24 -63.33 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 10.3 p30 -61.65 -37.04 82.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.56 ' CE1' ' CG2' ' A' ' 2' ' ' THR . 0.2 OUTLIER -59.87 -44.92 93.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.942 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 1.5 p30 -69.46 -27.83 65.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.186 -0.946 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -23.25 28.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.497 ' SG ' HG21 ' A' ' 21' ' ' THR . 5.3 t -92.78 -22.93 19.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.697 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -91.1 5.23 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.556 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.575 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -65.89 -46.47 65.05 Favored Pre-proline 0 C--N 1.306 -1.29 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.4 Cg_endo -74.8 -71.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.614 1.323 . . . . 0.0 110.581 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.1 27.31 0.09 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.505 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 2.7 m -84.23 141.35 39.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.064 -1.256 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.6 Cg_endo -74.17 124.73 9.25 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 O-C-N 124.546 1.814 . . . . 0.0 108.242 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -39.98 -23.37 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.8 -0.563 . . . . 0.0 110.209 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.19 -51.23 68.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.089 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -29.09 66.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 110.576 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.539 ' O ' ' CG2' ' A' ' 30' ' ' THR . 27.8 m -78.63 -44.92 22.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.039 -1.038 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 32' ' ' CYS . . . -68.89 -13.29 62.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.927 -1.108 . . . . 0.0 109.648 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.488 HG21 ' N ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -77.84 -47.03 19.8 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.537 0.684 . . . . 0.0 109.663 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.488 ' N ' HG21 ' A' ' 28' ' ' THR . 4.6 t80 -94.89 -41.03 9.4 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.616 0.722 . . . . 0.0 110.064 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -68.25 -31.87 71.65 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.438 -0.789 . . . . 0.0 110.357 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 30' ' ' THR . . . 124.26 -47.41 1.02 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.561 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 66.5 m -44.17 169.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.041 -1.27 . . . . 0.0 110.193 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.9 148.8 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.136 -0.977 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 24' ' ' ALA . 1.9 mp -80.39 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 35' ' ' ILE . 1.1 pp -134.97 133.16 20.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.79 6.66 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.95 1.5 . . . . 0.0 110.388 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.23 -138.9 5.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.9 -48.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.995 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -102.65 2.06 35.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.012 . . . . 0.0 110.42 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER 47.48 177.73 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.862 -0.524 . . . . 0.0 111.168 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' TYR . 47.7 Cg_endo -73.16 -157.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.032 1.543 . . . . 0.0 110.188 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.76 -8.54 54.23 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -19.33 14.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.246 . . . . 0.0 110.145 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 16.6 m-85 -114.25 10.27 17.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 41' ' ' PRO . . . -89.11 31.38 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 1.9 t30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.757 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 t -92.82 171.32 9.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 2' ' ' THR . 1.1 m -147.16 106.07 3.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.045 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 10' ' ' ARG . 1.2 m -99.58 144.07 27.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.917 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.8 Cg_endo -70.86 -3.35 12.56 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.951 1.5 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER 172.43 175.09 0.1 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.803 -1.186 . . . . 0.0 110.559 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 7' ' ' ILE . 30.9 mm -57.7 -36.08 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 110.05 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.49 -62.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.528 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -61.63 -54.24 45.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.944 . . . . 0.0 108.992 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.69 -52.63 4.84 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.302 -0.874 . . . . 0.0 109.555 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -64.45 -32.73 74.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.064 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.496 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 1.2 m-20 -59.85 -71.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.683 0.754 . . . . 0.0 109.83 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.649 ' CE2' ' CB ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -47.62 -33.64 6.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.562 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -70.35 -26.11 63.59 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.827 0.822 . . . . 0.0 109.165 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -70.95 -25.02 25.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.52 -22.64 26.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -74.05 -10.1 59.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.538 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.6 mt -72.4 -55.73 4.53 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.11 -34.14 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.732 1.385 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.6 7.9 1.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.479 HG21 ' HD2' ' A' ' 22' ' ' PRO . 32.9 m -65.26 131.61 95.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 120.91 -1.347 . . . . 0.0 110.363 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 40.3 Cg_endo -72.23 116.99 4.92 Favored 'Trans proline' 0 C--N 1.288 -2.647 0 O-C-N 124.431 1.753 . . . . 0.0 108.738 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 26.4 pt-20 -33.03 -31.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.433 0.635 . . . . 0.0 110.896 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.53 -43.08 99.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 110.734 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.513 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -72.15 -45.29 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.905 -1.122 . . . . 0.0 111.368 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.539 ' O ' ' CG2' ' A' ' 30' ' ' THR . 0.1 OUTLIER -84.37 -15.45 46.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 0.0 111.763 -178.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -75.99 -39.12 56.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.465 -1.397 . . . . 0.0 108.631 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -30.18 63.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.182 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 1.7 t80 -90.89 -48.36 7.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.805 . . . . 0.0 110.357 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 1.2 t -66.67 -12.83 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.569 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.95 -43.95 1.61 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.447 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' GLY . 1.5 t -46.77 175.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -1.203 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -140.39 156.72 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.112 -0.992 . . . . 0.0 109.808 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 73.5 mt -137.25 141.26 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.815 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -147.52 156.3 45.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 0.0 109.804 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.82 68.85 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.815 1.429 . . . . 0.0 110.046 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 149.11 4.97 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.37 32.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -1.006 . . . . 0.0 110.419 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' CYS . 1.5 t -84.06 14.35 4.26 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 110.768 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' THR . 62.4 m -36.19 154.75 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 122.095 -0.378 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.97 -176.72 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.943 1.496 . . . . 0.0 110.33 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.23 4.87 82.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.96 -22.5 12.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -1.201 . . . . 0.0 109.872 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -117.87 14.93 14.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 109.838 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.12 29.21 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.824 . . . . 0.0 110.551 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.459 ' HB3' ' N ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.127 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.843 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.474 ' O ' ' NH1' ' A' ' 10' ' ' ARG . 1.3 m -124.61 161.1 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -152.56 145.24 24.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -134.12 161.08 65.9 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.3 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 46.7 Cg_endo -73.59 -0.98 10.06 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.112 1.585 . . . . 0.0 111.607 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -176.17 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.669 -1.27 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -75.07 -31.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.968 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.2 t -65.61 -44.48 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.503 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -62.74 -70.22 0.22 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 109.049 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.84 -26.87 0.15 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.1 m -72.37 -61.78 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 36.3 p30 -58.14 -21.18 45.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.998 -1.064 . . . . 0.0 109.802 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.554 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 2.2 t80 -72.47 -45.13 60.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.662 0.744 . . . . 0.0 109.101 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -73.56 -20.13 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.79 . . . . 0.0 109.048 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.24 -25.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.452 0.644 . . . . 0.0 109.653 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -84.57 -25.88 28.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.783 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 15.5 ttt180 -88.32 7.32 32.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.758 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -61.07 -43.69 91.67 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.454 -0.778 . . . . 0.0 110.829 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -76.98 -21.41 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.611 1.322 . . . . 0.0 110.834 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.49 12.99 1.93 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.222 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.558 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.7 m -65.63 144.8 99.01 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.063 -1.257 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 42.1 Cg_endo -73.96 118.82 5.57 Favored 'Trans proline' 0 C--N 1.287 -2.693 0 O-C-N 124.614 1.849 . . . . 0.0 108.859 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 22' ' ' PRO . 75.2 mt-10 -36.34 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.145 0.498 . . . . 0.0 110.562 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.69 -38.85 89.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.195 -0.94 . . . . 0.0 109.953 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -30.88 32.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.049 -1.032 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.547 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 69.4 m -80.05 -14.44 58.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.05 . . . . 0.0 110.361 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.85 -27.47 13.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.371 1.081 . . . . 0.0 109.555 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.403 ' O ' HG21 ' A' ' 28' ' ' THR . 1.1 m -78.74 -23.58 45.33 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.798 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.8 t80 -102.28 -32.21 10.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.283 -0.885 . . . . 0.0 109.792 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -91.09 -5.11 55.62 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.03 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 105.64 -38.75 3.14 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.728 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -50.01 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.969 -1.312 . . . . 0.0 110.196 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 32' ' ' CYS . 1.2 pp -156.82 163.22 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.871 -1.143 . . . . 0.0 110.499 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 7.4 mm -100.79 165.92 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.078 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 1.3 pt -171.56 170.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 109.646 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.5 Cg_endo -69.75 -16.84 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.865 1.455 . . . . 0.0 110.139 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 105.03 141.04 10.6 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 37' ' ' GLY . . . 74.6 -6.84 1.83 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.686 -0.891 . . . . 0.0 111.323 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.472 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -96.78 10.87 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' CD1' ' A' ' 35' ' ' ILE . 52.0 m -62.32 130.1 92.87 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 110.112 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HG2' ' OD2' ' A' ' 43' ' ' ASP . 43.7 Cg_endo -70.38 -165.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.817 1.43 . . . . 0.0 110.717 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.98 -14.01 55.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 43' ' ' ASP . 37.2 p-10 -98.18 -20.22 17.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -1.208 . . . . 0.0 109.498 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.453 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 11.9 m-85 -119.49 23.34 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.93 21.64 3.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 4.8 m120 . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.836 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 35' ' ' ILE . 9.4 t -138.75 173.93 11.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.1 m -152.38 110.83 3.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.889 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 19.4 m -99.46 162.94 19.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.0 Cg_endo -71.41 -7.84 22.11 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 7' ' ' ILE . 9.0 t 175.14 -171.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.8 -1.187 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.2 mm -70.72 -33.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.1 t -55.54 -61.41 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.589 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -56.99 -66.46 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.64 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -41.99 -37.7 1.42 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.368 -0.833 . . . . 0.0 110.386 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 t -66.81 -49.71 64.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.949 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 12.2 m-20 -57.14 -59.34 5.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.627 ' CE2' ' CB ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -50.09 -38.88 40.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.39 -0.819 . . . . 0.0 109.573 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 3.3 m-20 -68.4 -32.79 73.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.905 0.859 . . . . 0.0 108.866 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.49 -18.33 23.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.803 0.811 . . . . 0.0 108.966 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.512 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.89 -26.93 22.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.779 -0.575 . . . . 0.0 110.723 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.32 -9.17 58.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.52 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.2 mt -73.19 -56.55 3.23 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.606 -0.684 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.0 Cg_endo -70.26 -85.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.959 1.505 . . . . 0.0 110.825 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.58 27.32 0.22 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.512 ' CG2' ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -89.8 127.71 53.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.294 -1.121 . . . . 0.0 110.843 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.6 Cg_endo -71.86 121.29 7.49 Favored 'Trans proline' 0 C--N 1.286 -2.715 0 O-C-N 124.302 1.685 . . . . 0.0 108.78 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.627 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 8.5 pt-20 -34.03 -28.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.158 0.504 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.18 -43.5 74.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.01 -1.056 . . . . 0.0 110.887 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.52 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -69.61 -35.51 75.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 111.661 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.74 -14.59 27.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.658 -1.276 . . . . 0.0 111.196 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -82.02 -32.17 30.65 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.692 1.234 . . . . 0.0 107.925 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -79.19 -28.83 42.68 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.917 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -88.0 -33.69 18.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.468 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 2.1 t -86.97 -12.15 48.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.085 . . . . 0.0 110.761 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 113.66 -46.26 1.2 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' ALA . 16.6 t -45.93 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -1.206 . . . . 0.0 110.036 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 32' ' ' CYS . 4.2 pt -140.74 153.18 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.555 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 5.7 mm -90.28 163.68 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.256 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 2.1 pt -167.7 156.82 8.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.44 -0.787 . . . . 0.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.16 -28.75 8.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.14 1.6 . . . . 0.0 109.918 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.32 -141.74 4.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.47 33.26 3.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -1.087 . . . . 0.0 110.033 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -79.45 9.03 5.24 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.676 -0.64 . . . . 0.0 111.133 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -43.45 165.87 0.11 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.69 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.563 ' CG ' ' CD2' ' A' ' 44' ' ' TYR . 45.3 Cg_endo -70.04 179.56 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.911 1.479 . . . . 0.0 111.187 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.61 -10.91 85.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -95.54 -19.93 19.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.672 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.563 ' CD2' ' CG ' ' A' ' 41' ' ' PRO . 11.3 m-85 -117.78 11.99 13.75 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.525 -0.734 . . . . 0.0 109.933 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . . . -87.89 30.8 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.2 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.848 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.3 m -79.37 169.43 18.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.1 m -147.67 128.39 14.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 110.648 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.488 ' HB3' ' HB1' ' A' ' 9' ' ' ALA . 89.8 m -126.52 141.26 39.6 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 109.923 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.8 Cg_endo -72.0 -6.69 19.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.99 1.521 . . . . 0.0 111.488 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 10.9 p 176.41 161.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 34.3 mt -45.88 -29.88 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.892 . . . . 0.0 109.456 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.7 t -52.19 -62.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.515 ' CB ' ' SG ' ' A' ' 32' ' ' CYS . . . -67.03 -53.35 32.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.153 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -43.63 -33.37 1.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 33.0 t -70.8 -49.44 46.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.311 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 7.3 m-20 -63.82 -56.86 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.463 ' O ' ' HB3' ' A' ' 26' ' ' CYS . 1.1 t80 -40.95 -42.06 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 109.8 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -83.82 -24.26 31.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.919 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -72.25 -31.41 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.802 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.84 -27.14 23.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -86.5 -2.08 58.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.274 -0.892 . . . . 0.0 109.757 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.4 mt -77.1 -45.19 2.81 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.343 -0.848 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -71.75 -81.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.523 1.275 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.93 29.09 0.59 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.39 -1.386 . . . . 0.0 109.984 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.54 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.9 m -101.01 142.61 24.97 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.921 -1.341 . . . . 0.0 110.444 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.5 Cg_endo -74.93 126.1 9.79 Favored 'Trans proline' 0 C--N 1.286 -2.73 0 O-C-N 124.622 1.854 . . . . 0.0 108.555 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' OE1' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -34.23 -27.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.947 0.403 . . . . 0.0 111.532 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.56 -48.31 82.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.912 -1.117 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -39.1 75.48 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.176 -0.953 . . . . 0.0 110.203 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 13' ' ' PHE . 59.0 m -61.22 -30.48 70.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.625 -0.672 . . . . 0.0 111.826 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' CYS . . . -95.89 -11.3 26.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -26.79 30.76 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -89.64 -42.68 11.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.393 0.616 . . . . 0.0 109.95 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 2.4 t -85.51 -13.74 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.949 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 109.11 -42.01 2.07 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.084 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 74.9 m -41.31 154.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.267 -1.137 . . . . 0.0 110.198 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 32' ' ' CYS . 1.2 pt -142.61 147.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.016 -1.053 . . . . 0.0 110.627 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.459 HD11 ' OE1' ' A' ' 23' ' ' GLU . 3.0 mt -101.49 139.05 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.422 -0.799 . . . . 0.0 109.949 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -130.15 171.07 9.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.501 -179.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 50.1 Cg_endo -76.79 6.25 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.079 1.568 . . . . 0.0 110.875 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.04 -142.97 13.61 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.11 16.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -1.043 . . . . 0.0 111.705 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -130.81 5.32 4.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' THR . 68.2 m 53.07 165.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.84 0 O-C-N 121.753 -0.592 . . . . 0.0 110.531 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 49.5 Cg_endo -74.51 -158.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.873 1.46 . . . . 0.0 110.187 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.11 -18.42 24.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 44' ' ' TYR . 21.5 p30 -96.04 -21.76 17.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.131 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.54 ' CG ' ' OD1' ' A' ' 43' ' ' ASP . 2.4 m-85 -121.9 26.6 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 41' ' ' PRO . . . -85.75 30.74 0.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.4 -0.812 . . . . 0.0 110.595 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.09 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 97.7 m -111.38 149.69 30.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.462 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m -155.16 105.83 2.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 35.0 m -99.05 150.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.123 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.513 ' CD ' ' HA ' ' A' ' 32' ' ' CYS . 44.5 Cg_endo -69.36 -3.11 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 111.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.49 175.93 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.23 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.454 HG13 ' OD1' ' A' ' 46' ' ' ASN . 1.8 mp -67.09 -35.2 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.84 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 3.2 t -68.32 -47.92 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.855 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . . . -57.76 -33.95 69.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.532 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.57 -42.91 33.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.478 -0.764 . . . . 0.0 109.196 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.532 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 21.5 p -57.93 -49.89 75.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.767 . . . . 0.0 109.907 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 6.8 m-20 -66.66 -53.6 32.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 20.8 t80 -41.49 -45.9 3.35 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.519 0.676 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -74.14 -26.3 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.529 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -82.51 -25.27 33.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.891 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' CD ' ' O ' ' A' ' 21' ' ' THR . 8.0 tpt180 -85.09 -1.91 57.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -0.878 . . . . 0.0 109.295 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.618 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -70.67 -49.11 15.51 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.491 -0.756 . . . . 0.0 110.473 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 39.7 Cg_endo -69.12 -81.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.663 1.349 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.73 32.17 0.38 Allowed Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.529 ' CG2' ' SG ' ' A' ' 16' ' ' CYS . 3.6 m -101.1 137.22 19.65 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 121.147 -1.208 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.3 Cg_endo -73.08 124.62 9.7 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.481 1.779 . . . . 0.0 108.279 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 22' ' ' PRO . 71.0 mt-10 -31.84 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.269 0.557 . . . . 0.0 111.141 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -55.81 -52.1 65.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 110.062 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.2 OUTLIER -71.43 -26.71 62.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.609 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 61.6 m -71.54 -25.25 62.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.86 -17.39 17.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.082 -1.012 . . . . 0.0 109.357 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -81.24 -28.96 34.59 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -93.34 -37.18 12.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.379 -0.825 . . . . 0.0 109.904 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.2 t -88.23 -9.49 52.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 103.99 -40.46 2.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.513 ' HA ' ' CD ' ' A' ' 5' ' ' PRO . 41.9 t -42.58 159.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -1.201 . . . . 0.0 110.218 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 3' ' ' CYS . 2.5 pp -143.28 144.46 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 110.944 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.0 142.17 17.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.55 -0.719 . . . . 0.0 109.59 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.552 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 2.3 pp -145.94 136.56 12.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.74 62.45 7.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.967 1.509 . . . . 0.0 110.044 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -176.63 137.41 3.58 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 15.01 4.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.596 -0.943 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -84.85 12.27 7.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.301 -0.874 . . . . 0.0 110.62 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.2 m -35.48 140.77 0.32 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 122.096 -0.377 . . . . 0.0 110.648 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' CG ' ' CD1' ' A' ' 44' ' ' TYR . 47.2 Cg_endo -72.27 -171.54 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.539 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.65 -0.56 69.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -108.09 -8.9 15.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' CD1' ' CG ' ' A' ' 41' ' ' PRO . 23.1 m-30 -119.7 5.44 11.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.58 30.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.437 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.454 ' OD1' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.832 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.519 ' N ' HG22 ' A' ' 1' ' ' THR . 0.2 OUTLIER -136.61 176.98 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.195 . . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 40.4 m -154.19 144.56 22.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.569 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 11.4 m -144.97 141.82 17.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 40.5 Cg_endo -65.43 -8.61 19.47 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.098 1.578 . . . . 0.0 112.533 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 2.7 p 173.0 -170.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.446 -1.408 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' A' ' 11' ' ' SER . 29.6 mm -65.38 -40.93 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.816 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 74.9 t -53.26 -56.9 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.415 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -62.36 -66.6 0.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.285 -0.884 . . . . 0.0 109.005 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' CD ' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -40.76 -48.77 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.541 -0.725 . . . . 0.0 110.344 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 15' ' ' VAL . 47.7 t -49.99 -60.6 2.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.963 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 42.3 m-20 -51.73 -62.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.651 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' C ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.71 -41.94 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.248 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -76.48 -19.66 57.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 109.329 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -83.31 -27.97 7.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.536 -0.728 . . . . 0.0 109.343 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.02 -19.81 36.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -5.83 59.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.576 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -63.91 -48.95 77.56 Favored Pre-proline 0 C--N 1.305 -1.362 0 O-C-N 121.48 -0.763 . . . . 0.0 111.03 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -71.63 -25.79 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.602 1.317 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.66 11.18 2.73 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.076 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.573 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m -70.32 145.81 93.68 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.094 -1.239 . . . . 0.0 110.125 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 41.9 Cg_endo -75.32 122.91 7.34 Favored 'Trans proline' 0 C--N 1.286 -2.754 0 O-C-N 124.556 1.819 . . . . 0.0 108.559 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 11.2 pt-20 -35.32 -26.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.044 0.45 . . . . 0.0 111.279 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.42 -50.32 74.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.957 -1.089 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -18.98 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.061 -1.025 . . . . 0.0 110.131 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.49 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 48.3 m -80.89 -29.53 35.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.549 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -91.6 -12.37 34.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.71 -33.88 30.9 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -42.47 19.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.53 -0.731 . . . . 0.0 110.024 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 4.1 t -84.21 -5.25 59.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.796 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 96.72 -30.29 9.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 23.3 m -48.47 177.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.251 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 pt -141.63 168.17 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 110.498 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.453 HD13 HG21 ' A' ' 2' ' ' THR . 7.4 mm -102.21 178.23 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.008 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.518 HG22 ' CB ' ' A' ' 1' ' ' THR . 0.9 OUTLIER -170.31 135.98 1.21 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.123 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.92 -28.16 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.942 1.496 . . . . 0.0 110.648 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -124.92 -141.34 5.65 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' CA ' HD11 ' A' ' 35' ' ' ILE . . . -131.23 25.82 4.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.995 . . . . 0.0 110.328 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -78.48 7.21 7.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.504 -0.748 . . . . 0.0 110.879 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -41.87 163.33 0.12 Allowed Pre-proline 0 C--N 1.293 -1.871 0 O-C-N 121.627 -0.671 . . . . 0.0 110.183 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.03 -164.7 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.805 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.11 -8.05 34.45 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.9 OUTLIER -95.4 -19.5 19.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.698 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.426 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 10.5 m-85 -119.12 17.86 13.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.512 -0.743 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.87 28.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.512 ' O ' ' CD ' ' A' ' 10' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.142 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.448 ' OG1' HG13 ' A' ' 34' ' ' ILE . 7.2 t -126.77 167.22 16.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.853 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -157.68 112.02 2.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.638 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 16.8 m -94.75 164.09 20.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.88 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 6' ' ' SER . 45.3 Cg_endo -70.63 -4.87 15.48 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.018 1.536 . . . . 0.0 111.333 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 11.5 p -178.24 171.67 1.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.964 -1.085 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.464 HG12 ' OD1' ' A' ' 46' ' ' ASN . 41.3 mm -64.16 -34.49 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.14 -50.81 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 5' ' ' PRO . . . -52.21 -34.32 44.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -79.98 -32.02 39.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -46.15 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.585 -0.697 . . . . 0.0 109.682 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 4.0 m-20 -71.16 -47.34 58.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.308 -0.87 . . . . 0.0 109.085 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.57 -31.64 25.38 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.734 0.778 . . . . 0.0 109.507 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -81.84 -22.29 37.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -32.66 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.52 -28.08 28.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.488 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -88.03 5.13 42.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.445 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.571 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -75.45 -48.22 4.1 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.468 -0.77 . . . . 0.0 110.517 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -73.67 -84.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.732 1.385 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.44 29.66 0.63 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.529 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 2.1 m -91.32 142.01 26.69 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 120.729 -1.454 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.7 Cg_endo -72.56 125.63 10.79 Favored 'Trans proline' 0 C--N 1.283 -2.882 0 O-C-N 124.547 1.814 . . . . 0.0 108.594 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mt-10 -32.87 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.173 0.511 . . . . 0.0 111.259 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.15 -51.25 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.11 -32.72 74.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.016 . . . . 0.0 110.102 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 33.5 m -72.56 -36.72 68.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.948 . . . . 0.0 110.206 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 32' ' ' CYS . . . -89.67 4.5 49.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.743 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -91.74 -40.17 11.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -86.18 -28.5 23.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 31' ' ' GLY . 2.1 t -93.23 -21.12 19.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.99 . . . . 0.0 110.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 30' ' ' THR . . . 104.49 -37.93 3.53 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.196 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 39.3 t -41.52 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -1.163 . . . . 0.0 110.466 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.36 148.18 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 0.0 110.394 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 35' ' ' ILE . 4.7 mp -108.69 161.2 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 19.3 pt -151.15 167.32 13.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.947 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 41.5 Cg_endo -68.78 -20.88 39.18 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.771 1.406 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' ' CG2' ' A' ' 1' ' ' THR . . . 119.51 128.45 3.73 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.662 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.57 -89.57 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.885 -0.774 . . . . 0.0 109.366 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -156.42 2.51 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.024 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 39' ' ' THR . 71.2 m 53.05 160.04 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 110.901 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 51.4 Cg_endo -80.0 -157.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.62 1.326 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.26 -10.58 27.39 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 44' ' ' TYR . 19.0 p30 -104.74 -17.57 14.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -1.159 . . . . 0.0 109.96 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.496 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 10.4 m-85 -116.58 16.89 15.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.68 30.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.464 ' OD1' HG12 ' A' ' 7' ' ' ILE . 1.7 t-20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.835 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 3.3 m -94.41 160.69 14.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 66.1 m -151.71 111.99 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.558 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 88.0 m -111.01 144.42 30.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.728 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -74.42 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.044 1.549 . . . . 0.0 111.271 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -159.44 165.74 32.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.851 -1.156 . . . . 0.0 110.725 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -31.62 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.514 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 11.3 t -73.74 -53.79 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.932 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.471 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . . . -42.35 -37.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.237 -0.914 . . . . 0.0 110.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -83.69 -37.85 22.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.411 -0.806 . . . . 0.0 109.182 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 6.2 m -54.39 -32.86 58.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 4.0 m-20 -81.39 -50.12 9.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.035 . . . . 0.0 109.545 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HB2' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -54.35 -39.79 67.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.22 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.618 ' OD1' ' N ' ' A' ' 15' ' ' VAL . 4.7 p-10 -75.54 -24.52 56.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 t -80.41 -25.49 11.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.601 0.715 . . . . 0.0 109.346 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -83.19 -25.55 31.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 110.025 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 21' ' ' THR . 28.1 ttt180 -92.45 6.33 47.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -63.12 -43.88 82.52 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -75.32 -72.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.54 1.284 . . . . 0.0 110.685 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.59 26.4 0.14 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.517 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 9.5 m -83.04 142.0 44.04 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 121.125 -1.22 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -74.03 119.3 5.78 Favored 'Trans proline' 0 C--N 1.285 -2.782 0 O-C-N 124.616 1.851 . . . . 0.0 108.686 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . 11.1 pt-20 -34.82 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -60.74 -43.6 97.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -73.63 -37.33 65.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 110.371 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 64.3 m -73.0 -20.03 61.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -98.39 -18.18 18.43 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.272 1.035 . . . . 0.0 109.511 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -83.83 -26.33 29.62 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.15 -43.83 9.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.519 0.676 . . . . 0.0 109.847 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.2 t -81.26 -10.52 59.57 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.426 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 103.07 -39.75 2.68 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.488 ' O ' ' O ' ' A' ' 27' ' ' ALA . 48.9 m -40.4 160.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.285 -1.126 . . . . 0.0 110.632 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 ' C ' HG13 ' A' ' 34' ' ' ILE . 7.4 pt -127.83 158.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.98 -1.075 . . . . 0.0 109.777 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 23' ' ' GLU . 64.2 mt -137.22 139.72 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 110.72 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 1' ' ' THR . 0.2 OUTLIER -146.74 137.08 12.25 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.51 66.33 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.925 1.487 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.06 -139.68 2.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.47 24.33 0.08 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.602 -0.94 . . . . 0.0 109.937 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.31 11.31 24.06 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.757 0.789 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.69 151.22 4.34 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.774 -0.579 . . . . 0.0 110.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 44.6 Cg_endo -71.6 -172.21 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.993 1.523 . . . . 0.0 110.48 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.2 55.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' A' ' 44' ' ' TYR . 4.4 p30 -116.07 -20.23 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.819 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' OD2' ' A' ' 43' ' ' ASP . 19.5 m-85 -115.38 4.59 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.419 -0.801 . . . . 0.0 109.747 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.87 32.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.875 . . . . 0.0 110.175 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.092 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.843 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.711 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.537 ' CG2' ' CZ ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -134.98 117.57 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.456 . . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 134.48 55.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.904 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 9' ' ' ALA . 24.1 m -105.18 152.03 39.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -73.06 -4.99 16.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 111.087 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.491 ' CA ' ' HB3' ' A' ' 46' ' ' ASN . 3.3 p -152.39 145.11 24.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 7' ' ' ILE . 1.8 mp -49.7 -39.22 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 109.214 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.33 -50.4 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.707 . . . . 0.0 109.776 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 4' ' ' CYS . . . -51.25 -21.86 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.428 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -93.55 -36.27 12.49 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -47.42 81.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.278 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 25.0 p-10 -75.43 -36.09 60.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 8.2 t80 -56.94 -42.92 80.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.409 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -75.86 -18.3 59.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.334 -0.853 . . . . 0.0 108.942 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -77.11 -23.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.467 0.651 . . . . 0.0 109.725 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' HG22 ' A' ' 21' ' ' THR . 2.3 t -93.29 -21.51 19.54 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.523 -0.736 . . . . 0.0 110.52 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 6.3 ttt-85 -90.59 6.96 41.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.614 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -79.64 -41.78 1.5 Allowed Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.432 -0.792 . . . . 0.0 111.441 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -72.75 -18.07 25.35 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.379 1.199 . . . . 0.0 110.84 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.48 17.55 1.93 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.056 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.569 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 9.1 m -82.58 144.45 49.13 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.017 -1.284 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 40.3 Cg_endo -72.74 119.71 6.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 O-C-N 124.643 1.865 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' N ' ' HD2' ' A' ' 17' ' ' ARG . 12.1 pt-20 -37.27 -25.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.104 0.478 . . . . 0.0 110.838 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -64.65 -43.2 94.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 109.924 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -76.63 -21.26 55.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.092 -1.005 . . . . 0.0 110.241 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 30' ' ' THR . 73.2 m -87.15 -11.96 48.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.31 -19.91 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.284 1.04 . . . . 0.0 109.12 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -91.07 -22.53 20.69 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.09 -27.65 14.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.206 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -99.98 -13.55 19.04 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.552 -0.718 . . . . 0.0 110.27 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.67 -37.86 3.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.991 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ALA . 6.2 t -46.96 176.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.636 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.4 pt -138.39 154.88 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.943 -1.098 . . . . 0.0 110.455 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.531 ' CD1' ' CG2' ' A' ' 2' ' ' THR . 14.5 mm -102.82 168.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.017 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 23.6 pt -158.24 144.23 12.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.347 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.6 -15.82 27.22 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.027 1.54 . . . . 0.0 110.029 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . -98.72 -140.64 11.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . -175.67 25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.397 -1.061 . . . . 0.0 110.839 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' O ' ' A' ' 40' ' ' CYS . 9.5 t -94.79 -15.87 23.45 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 39' ' ' THR . 54.3 m 53.13 122.99 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.418 ' CG ' ' CD1' ' A' ' 44' ' ' TYR . 42.7 Cg_endo -70.96 -170.72 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.518 1.273 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -13.16 64.81 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -97.76 -18.58 18.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -1.218 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 9.6 m-85 -118.81 18.16 13.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.71 32.33 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.087 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.491 ' HB3' ' CA ' ' A' ' 6' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.12 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.844 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.495 HG22 ' CE2' ' A' ' 13' ' ' PHE . 4.4 m -126.99 131.21 51.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 10.9 m -119.02 123.69 45.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 10' ' ' ARG . 84.1 m -136.3 150.94 72.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 43.0 Cg_endo -68.87 -8.53 23.74 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.694 1.365 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.475 ' CA ' ' HB3' ' A' ' 46' ' ' ASN . 3.1 m -174.58 160.27 3.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.013 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 7.7 mt -50.74 -42.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.611 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.7 t -56.13 -58.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 109.899 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.497 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -45.98 -47.81 16.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -68.43 -40.58 81.12 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.21 -52.63 34.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.758 . . . . 0.0 109.824 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.76 -56.54 20.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.19 -37.84 10.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.525 -0.735 . . . . 0.0 110.018 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -83.1 -22.13 33.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 11' ' ' SER . 1.2 t -87.76 -20.59 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.671 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -85.46 -31.95 22.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.563 -0.711 . . . . 0.0 110.187 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 26.8 ttt-85 -88.73 7.37 34.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.164 -0.96 . . . . 0.0 109.279 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.586 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -63.65 -46.42 82.92 Favored Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.497 -0.752 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -73.87 -71.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.55 1.289 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.35 24.03 0.14 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.921 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.546 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 10.0 m -82.99 142.36 44.54 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 120.932 -1.334 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -73.87 118.38 5.41 Favored 'Trans proline' 0 C--N 1.286 -2.757 0 O-C-N 124.606 1.845 . . . . 0.0 108.542 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 18.6 pt-20 -36.37 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.039 0.447 . . . . 0.0 111.046 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.52 -42.53 99.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.028 -1.045 . . . . 0.0 109.67 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.18 -41.58 63.7 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.179 -0.951 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.7 m -66.75 -24.24 66.19 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 111.061 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -97.74 -7.85 29.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.0 109.467 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.3 -24.74 19.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.9 t80 -95.52 -32.73 12.71 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -95.24 -10.48 30.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 110.179 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 100.34 -38.82 2.96 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' ALA . 20.3 m -43.13 166.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.112 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' CG2' ' C ' ' A' ' 32' ' ' CYS . 2.1 pp -150.43 148.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.053 -1.029 . . . . 0.0 110.297 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 5.3 mp -108.22 146.83 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 0.0 110.263 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.493 ' CD1' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -130.81 174.83 4.21 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.258 -0.901 . . . . 0.0 110.114 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.4 Cg_endo -70.93 -32.59 13.45 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.55 . . . . 0.0 110.525 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' OG1' ' A' ' 1' ' ' THR . . . 140.53 134.28 3.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 174.81 -80.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.612 -0.934 . . . . 0.0 109.735 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -174.32 18.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.61 -0.681 . . . . 0.0 111.315 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.3 m 56.14 166.05 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.439 -0.788 . . . . 0.0 109.363 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 45.8 Cg_endo -72.59 -158.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.933 1.491 . . . . 0.0 109.924 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.68 -29.76 3.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -81.57 -21.16 38.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.928 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 43' ' ' ASP . 2.8 m-85 -119.23 33.67 5.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.88 29.67 0.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.475 ' HB3' ' CA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.839 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 163.46 26.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.721 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 33' ' ' ILE . 5.9 p -158.24 144.18 17.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -125.9 147.88 60.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.287 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 46.9 Cg_endo -73.01 -0.61 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.008 1.531 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -156.22 157.11 35.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.093 -1.004 . . . . 0.0 110.413 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 mp -61.73 -33.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.926 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 5.3 t -70.01 -56.31 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.509 ' CB ' ' SG ' ' A' ' 4' ' ' CYS . . . -42.68 -36.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -81.61 -35.09 30.48 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 8' ' ' VAL . 1.8 m -55.83 -42.27 75.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 109.565 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 15' ' ' VAL . 2.2 m-80 -73.83 -52.87 11.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 0.0 109.297 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' C ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -42.81 -36.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.47 -0.769 . . . . 0.0 109.453 179.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -73.42 -31.5 63.87 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.84 0.829 . . . . 0.0 109.182 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -71.52 -22.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.553 0.692 . . . . 0.0 109.338 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -80.74 -34.02 34.71 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.615 -0.678 . . . . 0.0 110.716 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -74.52 -6.38 48.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 2.1 mt -71.7 -57.67 4.06 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.471 -0.768 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -71.28 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.007 1.53 . . . . 0.0 110.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.93 23.08 0.24 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.53 ' CG2' ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -84.0 125.39 72.88 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.221 -1.164 . . . . 0.0 110.997 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 38.7 Cg_endo -70.82 121.87 8.3 Favored 'Trans proline' 0 C--N 1.288 -2.651 0 O-C-N 124.286 1.677 . . . . 0.0 108.801 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.3 pt-20 -34.23 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.413 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.4 -40.35 77.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.374 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -65.61 -43.78 88.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 110.645 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.456 ' O ' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -85.63 -23.81 27.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.071 -1.018 . . . . 0.0 111.427 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 32' ' ' CYS . . . -71.86 -27.17 62.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.764 -1.21 . . . . 0.0 108.711 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -80.28 -32.76 38.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.247 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -94.01 -35.26 12.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.448 -0.782 . . . . 0.0 110.56 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.499 HG22 ' HB2' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -82.3 -11.73 58.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.552 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 19.13 23.27 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -104.5 -179.32 3.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -1.169 . . . . 0.0 110.005 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.512 ' CG1' ' SG ' ' A' ' 3' ' ' CYS . 45.1 pt -154.78 144.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.061 -1.024 . . . . 0.0 110.178 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG12 ' HG3' ' A' ' 23' ' ' GLU . 2.3 mp -95.97 142.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.444 -0.785 . . . . 0.0 110.114 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 1' ' ' THR . 8.5 pt -147.74 153.85 43.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.842 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.86 58.84 4.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.975 1.513 . . . . 0.0 110.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 76.66 132.36 0.47 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 37' ' ' GLY . . . 163.38 -28.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.818 -0.813 . . . . 0.0 109.668 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 69.69 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.716 0.769 . . . . 0.0 110.378 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' CB ' ' HD2' ' A' ' 41' ' ' PRO . 0.5 OUTLIER 57.71 178.3 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 110.383 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 40' ' ' CYS . 45.5 Cg_endo -70.8 -168.1 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.99 1.521 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.6 2.43 87.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -103.96 -28.83 11.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -1.159 . . . . 0.0 109.653 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 3' ' ' CYS . 14.8 m-85 -103.45 1.8 32.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.5 -0.75 . . . . 0.0 110.038 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.11 29.76 0.47 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 0.0 110.718 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 5.0 m-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.075 -0.965 . . . . 0.0 109.982 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.842 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.537 ' CG2' ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -86.59 156.82 19.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.798 . . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 2' ' ' THR . 56.1 m -153.33 122.85 6.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 10' ' ' ARG . 74.9 m -132.7 139.66 35.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.36 -2.6 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.883 1.465 . . . . 0.0 111.091 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -160.95 149.23 16.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.474 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.1 mt -51.54 -32.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.727 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 9' ' ' ALA . 50.5 t -69.71 -55.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.738 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.455 ' O ' ' SG ' ' A' ' 32' ' ' CYS . . . -43.12 -36.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.846 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -82.5 -44.14 16.32 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.35 -0.844 . . . . 0.0 108.91 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -39.44 41.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 5.4 m-20 -68.58 -50.78 49.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 108.95 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 0.1 OUTLIER -47.31 -42.31 20.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.58 -0.7 . . . . 0.0 109.407 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -78.0 -16.57 58.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.612 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -83.16 -25.4 8.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.591 -0.693 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.08 -26.97 22.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.545 -0.722 . . . . 0.0 110.386 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 21' ' ' THR . 4.4 ttt180 -91.02 9.97 28.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.326 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -73.11 -45.05 8.2 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.546 -0.721 . . . . 0.0 110.529 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 43.7 Cg_endo -75.81 -81.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.665 1.35 . . . . 0.0 110.776 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -150.86 36.43 0.9 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.996 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 17' ' ' ARG . 12.0 m -106.46 134.44 19.8 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.921 -1.341 . . . . 0.0 110.403 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -71.18 119.86 6.59 Favored 'Trans proline' 0 C--N 1.286 -2.734 0 O-C-N 124.476 1.777 . . . . 0.0 109.051 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 10.3 mt-10 -28.91 -35.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.707 0.765 . . . . 0.0 111.116 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.7 -48.18 78.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.299 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -74.34 -19.39 60.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.014 . . . . 0.0 110.372 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 84.3 m -84.99 -19.31 32.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.248 -0.908 . . . . 0.0 110.742 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -96.47 -24.33 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.38 1.086 . . . . 0.0 109.208 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -85.3 -21.54 28.94 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.861 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -93.3 -30.95 14.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.619 -0.675 . . . . 0.0 109.639 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.1 t -95.43 -11.91 26.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 114.46 -39.36 2.83 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.367 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.492 ' C ' ' CG2' ' A' ' 33' ' ' ILE . 66.2 m -48.24 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.333 -1.098 . . . . 0.0 111.028 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.492 ' CG2' ' C ' ' A' ' 32' ' ' CYS . 5.3 pt -151.68 157.58 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 2' ' ' THR . 35.9 mt -135.32 142.36 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.493 HG13 ' HB1' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -138.79 163.92 43.27 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 46.6 Cg_endo -73.7 54.44 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.993 1.523 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 90.13 137.36 6.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.493 ' HB1' HG13 ' A' ' 35' ' ' ILE . . . 175.02 -28.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.959 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 73.64 -1.61 3.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.801 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' O ' ' A' ' 39' ' ' THR . 3.3 m 47.47 171.77 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.332 0.587 . . . . 0.0 111.915 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 54.2 Cg_endo -75.04 -158.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.872 1.459 . . . . 0.0 110.098 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 7.65 59.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 -23.22 10.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 109.642 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.481 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 19.4 m-85 -110.48 9.17 23.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 110.066 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.95 30.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.847 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.612 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 86.0 m -135.65 131.9 36.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.3 m -132.13 99.68 4.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 109.883 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.466 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 37.2 m -97.06 159.98 30.13 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 42.1 Cg_endo -67.64 -9.19 24.62 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.97 1.511 . . . . 0.0 112.28 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 170.91 175.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.54 -1.35 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' A' ' 11' ' ' SER . 27.0 mm -55.58 -40.16 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.483 -0.761 . . . . 0.0 109.797 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 11' ' ' SER . 78.9 t -54.44 -64.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.54 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -49.21 -65.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.206 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -44.48 -25.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.404 -0.81 . . . . 0.0 110.144 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 0.3 OUTLIER -69.04 -52.05 32.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.027 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.4 m-80 -70.45 -51.87 26.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.612 ' CE1' ' CG2' ' A' ' 2' ' ' THR . 38.1 t80 -42.31 -46.29 4.52 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.528 -0.733 . . . . 0.0 110.297 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -77.09 -20.57 55.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 109.622 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -81.24 -26.23 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 109.725 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -86.31 -22.82 26.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.173 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' CD ' ' O ' ' A' ' 21' ' ' THR . 16.2 tpt180 -89.28 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.742 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.616 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -68.34 -43.86 34.15 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.527 -0.733 . . . . 0.0 110.646 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -72.91 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.488 1.257 . . . . 0.0 110.857 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.64 28.75 0.18 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 2.4 m -96.2 142.27 24.32 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.2 Cg_endo -74.82 124.99 9.12 Favored 'Trans proline' 0 C--N 1.286 -2.741 0 O-C-N 124.622 1.854 . . . . 0.0 108.37 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 22' ' ' PRO . 81.6 mt-10 -33.29 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.125 0.488 . . . . 0.0 111.297 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.26 -49.55 76.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.021 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.61 -27.75 64.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.983 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.453 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 33.9 m -76.06 -32.82 59.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.446 -0.784 . . . . 0.0 110.572 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -94.13 -3.1 51.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 109.738 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -86.23 -36.81 19.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -88.21 -40.05 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.97 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.451 HG22 ' HB2' ' A' ' 13' ' ' PHE . 1.6 t -80.02 -16.95 54.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 110.239 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 101.6 -37.12 3.79 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 42.4 t -42.41 159.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -1.208 . . . . 0.0 110.195 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 3' ' ' CYS . 1.1 pp -137.05 145.61 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 27' ' ' ALA . 4.0 mp -107.35 153.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.418 -0.801 . . . . 0.0 109.976 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 37' ' ' GLY . 9.9 pt -143.42 155.99 60.66 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.081 -1.012 . . . . 0.0 110.554 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.44 -1.27 11.1 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.083 1.57 . . . . 0.0 110.061 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 1' ' ' THR . . . -143.97 -141.83 3.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.96 47.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.986 . . . . 0.0 109.749 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.44 8.87 27.63 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.485 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 28.6 p -48.12 162.93 0.31 Allowed Pre-proline 0 C--N 1.291 -1.949 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.187 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 44.3 Cg_endo -69.78 162.18 43.06 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.839 1.442 . . . . 0.0 111.33 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 -8.33 78.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 10.8 m-20 -90.65 -21.33 21.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.239 . . . . 0.0 109.067 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 41' ' ' PRO . 9.2 m-85 -119.61 10.58 11.79 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.519 0.676 . . . . 0.0 109.493 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . -87.62 31.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 110.28 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.27 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.85 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.646 ' CG2' ' CD2' ' A' ' 13' ' ' PHE . 1.5 m -97.77 144.37 27.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.6 m -145.75 115.01 7.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.256 -0.903 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' HB3' ' HB1' ' A' ' 9' ' ' ALA . 1.7 m -106.28 158.46 32.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 48.3 Cg_endo -76.17 -21.89 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.193 1.628 . . . . 0.0 111.174 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 p -140.75 172.1 13.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.007 -1.058 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -69.92 -32.01 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.875 . . . . 0.0 110.019 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.472 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . . . -64.3 -34.64 78.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -42.77 81.28 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.446 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -63.44 -45.77 89.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.753 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 15' ' ' VAL . 6.3 m-20 -65.66 -53.18 44.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' CG2' ' A' ' 2' ' ' THR . 1.0 OUTLIER -44.65 -48.45 10.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.944 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.62 -14.43 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 0.0 109.637 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -84.58 -20.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 109.89 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.482 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 2.8 t -92.77 -22.41 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 0.0 110.567 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 5.0 mtp180 -85.38 0.6 51.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 109.597 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.6 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -67.82 -47.96 42.27 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 41.5 Cg_endo -69.45 -17.76 38.84 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.449 1.236 . . . . 0.0 110.836 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 19.99 3.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.563 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.3 m -77.27 145.85 73.4 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.361 -1.082 . . . . 0.0 110.295 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.0 Cg_endo -75.38 120.78 6.09 Favored 'Trans proline' 0 C--N 1.286 -2.744 0 O-C-N 124.593 1.839 . . . . 0.0 108.403 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 14.6 pm0 -35.68 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.973 0.416 . . . . 0.0 111.221 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.71 -52.13 66.82 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -42.94 97.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 109.759 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 27.8 m -70.22 -16.58 63.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -92.18 -7.19 49.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.241 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.0 -34.33 18.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -83.49 -39.69 20.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.429 -0.794 . . . . 0.0 109.632 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 26' ' ' CYS 0.271 23.8 p -75.54 -26.62 58.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.45 -0.781 . . . . 0.0 110.429 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.23 14.26 64.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 9' ' ' ALA . 33.2 m -93.86 -174.56 3.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -1.091 . . . . 0.0 110.389 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -144.62 151.86 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 1' ' ' THR . 2.8 mp -111.2 138.89 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.398 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -125.36 171.77 7.11 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 44.5 Cg_endo -71.44 -26.35 20.39 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.99 1.521 . . . . 0.0 111.884 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -151.28 -141.64 3.38 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.493 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.63 29.56 1.29 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.672 -0.899 . . . . 0.0 110.592 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.81 7.42 7.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' HD13 ' A' ' 35' ' ' ILE . 55.7 m -51.15 151.13 5.09 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 121.587 -0.696 . . . . 0.0 110.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 50.1 Cg_endo -75.57 -159.66 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.883 1.465 . . . . 0.0 110.339 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 -13.04 25.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 3.9 m-20 -96.89 -16.15 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.922 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 15.4 m-85 -116.81 19.75 14.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 110.16 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.51 30.88 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.263 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.853 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.809 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.526 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 7.3 t -81.05 165.34 21.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 12.6 m -156.85 109.7 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 110.406 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.5 ' SG ' ' CB ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -121.62 163.2 32.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 110.288 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.4 Cg_endo -72.04 -7.1 20.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.052 1.554 . . . . 0.0 111.063 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 m -158.53 154.03 26.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.014 -1.054 . . . . 0.0 110.798 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 mt -61.75 -28.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.799 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 91.6 t -65.9 -48.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.5 ' CB ' ' SG ' ' A' ' 4' ' ' CYS . . . -58.83 -49.4 77.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.8 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -69.43 -36.75 76.97 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.43 -39.89 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.672 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 5.4 m-20 -72.75 -51.57 18.62 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.026 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -44.2 -50.37 8.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.529 -0.732 . . . . 0.0 109.568 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.69 -39.9 95.46 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 1.2 t -58.02 -25.81 27.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.615 0.721 . . . . 0.0 109.06 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.488 ' SG ' HG23 ' A' ' 21' ' ' THR . 0.4 OUTLIER -86.01 -16.04 39.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.768 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 14.1 tpt180 -84.43 -7.21 59.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 109.355 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -56.07 -50.94 84.48 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.364 -0.835 . . . . 0.0 111.142 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.72 -25.7 23.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.604 1.318 . . . . 0.0 110.713 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.46 17.69 2.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.534 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.3 m -68.09 144.17 96.71 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.186 -1.185 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.5 Cg_endo -74.1 122.13 7.39 Favored 'Trans proline' 0 C--N 1.283 -2.886 0 O-C-N 124.517 1.798 . . . . 0.0 108.757 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -32.04 -31.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.138 0.494 . . . . 0.0 111.054 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.01 -47.59 77.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.134 -0.978 . . . . 0.0 109.371 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -68.66 -41.44 79.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.405 -0.809 . . . . 0.0 110.414 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.494 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 16.3 m -70.38 -25.0 63.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.344 -0.848 . . . . 0.0 110.809 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 23' ' ' GLU . . . -96.02 -2.06 47.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.064 . . . . 0.0 109.685 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -101.98 -22.92 14.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -93.47 -29.05 15.75 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.484 ' CG2' ' SG ' ' A' ' 32' ' ' CYS . 0.6 OUTLIER -102.91 -21.23 14.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.838 -0.539 . . . . 0.0 110.13 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 109.67 -35.0 5.14 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.481 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' SG ' ' CG2' ' A' ' 30' ' ' THR . 71.2 m -41.38 160.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.119 -1.224 . . . . 0.0 110.542 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.2 pt -133.24 145.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.883 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 1' ' ' THR . 2.7 mp -110.42 147.37 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 110.825 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.518 HD13 HG21 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.37 147.57 31.45 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.561 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.03 69.57 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.851 1.448 . . . . 0.0 110.292 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.92 145.95 4.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.42 25.38 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.98 . . . . 0.0 110.523 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -84.99 14.13 5.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 110.625 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.6 m -38.79 161.57 0.07 OUTLIER Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.989 -0.444 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.1 Cg_endo -70.69 -161.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.884 1.465 . . . . 0.0 110.902 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.61 -5.25 26.11 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.536 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 1.3 t0 -93.63 -31.4 14.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -1.232 . . . . 0.0 110.039 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.536 ' CE2' ' HB3' ' A' ' 43' ' ' ASP . 2.3 m-85 -114.49 23.13 13.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.634 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.91 32.12 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.85 . . . . 0.0 110.509 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.687 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 97.2 m -89.14 133.48 34.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.408 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 41.4 m -137.69 93.49 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 109.985 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 29.0 m -105.45 161.75 21.83 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.393 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.6 Cg_endo -70.08 -10.2 27.75 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.173 1.617 . . . . 0.0 111.605 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 172.57 -169.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.257 . . . . 0.0 111.005 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 11' ' ' SER . 11.2 mm -65.76 -33.4 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.106 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.7 t -53.7 -66.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.818 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -60.32 -58.6 7.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.888 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -40.54 -37.06 0.65 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.533 -0.729 . . . . 0.0 110.318 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 6.2 t -76.12 -36.22 58.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' CB ' ' OG1' ' A' ' 30' ' ' THR . 68.7 m-20 -69.13 -63.01 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.583 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 0.7 OUTLIER -47.41 -34.62 7.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 13.3 m-20 -78.14 -14.3 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -96.66 -19.57 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.442 -0.786 . . . . 0.0 110.034 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -91.28 -23.69 20.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.412 -0.805 . . . . 0.0 110.868 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 26.4 tpt180 -88.95 -8.21 54.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.499 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.601 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.1 mt -60.8 -45.17 96.8 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.488 -0.757 . . . . 0.0 110.75 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.1 Cg_endo -73.65 -76.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.635 1.334 . . . . 0.0 110.895 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.11 25.91 0.11 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.502 HG22 ' HD2' ' A' ' 22' ' ' PRO . 4.1 m -91.34 141.33 26.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.134 -1.215 . . . . 0.0 110.261 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.91 122.96 8.08 Favored 'Trans proline' 0 C--N 1.285 -2.773 0 O-C-N 124.557 1.819 . . . . 0.0 108.5 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 1.8 pt-20 -34.74 -28.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.052 0.453 . . . . 0.0 110.986 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.26 -47.47 85.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.09 -1.006 . . . . 0.0 109.524 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -20.34 60.44 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.316 -0.865 . . . . 0.0 109.837 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -86.95 -24.94 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -100.17 -3.52 31.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.305 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -97.18 -29.02 13.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -90.04 -33.57 16.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.507 ' OG1' ' CB ' ' A' ' 12' ' ' ASN . 1.2 t -93.19 -19.74 21.15 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.353 -0.842 . . . . 0.0 110.354 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 108.87 -42.16 2.03 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.405 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' O ' ' O ' ' A' ' 27' ' ' ALA . 43.1 t -43.79 166.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.31 . . . . 0.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.411 HD12 ' HG3' ' A' ' 41' ' ' PRO . 1.4 pt -145.59 146.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.458 HG21 ' N ' ' A' ' 35' ' ' ILE . 2.9 mp -108.21 156.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.418 -0.801 . . . . 0.0 109.562 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.502 HG22 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -142.03 145.2 35.06 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.145 -0.972 . . . . 0.0 110.282 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.35 62.01 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.11 1.584 . . . . 0.0 110.518 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.91 -139.36 2.78 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -148.21 12.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.976 . . . . 0.0 110.481 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 106.33 13.52 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.251 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 76.0 m -74.83 164.46 61.23 Favored Pre-proline 0 C--N 1.291 -1.956 0 O-C-N 121.859 -0.526 . . . . 0.0 109.66 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 47.0 Cg_endo -74.06 -165.44 0.26 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.944 1.497 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.69 -25.22 10.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.508 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 2.4 m-20 -85.62 -23.47 27.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -1.183 . . . . 0.0 109.666 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.508 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 2.8 m-85 -121.59 35.72 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.367 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.25 29.22 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.444 -0.785 . . . . 0.0 110.87 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.846 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.755 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.495 HG21 ' CD1' ' A' ' 13' ' ' PHE . 4.3 m -87.97 157.84 18.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -155.45 111.14 3.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 111.093 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -113.69 150.2 42.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.63 30.86 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.75 1.395 . . . . 0.0 112.046 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.532 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 7.5 t -178.21 155.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 110.928 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 13.4 mt -65.53 -25.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.499 -0.751 . . . . 0.0 109.792 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 4.1 t -80.78 -54.03 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.803 . . . . 0.0 109.884 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.52 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -53.81 -48.13 70.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 109.495 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -68.51 -27.12 65.84 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.1 t -74.62 -45.23 46.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.152 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.9 m-20 -52.17 -48.67 64.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.464 -0.773 . . . . 0.0 108.967 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.495 ' CD1' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -52.96 -41.39 64.49 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.534 0.683 . . . . 0.0 109.629 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -75.04 -11.98 60.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.64 -23.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.587 -0.695 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' HG22 ' A' ' 21' ' ' THR . 2.0 t -89.92 -17.11 28.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.64 0.99 55.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.899 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.572 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -55.41 -44.61 99.73 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.483 -0.76 . . . . 0.0 110.957 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.7 Cg_endo -76.62 -22.88 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.678 1.357 . . . . 0.0 110.852 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.58 15.2 2.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.585 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.3 m -65.3 145.16 99.11 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.975 -1.309 . . . . 0.0 110.293 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 42.3 Cg_endo -74.95 119.07 5.5 Favored 'Trans proline' 0 C--N 1.287 -2.685 0 O-C-N 124.613 1.849 . . . . 0.0 108.696 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 6.3 pt-20 -35.54 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.246 0.546 . . . . 0.0 110.528 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.18 -40.46 81.55 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.119 -0.988 . . . . 0.0 109.572 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -33.54 43.61 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 36.2 m -83.45 -17.88 40.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 111.155 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -100.85 -11.68 19.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 109.68 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.6 m -93.64 -25.47 17.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.85 -29.35 13.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.246 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -95.71 -16.59 21.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.439 -0.788 . . . . 0.0 110.36 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 110.95 -42.16 2.04 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.761 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 27' ' ' ALA . 73.0 m -40.5 149.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.165 -1.197 . . . . 0.0 110.438 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 33' ' ' ILE . 18.2 pt -129.77 148.38 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.417 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' CD1' ' HG3' ' A' ' 23' ' ' GLU . 3.3 mp -113.29 151.34 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -145.79 162.69 34.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.03 -3.82 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.83 1.437 . . . . 0.0 110.838 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.19 -142.65 12.54 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.94 7.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.469 -1.018 . . . . 0.0 111.233 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' CYS . 1.4 t -130.23 -2.63 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.798 -1.189 . . . . 0.0 111.101 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.582 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 9.0 p 37.64 -163.25 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 122.064 -0.398 . . . . 0.0 110.391 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.582 ' CD ' ' HB2' ' A' ' 40' ' ' CYS . 54.9 Cg_endo -79.24 176.98 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 122.84 0.916 . . . . 0.0 111.253 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.05 -2.34 66.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.41 -28.08 14.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 5.3 m-85 -114.36 23.69 12.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.31 -0.869 . . . . 0.0 109.544 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . -84.99 30.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.532 ' HB3' ' N ' ' A' ' 6' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.852 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.779 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.6 m -111.37 154.07 25.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -144.93 86.58 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.455 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 33.7 m -109.74 132.56 21.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.434 ' C ' ' OG ' ' A' ' 6' ' ' SER . 50.3 Cg_endo -76.18 47.57 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.862 1.454 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 179.47 121.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.084 -1.01 . . . . 0.0 109.903 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.6 mm -45.59 -32.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.007 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.0 t -79.3 -50.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.847 . . . . 0.0 109.951 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.421 ' CB ' ' OG ' ' A' ' 6' ' ' SER . . . -46.25 -31.1 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.901 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.546 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.35 -42.52 36.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.44 -0.787 . . . . 0.0 109.653 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.546 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -63.95 -53.85 43.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.388 -0.82 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' HB2' ' CG2' ' A' ' 30' ' ' THR . 36.2 m-20 -50.54 -50.54 53.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 1.1 t80 -51.06 -37.67 46.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -76.57 -15.18 59.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -23.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.641 -0.662 . . . . 0.0 109.739 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.485 ' SG ' HG23 ' A' ' 21' ' ' THR . 1.5 t -89.05 -18.71 26.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.403 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -90.51 -5.67 55.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -64.51 -42.24 64.32 Favored Pre-proline 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 111.003 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 44.9 Cg_endo -74.15 -26.63 12.53 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.456 1.24 . . . . 0.0 110.604 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.65 10.96 1.98 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.236 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.549 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 8.6 m -70.39 143.99 91.31 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.019 -1.283 . . . . 0.0 110.352 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -74.94 120.03 5.91 Favored 'Trans proline' 0 C--N 1.285 -2.811 0 O-C-N 124.627 1.856 . . . . 0.0 108.989 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 24' ' ' ALA . 1.7 pp20? -32.74 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.957 0.408 . . . . 0.0 111.413 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.48 -40.67 95.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 0.0 109.396 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -73.66 -37.39 65.31 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.48 ' O ' ' OG1' ' A' ' 30' ' ' THR . 23.8 m -75.28 -19.84 59.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' HD13 ' A' ' 34' ' ' ILE . . . -95.7 -6.64 39.41 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.076 0.941 . . . . 0.0 109.524 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -29.21 19.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.29 -35.23 17.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.676 -0.64 . . . . 0.0 109.489 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 26' ' ' CYS 0.261 16.8 p -80.35 -23.62 40.42 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.396 -0.815 . . . . 0.0 110.284 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 23.45 47.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -116.85 175.1 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -1.029 . . . . 0.0 109.937 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 pp -132.95 148.0 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.539 HD13 ' CB ' ' A' ' 27' ' ' ALA . 3.3 mp -105.68 161.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.247 -0.908 . . . . 0.0 110.114 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.507 ' CG1' HG23 ' A' ' 1' ' ' THR . 48.6 pt -148.72 163.39 26.11 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 110.436 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.7 Cg_endo -70.12 -38.03 7.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.014 1.534 . . . . 0.0 110.198 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.54 130.77 1.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.472 ' O ' HG21 ' A' ' 39' ' ' THR . . . -174.2 17.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.603 -0.94 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 66.86 4.29 3.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 110.89 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.516 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER 56.14 142.61 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.778 -0.576 . . . . 0.0 110.867 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' CG ' ' CD2' ' A' ' 44' ' ' TYR . 45.9 Cg_endo -74.6 173.68 13.92 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.631 1.332 . . . . 0.0 110.054 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.23 -4.11 88.79 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.425 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 37.3 m-20 -102.0 -26.11 13.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -1.201 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 4.8 m-85 -118.12 21.14 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.8 30.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.455 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.998 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.778 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 t -113.27 169.4 8.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.473 ' O ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -157.54 102.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.133 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.85 159.34 41.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.136 -0.978 . . . . 0.0 110.49 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 49.4 Cg_endo -77.83 6.51 4.5 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.178 1.62 . . . . 0.0 111.246 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 5' ' ' PRO . 8.7 m -170.56 168.35 7.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.086 . . . . 0.0 110.815 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 7' ' ' ILE . 4.0 mm -68.76 -30.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.513 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 9' ' ' ALA . 10.4 t -80.89 -48.46 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -44.18 -36.71 2.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.184 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.523 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -78.0 -39.28 42.75 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.407 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.523 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 4.4 p -55.62 -48.05 75.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.587 -0.696 . . . . 0.0 110.216 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 7.7 p30 -69.93 -33.29 71.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.0 OUTLIER -59.75 -41.33 90.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 108.741 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -79.54 -30.38 41.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.516 0.674 . . . . 0.0 109.422 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 1.0 OUTLIER -64.97 -32.82 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.533 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.47 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -80.83 -27.83 36.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.503 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 21' ' ' THR . 2.0 ttt180 -94.3 6.39 48.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.299 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -74.16 -41.95 5.38 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.587 -0.695 . . . . 0.0 110.958 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -74.8 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.479 1.252 . . . . 0.0 110.941 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.19 24.84 0.2 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.533 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 7.6 m -94.95 141.42 23.25 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 120.995 -1.297 . . . . 0.0 110.255 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -73.7 119.74 6.07 Favored 'Trans proline' 0 C--N 1.285 -2.797 0 O-C-N 124.648 1.867 . . . . 0.0 108.793 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -35.13 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.225 0.536 . . . . 0.0 110.849 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.85 -45.58 93.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.848 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -70.85 -36.09 72.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 110.51 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.2 m -74.44 -23.46 58.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.689 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -96.0 -12.57 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.997 . . . . 0.0 109.761 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.1 m -95.13 -21.64 18.38 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -99.58 -20.46 16.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.512 ' OG1' ' OD1' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -111.55 -7.28 14.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.56 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 104.18 -34.48 5.75 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.686 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.533 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -46.15 174.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.027 -1.278 . . . . 0.0 110.42 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 32' ' ' CYS . 28.3 pt -158.32 145.74 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 4.8 mp -106.41 140.48 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 110.138 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 2.2 pp -160.98 134.1 4.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 110.186 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.98 70.81 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.918 1.483 . . . . 0.0 110.448 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . 168.87 138.27 2.44 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.48 15.35 5.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -81.9 10.29 6.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.524 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -40.57 163.53 0.09 OUTLIER Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.874 -0.516 . . . . 0.0 110.264 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 42.7 Cg_endo -69.8 169.28 19.34 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.068 1.562 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.69 61.83 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 43.4 p-10 -112.0 -19.86 12.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.03 -1.276 . . . . 0.0 109.519 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 16.2 m-85 -123.27 17.94 9.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.614 -0.678 . . . . 0.0 109.444 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.4 32.55 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.489 -0.757 . . . . 0.0 110.338 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 17.7 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.337 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.84 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.56 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 94.2 m -127.58 160.71 30.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.5 m -148.05 156.98 43.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.528 ' HB3' ' CB ' ' A' ' 9' ' ' ALA . 85.9 m -147.53 130.52 7.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 6' ' ' SER . 49.6 Cg_endo -77.74 25.26 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.977 1.514 . . . . 0.0 112.79 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER 174.25 164.95 0.21 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.254 -1.528 . . . . 0.0 111.059 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' SER . 56.4 mt -65.46 -30.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.508 -0.745 . . . . 0.0 109.328 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 64.8 t -66.74 -50.79 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.925 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 4' ' ' CYS . . . -55.24 -66.15 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -51.75 -22.52 3.63 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.531 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 2.1 t -80.24 -63.33 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 10.3 p30 -61.65 -37.04 82.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.56 ' CE1' ' CG2' ' A' ' 2' ' ' THR . 0.2 OUTLIER -59.87 -44.92 93.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.942 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 1.5 p30 -69.46 -27.83 65.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.186 -0.946 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -23.25 28.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.497 ' SG ' HG21 ' A' ' 21' ' ' THR . 5.3 t -92.78 -22.93 19.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.697 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -91.1 5.23 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.556 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.575 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -65.89 -46.47 65.05 Favored Pre-proline 0 C--N 1.306 -1.29 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.4 Cg_endo -74.8 -71.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.614 1.323 . . . . 0.0 110.581 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.1 27.31 0.09 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.505 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 2.7 m -84.23 141.35 39.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.064 -1.256 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.6 Cg_endo -74.17 124.73 9.25 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 O-C-N 124.546 1.814 . . . . 0.0 108.242 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -39.98 -23.37 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.8 -0.563 . . . . 0.0 110.209 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.19 -51.23 68.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.089 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -29.09 66.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 110.576 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.539 ' O ' ' CG2' ' A' ' 30' ' ' THR . 27.8 m -78.63 -44.92 22.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.039 -1.038 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 32' ' ' CYS . . . -68.89 -13.29 62.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.927 -1.108 . . . . 0.0 109.648 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.488 HG21 ' N ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -77.84 -47.03 19.8 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.537 0.684 . . . . 0.0 109.663 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.488 ' N ' HG21 ' A' ' 28' ' ' THR . 4.6 t80 -94.89 -41.03 9.4 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.616 0.722 . . . . 0.0 110.064 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -68.25 -31.87 71.65 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.438 -0.789 . . . . 0.0 110.357 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 30' ' ' THR . . . 124.26 -47.41 1.02 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.561 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 66.5 m -44.17 169.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.041 -1.27 . . . . 0.0 110.193 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.9 148.8 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.136 -0.977 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 24' ' ' ALA . 1.9 mp -80.39 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 35' ' ' ILE . 1.1 pp -134.97 133.16 20.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.79 6.66 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.95 1.5 . . . . 0.0 110.388 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.23 -138.9 5.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.9 -48.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.995 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -102.65 2.06 35.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.012 . . . . 0.0 110.42 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER 47.48 177.73 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.862 -0.524 . . . . 0.0 111.168 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' TYR . 47.7 Cg_endo -73.16 -157.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.032 1.543 . . . . 0.0 110.188 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.76 -8.54 54.23 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -19.33 14.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.246 . . . . 0.0 110.145 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 16.6 m-85 -114.25 10.27 17.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 41' ' ' PRO . . . -89.11 31.38 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 1.9 t30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.757 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 t -92.82 171.32 9.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 2' ' ' THR . 1.1 m -147.16 106.07 3.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.045 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 10' ' ' ARG . 1.2 m -99.58 144.07 27.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.917 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.8 Cg_endo -70.86 -3.35 12.56 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.951 1.5 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER 172.43 175.09 0.1 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.803 -1.186 . . . . 0.0 110.559 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 7' ' ' ILE . 30.9 mm -57.7 -36.08 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 110.05 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.49 -62.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.528 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -61.63 -54.24 45.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.944 . . . . 0.0 108.992 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.69 -52.63 4.84 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.302 -0.874 . . . . 0.0 109.555 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -64.45 -32.73 74.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.064 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.496 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 1.2 m-20 -59.85 -71.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.683 0.754 . . . . 0.0 109.83 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.649 ' CE2' ' CB ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -47.62 -33.64 6.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.562 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -70.35 -26.11 63.59 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.827 0.822 . . . . 0.0 109.165 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -70.95 -25.02 25.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.52 -22.64 26.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -74.05 -10.1 59.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.538 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.6 mt -72.4 -55.73 4.53 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.11 -34.14 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.732 1.385 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.6 7.9 1.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.479 HG21 ' HD2' ' A' ' 22' ' ' PRO . 32.9 m -65.26 131.61 95.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 120.91 -1.347 . . . . 0.0 110.363 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 40.3 Cg_endo -72.23 116.99 4.92 Favored 'Trans proline' 0 C--N 1.288 -2.647 0 O-C-N 124.431 1.753 . . . . 0.0 108.738 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 26.4 pt-20 -33.03 -31.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.433 0.635 . . . . 0.0 110.896 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.53 -43.08 99.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 110.734 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.513 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -72.15 -45.29 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.905 -1.122 . . . . 0.0 111.368 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.539 ' O ' ' CG2' ' A' ' 30' ' ' THR . 0.1 OUTLIER -84.37 -15.45 46.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 0.0 111.763 -178.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -75.99 -39.12 56.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.465 -1.397 . . . . 0.0 108.631 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -30.18 63.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.182 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 1.7 t80 -90.89 -48.36 7.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.805 . . . . 0.0 110.357 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 1.2 t -66.67 -12.83 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.569 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.95 -43.95 1.61 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.447 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' GLY . 1.5 t -46.77 175.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -1.203 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -140.39 156.72 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.112 -0.992 . . . . 0.0 109.808 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 73.5 mt -137.25 141.26 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.815 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -147.52 156.3 45.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 0.0 109.804 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.82 68.85 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.815 1.429 . . . . 0.0 110.046 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 149.11 4.97 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.37 32.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -1.006 . . . . 0.0 110.419 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' CYS . 1.5 t -84.06 14.35 4.26 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 110.768 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' THR . 62.4 m -36.19 154.75 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 122.095 -0.378 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.97 -176.72 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.943 1.496 . . . . 0.0 110.33 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.23 4.87 82.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.96 -22.5 12.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -1.201 . . . . 0.0 109.872 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -117.87 14.93 14.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 109.838 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.12 29.21 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.824 . . . . 0.0 110.551 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.459 ' HB3' ' N ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.127 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.843 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.474 ' O ' ' NH1' ' A' ' 10' ' ' ARG . 1.3 m -124.61 161.1 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -152.56 145.24 24.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -134.12 161.08 65.9 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.3 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 46.7 Cg_endo -73.59 -0.98 10.06 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.112 1.585 . . . . 0.0 111.607 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -176.17 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.669 -1.27 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -75.07 -31.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.968 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.2 t -65.61 -44.48 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.503 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -62.74 -70.22 0.22 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 109.049 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.84 -26.87 0.15 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.1 m -72.37 -61.78 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 36.3 p30 -58.14 -21.18 45.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.998 -1.064 . . . . 0.0 109.802 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.554 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 2.2 t80 -72.47 -45.13 60.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.662 0.744 . . . . 0.0 109.101 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -73.56 -20.13 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.79 . . . . 0.0 109.048 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.24 -25.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.452 0.644 . . . . 0.0 109.653 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -84.57 -25.88 28.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.783 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 15.5 ttt180 -88.32 7.32 32.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.758 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.575 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -61.07 -43.69 91.67 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.454 -0.778 . . . . 0.0 110.829 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -76.98 -21.41 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.611 1.322 . . . . 0.0 110.834 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.49 12.99 1.93 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.222 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.558 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.7 m -65.63 144.8 99.01 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.063 -1.257 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 42.1 Cg_endo -73.96 118.82 5.57 Favored 'Trans proline' 0 C--N 1.287 -2.693 0 O-C-N 124.614 1.849 . . . . 0.0 108.859 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 22' ' ' PRO . 75.2 mt-10 -36.34 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.145 0.498 . . . . 0.0 110.562 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.69 -38.85 89.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.195 -0.94 . . . . 0.0 109.953 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -30.88 32.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.049 -1.032 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.547 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 69.4 m -80.05 -14.44 58.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.05 . . . . 0.0 110.361 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.85 -27.47 13.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.371 1.081 . . . . 0.0 109.555 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.403 ' O ' HG21 ' A' ' 28' ' ' THR . 1.1 m -78.74 -23.58 45.33 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.798 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.8 t80 -102.28 -32.21 10.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.283 -0.885 . . . . 0.0 109.792 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -91.09 -5.11 55.62 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.03 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 105.64 -38.75 3.14 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.728 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.533 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -50.01 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.969 -1.312 . . . . 0.0 110.196 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 32' ' ' CYS . 1.2 pp -156.82 163.22 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.871 -1.143 . . . . 0.0 110.499 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 7.4 mm -100.79 165.92 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.078 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 1.3 pt -171.56 170.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 109.646 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.5 Cg_endo -69.75 -16.84 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.865 1.455 . . . . 0.0 110.139 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 105.03 141.04 10.6 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 37' ' ' GLY . . . 74.6 -6.84 1.83 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.686 -0.891 . . . . 0.0 111.323 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.472 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -96.78 10.87 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' CD1' ' A' ' 35' ' ' ILE . 52.0 m -62.32 130.1 92.87 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 110.112 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HG2' ' OD2' ' A' ' 43' ' ' ASP . 43.7 Cg_endo -70.38 -165.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.817 1.43 . . . . 0.0 110.717 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.98 -14.01 55.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 43' ' ' ASP . 37.2 p-10 -98.18 -20.22 17.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -1.208 . . . . 0.0 109.498 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.453 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 11.9 m-85 -119.49 23.34 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.93 21.64 3.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 4.8 m120 . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.836 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 35' ' ' ILE . 9.4 t -138.75 173.93 11.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.1 m -152.38 110.83 3.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.889 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 19.4 m -99.46 162.94 19.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.0 Cg_endo -71.41 -7.84 22.11 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 7' ' ' ILE . 9.0 t 175.14 -171.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.8 -1.187 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.2 mm -70.72 -33.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.1 t -55.54 -61.41 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.589 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -56.99 -66.46 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.64 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -41.99 -37.7 1.42 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.368 -0.833 . . . . 0.0 110.386 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 t -66.81 -49.71 64.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.949 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 12.2 m-20 -57.14 -59.34 5.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.627 ' CE2' ' CB ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -50.09 -38.88 40.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.39 -0.819 . . . . 0.0 109.573 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 3.3 m-20 -68.4 -32.79 73.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.905 0.859 . . . . 0.0 108.866 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.49 -18.33 23.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.803 0.811 . . . . 0.0 108.966 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.512 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.89 -26.93 22.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.779 -0.575 . . . . 0.0 110.723 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.32 -9.17 58.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.2 mt -73.19 -56.55 3.23 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.606 -0.684 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.0 Cg_endo -70.26 -85.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.959 1.505 . . . . 0.0 110.825 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.58 27.32 0.22 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.512 ' CG2' ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -89.8 127.71 53.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.294 -1.121 . . . . 0.0 110.843 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.6 Cg_endo -71.86 121.29 7.49 Favored 'Trans proline' 0 C--N 1.286 -2.715 0 O-C-N 124.302 1.685 . . . . 0.0 108.78 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.627 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 8.5 pt-20 -34.03 -28.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.158 0.504 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.18 -43.5 74.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.01 -1.056 . . . . 0.0 110.887 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.52 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -69.61 -35.51 75.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 111.661 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.74 -14.59 27.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.658 -1.276 . . . . 0.0 111.196 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -82.02 -32.17 30.65 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.692 1.234 . . . . 0.0 107.925 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -79.19 -28.83 42.68 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.917 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -88.0 -33.69 18.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.468 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 2.1 t -86.97 -12.15 48.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.085 . . . . 0.0 110.761 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 113.66 -46.26 1.2 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' ALA . 16.6 t -45.93 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -1.206 . . . . 0.0 110.036 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 32' ' ' CYS . 4.2 pt -140.74 153.18 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.555 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 5.7 mm -90.28 163.68 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.256 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 2.1 pt -167.7 156.82 8.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.44 -0.787 . . . . 0.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.16 -28.75 8.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.14 1.6 . . . . 0.0 109.918 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.32 -141.74 4.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.47 33.26 3.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -1.087 . . . . 0.0 110.033 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -79.45 9.03 5.24 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.676 -0.64 . . . . 0.0 111.133 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.478 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -43.45 165.87 0.11 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.69 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.563 ' CG ' ' CD2' ' A' ' 44' ' ' TYR . 45.3 Cg_endo -70.04 179.56 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.911 1.479 . . . . 0.0 111.187 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.61 -10.91 85.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -95.54 -19.93 19.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.672 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.563 ' CD2' ' CG ' ' A' ' 41' ' ' PRO . 11.3 m-85 -117.78 11.99 13.75 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.525 -0.734 . . . . 0.0 109.933 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . . . -87.89 30.8 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.2 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.848 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.3 m -79.37 169.43 18.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.1 m -147.67 128.39 14.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 110.648 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.488 ' HB3' ' HB1' ' A' ' 9' ' ' ALA . 89.8 m -126.52 141.26 39.6 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 109.923 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.8 Cg_endo -72.0 -6.69 19.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.99 1.521 . . . . 0.0 111.488 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 10.9 p 176.41 161.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 34.3 mt -45.88 -29.88 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.892 . . . . 0.0 109.456 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.7 t -52.19 -62.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.515 ' CB ' ' SG ' ' A' ' 32' ' ' CYS . . . -67.03 -53.35 32.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.153 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -43.63 -33.37 1.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 33.0 t -70.8 -49.44 46.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.311 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 7.3 m-20 -63.82 -56.86 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.463 ' O ' ' HB3' ' A' ' 26' ' ' CYS . 1.1 t80 -40.95 -42.06 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 109.8 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -83.82 -24.26 31.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.919 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -72.25 -31.41 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.802 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.84 -27.14 23.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -86.5 -2.08 58.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.274 -0.892 . . . . 0.0 109.757 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.4 mt -77.1 -45.19 2.81 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.343 -0.848 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -71.75 -81.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.523 1.275 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.93 29.09 0.59 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.39 -1.386 . . . . 0.0 109.984 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.54 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.9 m -101.01 142.61 24.97 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.921 -1.341 . . . . 0.0 110.444 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.5 Cg_endo -74.93 126.1 9.79 Favored 'Trans proline' 0 C--N 1.286 -2.73 0 O-C-N 124.622 1.854 . . . . 0.0 108.555 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' OE1' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -34.23 -27.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.947 0.403 . . . . 0.0 111.532 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.56 -48.31 82.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.912 -1.117 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -39.1 75.48 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.176 -0.953 . . . . 0.0 110.203 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 13' ' ' PHE . 59.0 m -61.22 -30.48 70.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.625 -0.672 . . . . 0.0 111.826 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' CYS . . . -95.89 -11.3 26.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -26.79 30.76 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -89.64 -42.68 11.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.393 0.616 . . . . 0.0 109.95 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 2.4 t -85.51 -13.74 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.949 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 109.11 -42.01 2.07 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.084 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 74.9 m -41.31 154.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.267 -1.137 . . . . 0.0 110.198 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 32' ' ' CYS . 1.2 pt -142.61 147.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.016 -1.053 . . . . 0.0 110.627 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.459 HD11 ' OE1' ' A' ' 23' ' ' GLU . 3.0 mt -101.49 139.05 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.422 -0.799 . . . . 0.0 109.949 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -130.15 171.07 9.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.501 -179.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 50.1 Cg_endo -76.79 6.25 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.079 1.568 . . . . 0.0 110.875 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.04 -142.97 13.61 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.11 16.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -1.043 . . . . 0.0 111.705 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -130.81 5.32 4.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' THR . 68.2 m 53.07 165.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.84 0 O-C-N 121.753 -0.592 . . . . 0.0 110.531 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 49.5 Cg_endo -74.51 -158.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.873 1.46 . . . . 0.0 110.187 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.11 -18.42 24.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 44' ' ' TYR . 21.5 p30 -96.04 -21.76 17.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.131 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.54 ' CG ' ' OD1' ' A' ' 43' ' ' ASP . 2.4 m-85 -121.9 26.6 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 41' ' ' PRO . . . -85.75 30.74 0.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.4 -0.812 . . . . 0.0 110.595 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.09 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 97.7 m -111.38 149.69 30.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m -155.16 105.83 2.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 35.0 m -99.05 150.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.123 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' CD ' ' HA ' ' A' ' 32' ' ' CYS . 44.5 Cg_endo -69.36 -3.11 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 111.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.49 175.93 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.23 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.454 HG13 ' OD1' ' A' ' 46' ' ' ASN . 1.8 mp -67.09 -35.2 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.84 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 3.2 t -68.32 -47.92 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.855 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . . . -57.76 -33.95 69.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.532 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.57 -42.91 33.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.478 -0.764 . . . . 0.0 109.196 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.532 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 21.5 p -57.93 -49.89 75.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.767 . . . . 0.0 109.907 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 6.8 m-20 -66.66 -53.6 32.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 20.8 t80 -41.49 -45.9 3.35 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.519 0.676 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -74.14 -26.3 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.529 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -82.51 -25.27 33.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.891 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' CD ' ' O ' ' A' ' 21' ' ' THR . 8.0 tpt180 -85.09 -1.91 57.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -0.878 . . . . 0.0 109.295 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.618 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -70.67 -49.11 15.51 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.491 -0.756 . . . . 0.0 110.473 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 39.7 Cg_endo -69.12 -81.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.663 1.349 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.73 32.17 0.38 Allowed Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.529 ' CG2' ' SG ' ' A' ' 16' ' ' CYS . 3.6 m -101.1 137.22 19.65 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 121.147 -1.208 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.3 Cg_endo -73.08 124.62 9.7 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.481 1.779 . . . . 0.0 108.279 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 22' ' ' PRO . 71.0 mt-10 -31.84 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.269 0.557 . . . . 0.0 111.141 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -55.81 -52.1 65.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 110.062 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.524 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.2 OUTLIER -71.43 -26.71 62.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.609 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 61.6 m -71.54 -25.25 62.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.86 -17.39 17.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.082 -1.012 . . . . 0.0 109.357 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -81.24 -28.96 34.59 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -93.34 -37.18 12.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.379 -0.825 . . . . 0.0 109.904 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.2 t -88.23 -9.49 52.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 103.99 -40.46 2.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.513 ' HA ' ' CD ' ' A' ' 5' ' ' PRO . 41.9 t -42.58 159.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -1.201 . . . . 0.0 110.218 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 3' ' ' CYS . 2.5 pp -143.28 144.46 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 110.944 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.0 142.17 17.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.55 -0.719 . . . . 0.0 109.59 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.552 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 2.3 pp -145.94 136.56 12.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.74 62.45 7.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.967 1.509 . . . . 0.0 110.044 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -176.63 137.41 3.58 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 15.01 4.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.596 -0.943 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -84.85 12.27 7.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.301 -0.874 . . . . 0.0 110.62 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.2 m -35.48 140.77 0.32 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 122.096 -0.377 . . . . 0.0 110.648 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' CG ' ' CD1' ' A' ' 44' ' ' TYR . 47.2 Cg_endo -72.27 -171.54 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.539 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.65 -0.56 69.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -108.09 -8.9 15.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' CD1' ' CG ' ' A' ' 41' ' ' PRO . 23.1 m-30 -119.7 5.44 11.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.58 30.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.437 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.454 ' OD1' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.832 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.519 ' N ' HG22 ' A' ' 1' ' ' THR . 0.2 OUTLIER -136.61 176.98 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.195 . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 40.4 m -154.19 144.56 22.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.569 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 11.4 m -144.97 141.82 17.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 40.5 Cg_endo -65.43 -8.61 19.47 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.098 1.578 . . . . 0.0 112.533 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 2.7 p 173.0 -170.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.446 -1.408 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' A' ' 11' ' ' SER . 29.6 mm -65.38 -40.93 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.816 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 74.9 t -53.26 -56.9 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.415 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -62.36 -66.6 0.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.285 -0.884 . . . . 0.0 109.005 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' CD ' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -40.76 -48.77 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.541 -0.725 . . . . 0.0 110.344 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 15' ' ' VAL . 47.7 t -49.99 -60.6 2.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.963 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 42.3 m-20 -51.73 -62.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.651 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' C ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.71 -41.94 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.248 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -76.48 -19.66 57.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 109.329 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -83.31 -27.97 7.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.536 -0.728 . . . . 0.0 109.343 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.02 -19.81 36.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -5.83 59.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.576 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -63.91 -48.95 77.56 Favored Pre-proline 0 C--N 1.305 -1.362 0 O-C-N 121.48 -0.763 . . . . 0.0 111.03 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -71.63 -25.79 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.602 1.317 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.66 11.18 2.73 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.076 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.573 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m -70.32 145.81 93.68 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.094 -1.239 . . . . 0.0 110.125 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 41.9 Cg_endo -75.32 122.91 7.34 Favored 'Trans proline' 0 C--N 1.286 -2.754 0 O-C-N 124.556 1.819 . . . . 0.0 108.559 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 11.2 pt-20 -35.32 -26.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.044 0.45 . . . . 0.0 111.279 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.42 -50.32 74.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.957 -1.089 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -18.98 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.061 -1.025 . . . . 0.0 110.131 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.49 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 48.3 m -80.89 -29.53 35.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.549 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -91.6 -12.37 34.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.71 -33.88 30.9 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -42.47 19.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.53 -0.731 . . . . 0.0 110.024 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 4.1 t -84.21 -5.25 59.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.796 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 96.72 -30.29 9.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 23.3 m -48.47 177.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.251 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 pt -141.63 168.17 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 110.498 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 HD13 HG21 ' A' ' 2' ' ' THR . 7.4 mm -102.21 178.23 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.008 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.518 HG22 ' CB ' ' A' ' 1' ' ' THR . 0.9 OUTLIER -170.31 135.98 1.21 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.123 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.92 -28.16 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.942 1.496 . . . . 0.0 110.648 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -124.92 -141.34 5.65 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' CA ' HD11 ' A' ' 35' ' ' ILE . . . -131.23 25.82 4.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.995 . . . . 0.0 110.328 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -78.48 7.21 7.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.504 -0.748 . . . . 0.0 110.879 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -41.87 163.33 0.12 Allowed Pre-proline 0 C--N 1.293 -1.871 0 O-C-N 121.627 -0.671 . . . . 0.0 110.183 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.03 -164.7 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.805 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.11 -8.05 34.45 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.9 OUTLIER -95.4 -19.5 19.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.698 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.426 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 10.5 m-85 -119.12 17.86 13.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.512 -0.743 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.87 28.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' O ' ' CD ' ' A' ' 10' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.142 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.448 ' OG1' HG13 ' A' ' 34' ' ' ILE . 7.2 t -126.77 167.22 16.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.853 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -157.68 112.02 2.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.638 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 16.8 m -94.75 164.09 20.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.88 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 6' ' ' SER . 45.3 Cg_endo -70.63 -4.87 15.48 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.018 1.536 . . . . 0.0 111.333 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 11.5 p -178.24 171.67 1.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.964 -1.085 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.464 HG12 ' OD1' ' A' ' 46' ' ' ASN . 41.3 mm -64.16 -34.49 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.14 -50.81 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 5' ' ' PRO . . . -52.21 -34.32 44.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -79.98 -32.02 39.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -46.15 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.585 -0.697 . . . . 0.0 109.682 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 4.0 m-20 -71.16 -47.34 58.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.308 -0.87 . . . . 0.0 109.085 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.57 -31.64 25.38 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.734 0.778 . . . . 0.0 109.507 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -81.84 -22.29 37.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -32.66 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.52 -28.08 28.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.488 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -88.03 5.13 42.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.445 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.571 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -75.45 -48.22 4.1 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.468 -0.77 . . . . 0.0 110.517 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -73.67 -84.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.732 1.385 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.44 29.66 0.63 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.529 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 2.1 m -91.32 142.01 26.69 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 120.729 -1.454 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.7 Cg_endo -72.56 125.63 10.79 Favored 'Trans proline' 0 C--N 1.283 -2.882 0 O-C-N 124.547 1.814 . . . . 0.0 108.594 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mt-10 -32.87 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.173 0.511 . . . . 0.0 111.259 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.15 -51.25 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.11 -32.72 74.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.016 . . . . 0.0 110.102 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 33.5 m -72.56 -36.72 68.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.948 . . . . 0.0 110.206 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 32' ' ' CYS . . . -89.67 4.5 49.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.743 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -91.74 -40.17 11.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -86.18 -28.5 23.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 31' ' ' GLY . 2.1 t -93.23 -21.12 19.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.99 . . . . 0.0 110.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 30' ' ' THR . . . 104.49 -37.93 3.53 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.196 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 39.3 t -41.52 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -1.163 . . . . 0.0 110.466 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.36 148.18 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 0.0 110.394 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 35' ' ' ILE . 4.7 mp -108.69 161.2 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 19.3 pt -151.15 167.32 13.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.947 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 41.5 Cg_endo -68.78 -20.88 39.18 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.771 1.406 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' ' CG2' ' A' ' 1' ' ' THR . . . 119.51 128.45 3.73 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.662 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.57 -89.57 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.885 -0.774 . . . . 0.0 109.366 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -156.42 2.51 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.024 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 39' ' ' THR . 71.2 m 53.05 160.04 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 110.901 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 51.4 Cg_endo -80.0 -157.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.62 1.326 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.26 -10.58 27.39 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 44' ' ' TYR . 19.0 p30 -104.74 -17.57 14.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -1.159 . . . . 0.0 109.96 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.496 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 10.4 m-85 -116.58 16.89 15.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.68 30.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' OD1' HG12 ' A' ' 7' ' ' ILE . 1.7 t-20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.835 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 3.3 m -94.41 160.69 14.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 66.1 m -151.71 111.99 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.558 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 88.0 m -111.01 144.42 30.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.728 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -74.42 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.044 1.549 . . . . 0.0 111.271 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -159.44 165.74 32.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.851 -1.156 . . . . 0.0 110.725 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -31.62 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 11.3 t -73.74 -53.79 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.932 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.471 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . . . -42.35 -37.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.237 -0.914 . . . . 0.0 110.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -83.69 -37.85 22.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.411 -0.806 . . . . 0.0 109.182 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 6.2 m -54.39 -32.86 58.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 4.0 m-20 -81.39 -50.12 9.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.035 . . . . 0.0 109.545 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HB2' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -54.35 -39.79 67.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.22 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.618 ' OD1' ' N ' ' A' ' 15' ' ' VAL . 4.7 p-10 -75.54 -24.52 56.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 t -80.41 -25.49 11.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.601 0.715 . . . . 0.0 109.346 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -83.19 -25.55 31.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 110.025 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 21' ' ' THR . 28.1 ttt180 -92.45 6.33 47.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -63.12 -43.88 82.52 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -75.32 -72.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.54 1.284 . . . . 0.0 110.685 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.59 26.4 0.14 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.517 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 9.5 m -83.04 142.0 44.04 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 121.125 -1.22 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -74.03 119.3 5.78 Favored 'Trans proline' 0 C--N 1.285 -2.782 0 O-C-N 124.616 1.851 . . . . 0.0 108.686 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . 11.1 pt-20 -34.82 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -60.74 -43.6 97.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -73.63 -37.33 65.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 110.371 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 64.3 m -73.0 -20.03 61.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -98.39 -18.18 18.43 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.272 1.035 . . . . 0.0 109.511 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -83.83 -26.33 29.62 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.15 -43.83 9.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.519 0.676 . . . . 0.0 109.847 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.2 t -81.26 -10.52 59.57 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.426 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 103.07 -39.75 2.68 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.488 ' O ' ' O ' ' A' ' 27' ' ' ALA . 48.9 m -40.4 160.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.285 -1.126 . . . . 0.0 110.632 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 ' C ' HG13 ' A' ' 34' ' ' ILE . 7.4 pt -127.83 158.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.98 -1.075 . . . . 0.0 109.777 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 23' ' ' GLU . 64.2 mt -137.22 139.72 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 110.72 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 1' ' ' THR . 0.2 OUTLIER -146.74 137.08 12.25 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.51 66.33 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.925 1.487 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.06 -139.68 2.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.47 24.33 0.08 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.602 -0.94 . . . . 0.0 109.937 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.31 11.31 24.06 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.757 0.789 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.69 151.22 4.34 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.774 -0.579 . . . . 0.0 110.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 44.6 Cg_endo -71.6 -172.21 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.993 1.523 . . . . 0.0 110.48 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.2 55.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' A' ' 44' ' ' TYR . 4.4 p30 -116.07 -20.23 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.819 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' OD2' ' A' ' 43' ' ' ASP . 19.5 m-85 -115.38 4.59 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.419 -0.801 . . . . 0.0 109.747 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.87 32.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.875 . . . . 0.0 110.175 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.092 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.843 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.711 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.537 ' CG2' ' CZ ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -134.98 117.57 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.456 . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 134.48 55.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.904 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 9' ' ' ALA . 24.1 m -105.18 152.03 39.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -73.06 -4.99 16.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 111.087 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.491 ' CA ' ' HB3' ' A' ' 46' ' ' ASN . 3.3 p -152.39 145.11 24.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 7' ' ' ILE . 1.8 mp -49.7 -39.22 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 109.214 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.33 -50.4 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.707 . . . . 0.0 109.776 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 4' ' ' CYS . . . -51.25 -21.86 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.428 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -93.55 -36.27 12.49 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -47.42 81.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.278 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 25.0 p-10 -75.43 -36.09 60.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 8.2 t80 -56.94 -42.92 80.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.409 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -75.86 -18.3 59.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.334 -0.853 . . . . 0.0 108.942 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -77.11 -23.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.467 0.651 . . . . 0.0 109.725 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' HG22 ' A' ' 21' ' ' THR . 2.3 t -93.29 -21.51 19.54 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.523 -0.736 . . . . 0.0 110.52 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 6.3 ttt-85 -90.59 6.96 41.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.614 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -79.64 -41.78 1.5 Allowed Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.432 -0.792 . . . . 0.0 111.441 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -72.75 -18.07 25.35 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.379 1.199 . . . . 0.0 110.84 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.48 17.55 1.93 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.056 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.569 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 9.1 m -82.58 144.45 49.13 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.017 -1.284 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 40.3 Cg_endo -72.74 119.71 6.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 O-C-N 124.643 1.865 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' N ' ' HD2' ' A' ' 17' ' ' ARG . 12.1 pt-20 -37.27 -25.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.104 0.478 . . . . 0.0 110.838 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -64.65 -43.2 94.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 109.924 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -76.63 -21.26 55.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.092 -1.005 . . . . 0.0 110.241 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 30' ' ' THR . 73.2 m -87.15 -11.96 48.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.31 -19.91 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.284 1.04 . . . . 0.0 109.12 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -91.07 -22.53 20.69 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.09 -27.65 14.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.206 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -99.98 -13.55 19.04 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.552 -0.718 . . . . 0.0 110.27 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.67 -37.86 3.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.991 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ALA . 6.2 t -46.96 176.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.636 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.4 pt -138.39 154.88 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.943 -1.098 . . . . 0.0 110.455 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.531 ' CD1' ' CG2' ' A' ' 2' ' ' THR . 14.5 mm -102.82 168.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.017 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 23.6 pt -158.24 144.23 12.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.347 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.6 -15.82 27.22 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.027 1.54 . . . . 0.0 110.029 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . -98.72 -140.64 11.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . -175.67 25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.397 -1.061 . . . . 0.0 110.839 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' O ' ' A' ' 40' ' ' CYS . 9.5 t -94.79 -15.87 23.45 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 39' ' ' THR . 54.3 m 53.13 122.99 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.418 ' CG ' ' CD1' ' A' ' 44' ' ' TYR . 42.7 Cg_endo -70.96 -170.72 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.518 1.273 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -13.16 64.81 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -97.76 -18.58 18.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -1.218 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 9.6 m-85 -118.81 18.16 13.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.71 32.33 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.087 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.491 ' HB3' ' CA ' ' A' ' 6' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.12 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.844 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.495 HG22 ' CE2' ' A' ' 13' ' ' PHE . 4.4 m -126.99 131.21 51.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 10.9 m -119.02 123.69 45.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 10' ' ' ARG . 84.1 m -136.3 150.94 72.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 43.0 Cg_endo -68.87 -8.53 23.74 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.694 1.365 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.475 ' CA ' ' HB3' ' A' ' 46' ' ' ASN . 3.1 m -174.58 160.27 3.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.013 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 7.7 mt -50.74 -42.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.611 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.7 t -56.13 -58.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 109.899 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.497 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -45.98 -47.81 16.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -68.43 -40.58 81.12 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.21 -52.63 34.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.758 . . . . 0.0 109.824 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.76 -56.54 20.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.19 -37.84 10.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.525 -0.735 . . . . 0.0 110.018 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -83.1 -22.13 33.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 11' ' ' SER . 1.2 t -87.76 -20.59 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.671 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -85.46 -31.95 22.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.563 -0.711 . . . . 0.0 110.187 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 26.8 ttt-85 -88.73 7.37 34.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.164 -0.96 . . . . 0.0 109.279 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -63.65 -46.42 82.92 Favored Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.497 -0.752 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -73.87 -71.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.55 1.289 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.35 24.03 0.14 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.921 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.546 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 10.0 m -82.99 142.36 44.54 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 120.932 -1.334 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -73.87 118.38 5.41 Favored 'Trans proline' 0 C--N 1.286 -2.757 0 O-C-N 124.606 1.845 . . . . 0.0 108.542 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 18.6 pt-20 -36.37 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.039 0.447 . . . . 0.0 111.046 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.52 -42.53 99.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.028 -1.045 . . . . 0.0 109.67 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.18 -41.58 63.7 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.179 -0.951 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.7 m -66.75 -24.24 66.19 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 111.061 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -97.74 -7.85 29.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.0 109.467 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.3 -24.74 19.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.9 t80 -95.52 -32.73 12.71 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -95.24 -10.48 30.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 110.179 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 100.34 -38.82 2.96 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' ALA . 20.3 m -43.13 166.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.112 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' CG2' ' C ' ' A' ' 32' ' ' CYS . 2.1 pp -150.43 148.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.053 -1.029 . . . . 0.0 110.297 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 5.3 mp -108.22 146.83 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 0.0 110.263 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.493 ' CD1' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -130.81 174.83 4.21 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.258 -0.901 . . . . 0.0 110.114 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.4 Cg_endo -70.93 -32.59 13.45 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.55 . . . . 0.0 110.525 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' OG1' ' A' ' 1' ' ' THR . . . 140.53 134.28 3.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 174.81 -80.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.612 -0.934 . . . . 0.0 109.735 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -174.32 18.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.61 -0.681 . . . . 0.0 111.315 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.3 m 56.14 166.05 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.439 -0.788 . . . . 0.0 109.363 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 45.8 Cg_endo -72.59 -158.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.933 1.491 . . . . 0.0 109.924 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.68 -29.76 3.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -81.57 -21.16 38.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.928 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 43' ' ' ASP . 2.8 m-85 -119.23 33.67 5.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.88 29.67 0.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.475 ' HB3' ' CA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.839 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 163.46 26.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.721 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 33' ' ' ILE . 5.9 p -158.24 144.18 17.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -125.9 147.88 60.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.287 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 46.9 Cg_endo -73.01 -0.61 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.008 1.531 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -156.22 157.11 35.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.093 -1.004 . . . . 0.0 110.413 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 mp -61.73 -33.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.926 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 5.3 t -70.01 -56.31 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.509 ' CB ' ' SG ' ' A' ' 4' ' ' CYS . . . -42.68 -36.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -81.61 -35.09 30.48 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 8' ' ' VAL . 1.8 m -55.83 -42.27 75.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 109.565 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 15' ' ' VAL . 2.2 m-80 -73.83 -52.87 11.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 0.0 109.297 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' C ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -42.81 -36.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.47 -0.769 . . . . 0.0 109.453 179.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -73.42 -31.5 63.87 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.84 0.829 . . . . 0.0 109.182 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -71.52 -22.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.553 0.692 . . . . 0.0 109.338 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -80.74 -34.02 34.71 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.615 -0.678 . . . . 0.0 110.716 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -74.52 -6.38 48.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 2.1 mt -71.7 -57.67 4.06 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.471 -0.768 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -71.28 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.007 1.53 . . . . 0.0 110.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.93 23.08 0.24 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.53 ' CG2' ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -84.0 125.39 72.88 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.221 -1.164 . . . . 0.0 110.997 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 38.7 Cg_endo -70.82 121.87 8.3 Favored 'Trans proline' 0 C--N 1.288 -2.651 0 O-C-N 124.286 1.677 . . . . 0.0 108.801 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.3 pt-20 -34.23 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.413 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.4 -40.35 77.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.374 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -65.61 -43.78 88.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 110.645 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.456 ' O ' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -85.63 -23.81 27.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.071 -1.018 . . . . 0.0 111.427 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 32' ' ' CYS . . . -71.86 -27.17 62.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.764 -1.21 . . . . 0.0 108.711 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -80.28 -32.76 38.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.247 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -94.01 -35.26 12.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.448 -0.782 . . . . 0.0 110.56 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.499 HG22 ' HB2' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -82.3 -11.73 58.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.552 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 19.13 23.27 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -104.5 -179.32 3.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -1.169 . . . . 0.0 110.005 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.512 ' CG1' ' SG ' ' A' ' 3' ' ' CYS . 45.1 pt -154.78 144.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.061 -1.024 . . . . 0.0 110.178 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG12 ' HG3' ' A' ' 23' ' ' GLU . 2.3 mp -95.97 142.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.444 -0.785 . . . . 0.0 110.114 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 1' ' ' THR . 8.5 pt -147.74 153.85 43.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.842 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.86 58.84 4.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.975 1.513 . . . . 0.0 110.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 76.66 132.36 0.47 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 37' ' ' GLY . . . 163.38 -28.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.818 -0.813 . . . . 0.0 109.668 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 69.69 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.716 0.769 . . . . 0.0 110.378 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' CB ' ' HD2' ' A' ' 41' ' ' PRO . 0.5 OUTLIER 57.71 178.3 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 110.383 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 40' ' ' CYS . 45.5 Cg_endo -70.8 -168.1 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.99 1.521 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.6 2.43 87.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -103.96 -28.83 11.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -1.159 . . . . 0.0 109.653 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 3' ' ' CYS . 14.8 m-85 -103.45 1.8 32.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.5 -0.75 . . . . 0.0 110.038 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.11 29.76 0.47 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 0.0 110.718 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 5.0 m-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.075 -0.965 . . . . 0.0 109.982 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.842 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.537 ' CG2' ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -86.59 156.82 19.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.798 . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 2' ' ' THR . 56.1 m -153.33 122.85 6.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 10' ' ' ARG . 74.9 m -132.7 139.66 35.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.36 -2.6 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.883 1.465 . . . . 0.0 111.091 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -160.95 149.23 16.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.474 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.1 mt -51.54 -32.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.727 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 9' ' ' ALA . 50.5 t -69.71 -55.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.738 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.455 ' O ' ' SG ' ' A' ' 32' ' ' CYS . . . -43.12 -36.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.846 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -82.5 -44.14 16.32 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.35 -0.844 . . . . 0.0 108.91 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -39.44 41.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 5.4 m-20 -68.58 -50.78 49.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 108.95 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 0.1 OUTLIER -47.31 -42.31 20.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.58 -0.7 . . . . 0.0 109.407 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -78.0 -16.57 58.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.612 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -83.16 -25.4 8.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.591 -0.693 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.08 -26.97 22.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.545 -0.722 . . . . 0.0 110.386 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 21' ' ' THR . 4.4 ttt180 -91.02 9.97 28.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.326 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -73.11 -45.05 8.2 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.546 -0.721 . . . . 0.0 110.529 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 43.7 Cg_endo -75.81 -81.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.665 1.35 . . . . 0.0 110.776 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -150.86 36.43 0.9 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.996 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 17' ' ' ARG . 12.0 m -106.46 134.44 19.8 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.921 -1.341 . . . . 0.0 110.403 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -71.18 119.86 6.59 Favored 'Trans proline' 0 C--N 1.286 -2.734 0 O-C-N 124.476 1.777 . . . . 0.0 109.051 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 10.3 mt-10 -28.91 -35.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.707 0.765 . . . . 0.0 111.116 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.7 -48.18 78.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.299 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -74.34 -19.39 60.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.014 . . . . 0.0 110.372 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 84.3 m -84.99 -19.31 32.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.248 -0.908 . . . . 0.0 110.742 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -96.47 -24.33 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.38 1.086 . . . . 0.0 109.208 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -85.3 -21.54 28.94 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.861 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -93.3 -30.95 14.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.619 -0.675 . . . . 0.0 109.639 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.1 t -95.43 -11.91 26.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 114.46 -39.36 2.83 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.367 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.492 ' C ' ' CG2' ' A' ' 33' ' ' ILE . 66.2 m -48.24 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.333 -1.098 . . . . 0.0 111.028 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.492 ' CG2' ' C ' ' A' ' 32' ' ' CYS . 5.3 pt -151.68 157.58 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 2' ' ' THR . 35.9 mt -135.32 142.36 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.493 HG13 ' HB1' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -138.79 163.92 43.27 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 46.6 Cg_endo -73.7 54.44 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.993 1.523 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 90.13 137.36 6.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.493 ' HB1' HG13 ' A' ' 35' ' ' ILE . . . 175.02 -28.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.959 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 73.64 -1.61 3.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.801 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' O ' ' A' ' 39' ' ' THR . 3.3 m 47.47 171.77 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.332 0.587 . . . . 0.0 111.915 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 54.2 Cg_endo -75.04 -158.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.872 1.459 . . . . 0.0 110.098 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 7.65 59.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 -23.22 10.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 109.642 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.481 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 19.4 m-85 -110.48 9.17 23.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 110.066 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.95 30.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.847 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.612 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 86.0 m -135.65 131.9 36.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.3 m -132.13 99.68 4.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 109.883 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.466 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 37.2 m -97.06 159.98 30.13 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 42.1 Cg_endo -67.64 -9.19 24.62 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.97 1.511 . . . . 0.0 112.28 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 170.91 175.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.54 -1.35 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' A' ' 11' ' ' SER . 27.0 mm -55.58 -40.16 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.483 -0.761 . . . . 0.0 109.797 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 11' ' ' SER . 78.9 t -54.44 -64.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.54 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -49.21 -65.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.206 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -44.48 -25.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.404 -0.81 . . . . 0.0 110.144 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 0.3 OUTLIER -69.04 -52.05 32.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.027 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.4 m-80 -70.45 -51.87 26.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.612 ' CE1' ' CG2' ' A' ' 2' ' ' THR . 38.1 t80 -42.31 -46.29 4.52 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.528 -0.733 . . . . 0.0 110.297 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -77.09 -20.57 55.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 109.622 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -81.24 -26.23 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 109.725 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -86.31 -22.82 26.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.173 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' CD ' ' O ' ' A' ' 21' ' ' THR . 16.2 tpt180 -89.28 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.742 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.616 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -68.34 -43.86 34.15 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.527 -0.733 . . . . 0.0 110.646 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -72.91 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.488 1.257 . . . . 0.0 110.857 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.64 28.75 0.18 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 2.4 m -96.2 142.27 24.32 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.2 Cg_endo -74.82 124.99 9.12 Favored 'Trans proline' 0 C--N 1.286 -2.741 0 O-C-N 124.622 1.854 . . . . 0.0 108.37 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 22' ' ' PRO . 81.6 mt-10 -33.29 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.125 0.488 . . . . 0.0 111.297 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.26 -49.55 76.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.021 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.61 -27.75 64.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.983 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.453 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 33.9 m -76.06 -32.82 59.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.446 -0.784 . . . . 0.0 110.572 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -94.13 -3.1 51.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 109.738 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -86.23 -36.81 19.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -88.21 -40.05 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.97 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.451 HG22 ' HB2' ' A' ' 13' ' ' PHE . 1.6 t -80.02 -16.95 54.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 110.239 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 101.6 -37.12 3.79 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 42.4 t -42.41 159.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -1.208 . . . . 0.0 110.195 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 3' ' ' CYS . 1.1 pp -137.05 145.61 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 27' ' ' ALA . 4.0 mp -107.35 153.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.418 -0.801 . . . . 0.0 109.976 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 37' ' ' GLY . 9.9 pt -143.42 155.99 60.66 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.081 -1.012 . . . . 0.0 110.554 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.44 -1.27 11.1 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.083 1.57 . . . . 0.0 110.061 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 1' ' ' THR . . . -143.97 -141.83 3.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.96 47.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.986 . . . . 0.0 109.749 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.44 8.87 27.63 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.485 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 28.6 p -48.12 162.93 0.31 Allowed Pre-proline 0 C--N 1.291 -1.949 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.187 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 44.3 Cg_endo -69.78 162.18 43.06 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.839 1.442 . . . . 0.0 111.33 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 -8.33 78.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 10.8 m-20 -90.65 -21.33 21.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.239 . . . . 0.0 109.067 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 41' ' ' PRO . 9.2 m-85 -119.61 10.58 11.79 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.519 0.676 . . . . 0.0 109.493 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . -87.62 31.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 110.28 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.27 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.85 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.646 ' CG2' ' CD2' ' A' ' 13' ' ' PHE . 1.5 m -97.77 144.37 27.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.6 m -145.75 115.01 7.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.256 -0.903 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' HB3' ' HB1' ' A' ' 9' ' ' ALA . 1.7 m -106.28 158.46 32.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 48.3 Cg_endo -76.17 -21.89 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.193 1.628 . . . . 0.0 111.174 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 p -140.75 172.1 13.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.007 -1.058 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -69.92 -32.01 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.875 . . . . 0.0 110.019 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.472 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . . . -64.3 -34.64 78.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -42.77 81.28 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.446 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -63.44 -45.77 89.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.753 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 15' ' ' VAL . 6.3 m-20 -65.66 -53.18 44.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' CG2' ' A' ' 2' ' ' THR . 1.0 OUTLIER -44.65 -48.45 10.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.944 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.62 -14.43 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 0.0 109.637 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -84.58 -20.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 109.89 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.482 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 2.8 t -92.77 -22.41 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 0.0 110.567 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 5.0 mtp180 -85.38 0.6 51.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 109.597 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.6 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -67.82 -47.96 42.27 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 41.5 Cg_endo -69.45 -17.76 38.84 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.449 1.236 . . . . 0.0 110.836 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 19.99 3.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.563 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.3 m -77.27 145.85 73.4 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.361 -1.082 . . . . 0.0 110.295 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.0 Cg_endo -75.38 120.78 6.09 Favored 'Trans proline' 0 C--N 1.286 -2.744 0 O-C-N 124.593 1.839 . . . . 0.0 108.403 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 14.6 pm0 -35.68 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.973 0.416 . . . . 0.0 111.221 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.71 -52.13 66.82 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -42.94 97.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 109.759 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 27.8 m -70.22 -16.58 63.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -92.18 -7.19 49.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.241 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.0 -34.33 18.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -83.49 -39.69 20.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.429 -0.794 . . . . 0.0 109.632 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 26' ' ' CYS 0.271 23.8 p -75.54 -26.62 58.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.45 -0.781 . . . . 0.0 110.429 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.23 14.26 64.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 9' ' ' ALA . 33.2 m -93.86 -174.56 3.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -1.091 . . . . 0.0 110.389 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -144.62 151.86 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 1' ' ' THR . 2.8 mp -111.2 138.89 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.398 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -125.36 171.77 7.11 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 44.5 Cg_endo -71.44 -26.35 20.39 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.99 1.521 . . . . 0.0 111.884 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -151.28 -141.64 3.38 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.493 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.63 29.56 1.29 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.672 -0.899 . . . . 0.0 110.592 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.81 7.42 7.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' HD13 ' A' ' 35' ' ' ILE . 55.7 m -51.15 151.13 5.09 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 121.587 -0.696 . . . . 0.0 110.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 50.1 Cg_endo -75.57 -159.66 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.883 1.465 . . . . 0.0 110.339 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 -13.04 25.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 3.9 m-20 -96.89 -16.15 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.922 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 15.4 m-85 -116.81 19.75 14.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 110.16 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.51 30.88 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.263 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.853 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.809 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.526 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 7.3 t -81.05 165.34 21.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 12.6 m -156.85 109.7 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 110.406 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' SG ' ' CB ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -121.62 163.2 32.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 110.288 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.4 Cg_endo -72.04 -7.1 20.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.052 1.554 . . . . 0.0 111.063 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 m -158.53 154.03 26.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.014 -1.054 . . . . 0.0 110.798 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 mt -61.75 -28.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.799 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 91.6 t -65.9 -48.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.5 ' CB ' ' SG ' ' A' ' 4' ' ' CYS . . . -58.83 -49.4 77.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.8 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -69.43 -36.75 76.97 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.43 -39.89 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.672 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 5.4 m-20 -72.75 -51.57 18.62 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.026 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -44.2 -50.37 8.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.529 -0.732 . . . . 0.0 109.568 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.69 -39.9 95.46 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 1.2 t -58.02 -25.81 27.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.615 0.721 . . . . 0.0 109.06 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.488 ' SG ' HG23 ' A' ' 21' ' ' THR . 0.4 OUTLIER -86.01 -16.04 39.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.768 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 14.1 tpt180 -84.43 -7.21 59.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 109.355 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -56.07 -50.94 84.48 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.364 -0.835 . . . . 0.0 111.142 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.72 -25.7 23.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.604 1.318 . . . . 0.0 110.713 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.46 17.69 2.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.534 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.3 m -68.09 144.17 96.71 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.186 -1.185 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.5 Cg_endo -74.1 122.13 7.39 Favored 'Trans proline' 0 C--N 1.283 -2.886 0 O-C-N 124.517 1.798 . . . . 0.0 108.757 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -32.04 -31.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.138 0.494 . . . . 0.0 111.054 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.01 -47.59 77.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.134 -0.978 . . . . 0.0 109.371 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -68.66 -41.44 79.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.405 -0.809 . . . . 0.0 110.414 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.494 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 16.3 m -70.38 -25.0 63.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.344 -0.848 . . . . 0.0 110.809 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 23' ' ' GLU . . . -96.02 -2.06 47.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.064 . . . . 0.0 109.685 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -101.98 -22.92 14.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -93.47 -29.05 15.75 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.484 ' CG2' ' SG ' ' A' ' 32' ' ' CYS . 0.6 OUTLIER -102.91 -21.23 14.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.838 -0.539 . . . . 0.0 110.13 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 109.67 -35.0 5.14 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.481 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' SG ' ' CG2' ' A' ' 30' ' ' THR . 71.2 m -41.38 160.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.119 -1.224 . . . . 0.0 110.542 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.2 pt -133.24 145.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.883 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 1' ' ' THR . 2.7 mp -110.42 147.37 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 110.825 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.518 HD13 HG21 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.37 147.57 31.45 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.561 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.03 69.57 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.851 1.448 . . . . 0.0 110.292 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.92 145.95 4.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.42 25.38 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.98 . . . . 0.0 110.523 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -84.99 14.13 5.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 110.625 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.6 m -38.79 161.57 0.07 OUTLIER Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.989 -0.444 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.1 Cg_endo -70.69 -161.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.884 1.465 . . . . 0.0 110.902 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.61 -5.25 26.11 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.536 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 1.3 t0 -93.63 -31.4 14.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -1.232 . . . . 0.0 110.039 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.536 ' CE2' ' HB3' ' A' ' 43' ' ' ASP . 2.3 m-85 -114.49 23.13 13.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.634 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.91 32.12 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.85 . . . . 0.0 110.509 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.687 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.621 HG23 ' CE1' ' A' ' 13' ' ' PHE . 97.2 m -89.14 133.48 34.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.097 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.568 ' SG ' HD12 ' A' ' 35' ' ' ILE . 41.4 m -137.69 93.49 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 109.985 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 29.0 m -105.45 161.75 21.83 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.393 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.6 Cg_endo -70.08 -10.2 27.75 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.173 1.617 . . . . 0.0 111.605 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 172.57 -169.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.257 . . . . 0.0 111.005 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 11' ' ' SER . 11.2 mm -65.76 -33.4 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.106 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.7 t -53.7 -66.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.818 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -60.32 -58.6 7.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.888 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -40.54 -37.06 0.65 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.533 -0.729 . . . . 0.0 110.318 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 6.2 t -76.12 -36.22 58.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' CB ' ' OG1' ' A' ' 30' ' ' THR . 68.7 m-20 -69.13 -63.01 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.621 ' CE1' HG23 ' A' ' 2' ' ' THR . 0.7 OUTLIER -47.41 -34.62 7.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 13.3 m-20 -78.14 -14.3 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -96.66 -19.57 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.442 -0.786 . . . . 0.0 110.034 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -91.28 -23.69 20.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.412 -0.805 . . . . 0.0 110.868 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 21' ' ' THR . 26.4 tpt180 -88.95 -8.21 54.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.499 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.1 mt -60.8 -45.17 96.8 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.488 -0.757 . . . . 0.0 110.75 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.1 Cg_endo -73.65 -76.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.635 1.334 . . . . 0.0 110.895 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.11 25.91 0.11 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.65 HG21 ' SG ' ' A' ' 16' ' ' CYS . 4.1 m -91.34 141.33 26.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.134 -1.215 . . . . 0.0 110.261 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.91 122.96 8.08 Favored 'Trans proline' 0 C--N 1.285 -2.773 0 O-C-N 124.557 1.819 . . . . 0.0 108.5 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' OE1' HG21 ' A' ' 34' ' ' ILE . 1.8 pt-20 -34.74 -28.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.052 0.453 . . . . 0.0 110.986 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.26 -47.47 85.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.09 -1.006 . . . . 0.0 109.524 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -20.34 60.44 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.316 -0.865 . . . . 0.0 109.837 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -86.95 -24.94 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -100.17 -3.52 31.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.305 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -97.18 -29.02 13.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -90.04 -33.57 16.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.2 t -93.19 -19.74 21.15 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.353 -0.842 . . . . 0.0 110.354 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 108.87 -42.16 2.03 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.405 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.811 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 43.1 t -43.79 166.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.31 . . . . 0.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' HG3' ' A' ' 41' ' ' PRO . 1.4 pt -145.59 146.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.571 HG21 ' OE1' ' A' ' 23' ' ' GLU . 2.9 mp -108.21 156.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.418 -0.801 . . . . 0.0 109.562 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.837 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -142.03 145.2 35.06 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.145 -0.972 . . . . 0.0 110.282 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.35 62.01 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.11 1.584 . . . . 0.0 110.518 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.91 -139.36 2.78 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -148.21 12.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.976 . . . . 0.0 110.481 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 106.33 13.52 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.251 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 76.0 m -74.83 164.46 61.23 Favored Pre-proline 0 C--N 1.291 -1.956 0 O-C-N 121.859 -0.526 . . . . 0.0 109.66 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.624 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.0 Cg_endo -74.06 -165.44 0.26 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.944 1.497 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.69 -25.22 10.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.508 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 2.4 m-20 -85.62 -23.47 27.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -1.183 . . . . 0.0 109.666 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.508 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 2.8 m-85 -121.59 35.72 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.367 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -84.25 29.22 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.444 -0.785 . . . . 0.0 110.87 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 8.1 t-20 . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.846 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.755 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.757 HG21 ' CD1' ' A' ' 13' ' ' PHE . 4.3 m -87.97 157.84 18.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -155.45 111.14 3.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 111.093 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.66 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -113.69 150.2 42.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 51.5 Cg_endo -78.63 30.86 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.75 1.395 . . . . 0.0 112.046 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.561 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 7.5 t -178.21 155.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 110.928 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.447 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 13.4 mt -65.53 -25.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.499 -0.751 . . . . 0.0 109.792 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 4.1 t -80.78 -54.03 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.803 . . . . 0.0 109.884 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.66 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -53.81 -48.13 70.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 109.495 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -68.51 -27.12 65.84 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.535 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.1 t -74.62 -45.23 46.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.152 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.54 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 9.9 m-20 -52.17 -48.67 64.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.464 -0.773 . . . . 0.0 108.967 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.757 ' CD1' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -52.96 -41.39 64.49 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.534 0.683 . . . . 0.0 109.629 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -75.04 -11.98 60.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.64 -23.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.587 -0.695 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.0 t -89.92 -17.11 28.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.64 0.99 55.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.899 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -55.41 -44.61 99.73 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.483 -0.76 . . . . 0.0 110.957 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.7 Cg_endo -76.62 -22.88 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.678 1.357 . . . . 0.0 110.852 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.58 15.2 2.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.583 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.3 m -65.3 145.16 99.11 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.975 -1.309 . . . . 0.0 110.293 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 42.3 Cg_endo -74.95 119.07 5.5 Favored 'Trans proline' 0 C--N 1.287 -2.685 0 O-C-N 124.613 1.849 . . . . 0.0 108.696 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 6.3 pt-20 -35.54 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.246 0.546 . . . . 0.0 110.528 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.18 -40.46 81.55 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.119 -0.988 . . . . 0.0 109.572 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -33.54 43.61 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 36.2 m -83.45 -17.88 40.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 111.155 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.82 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -100.85 -11.68 19.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 109.68 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.6 m -93.64 -25.47 17.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.85 -29.35 13.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.246 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -95.71 -16.59 21.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.439 -0.788 . . . . 0.0 110.36 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 110.95 -42.16 2.04 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.761 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.82 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 73.0 m -40.5 149.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.165 -1.197 . . . . 0.0 110.438 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 33' ' ' ILE . 18.2 pt -129.77 148.38 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.417 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.512 ' CD1' ' HG3' ' A' ' 23' ' ' GLU . 3.3 mp -113.29 151.34 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.764 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -145.79 162.69 34.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.8 Cg_endo -74.03 -3.82 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.83 1.437 . . . . 0.0 110.838 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.19 -142.65 12.54 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.94 7.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.469 -1.018 . . . . 0.0 111.233 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' CYS . 1.4 t -130.23 -2.63 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.798 -1.189 . . . . 0.0 111.101 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.609 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 9.0 p 37.64 -163.25 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 122.064 -0.398 . . . . 0.0 110.391 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.609 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 54.9 Cg_endo -79.24 176.98 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 122.84 0.916 . . . . 0.0 111.253 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.05 -2.34 66.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.41 -28.08 14.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 5.3 m-85 -114.36 23.69 12.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.31 -0.869 . . . . 0.0 109.544 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.493 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . -84.99 30.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.561 ' HB3' ' N ' ' A' ' 6' ' ' SER . 1.4 m-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.038 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.852 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.779 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.6 m -111.37 154.07 25.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -144.93 86.58 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.455 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 33.7 m -109.74 132.56 21.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' C ' ' OG ' ' A' ' 6' ' ' SER . 50.3 Cg_endo -76.18 47.57 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.862 1.454 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 179.47 121.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.084 -1.01 . . . . 0.0 109.903 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' OD1' ' A' ' 46' ' ' ASN . 43.6 mm -45.59 -32.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.007 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG12 ' OD1' ' A' ' 12' ' ' ASN . 31.0 t -79.3 -50.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.847 . . . . 0.0 109.951 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.421 ' CB ' ' OG ' ' A' ' 6' ' ' SER . . . -46.25 -31.1 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.901 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.35 -42.52 36.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.44 -0.787 . . . . 0.0 109.653 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.555 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -63.95 -53.85 43.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.388 -0.82 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' OD1' HG12 ' A' ' 8' ' ' VAL . 6.7 m120 -50.54 -50.54 53.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 1.1 t80 -51.06 -37.67 46.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -76.57 -15.18 59.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -23.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.641 -0.662 . . . . 0.0 109.739 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -89.05 -18.71 26.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.403 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -90.51 -5.67 55.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.627 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -64.51 -42.24 64.32 Favored Pre-proline 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 111.003 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 44.9 Cg_endo -74.15 -26.63 12.53 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.456 1.24 . . . . 0.0 110.604 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.65 10.96 1.98 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.236 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 16' ' ' CYS . 8.6 m -70.39 143.99 91.31 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.019 -1.283 . . . . 0.0 110.352 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -74.94 120.03 5.91 Favored 'Trans proline' 0 C--N 1.285 -2.811 0 O-C-N 124.627 1.856 . . . . 0.0 108.989 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 1.012 ' OE1' HD13 ' A' ' 34' ' ' ILE . 1.7 pp20? -32.74 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.957 0.408 . . . . 0.0 111.413 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.48 -40.67 95.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 0.0 109.396 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -73.66 -37.39 65.31 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 23.8 m -75.28 -19.84 59.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.894 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -95.7 -6.64 39.41 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.076 0.941 . . . . 0.0 109.524 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -29.21 19.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.29 -35.23 17.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.676 -0.64 . . . . 0.0 109.489 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 27' ' ' ALA 0.261 16.8 p -80.35 -23.62 40.42 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.396 -0.815 . . . . 0.0 110.284 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 23.45 47.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.693 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -116.85 175.1 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -1.029 . . . . 0.0 109.937 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 pp -132.95 148.0 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.012 HD13 ' OE1' ' A' ' 23' ' ' GLU . 3.3 mp -105.68 161.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.247 -0.908 . . . . 0.0 110.114 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.478 HG23 ' C ' ' A' ' 34' ' ' ILE . 48.6 pt -148.72 163.39 26.11 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 110.436 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.7 Cg_endo -70.12 -38.03 7.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.014 1.534 . . . . 0.0 110.198 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.54 130.77 1.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 39' ' ' THR . . . -174.2 17.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.603 -0.94 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 66.86 4.29 3.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 110.89 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.516 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER 56.14 142.61 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.778 -0.576 . . . . 0.0 110.867 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.9 Cg_endo -74.6 173.68 13.92 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.631 1.332 . . . . 0.0 110.054 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.23 -4.11 88.79 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.425 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 37.3 m-20 -102.0 -26.11 13.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -1.201 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 4.8 m-85 -118.12 21.14 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.8 30.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.455 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.998 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.778 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 t -113.27 169.4 8.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.497 ' O ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -157.54 102.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.133 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.85 159.34 41.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.136 -0.978 . . . . 0.0 110.49 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 49.4 Cg_endo -77.83 6.51 4.5 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.178 1.62 . . . . 0.0 111.246 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 5' ' ' PRO . 8.7 m -170.56 168.35 7.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.086 . . . . 0.0 110.815 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.614 ' N ' HD13 ' A' ' 7' ' ' ILE . 4.0 mm -68.76 -30.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.513 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 9' ' ' ALA . 10.4 t -80.89 -48.46 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.529 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -44.18 -36.71 2.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.184 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -78.0 -39.28 42.75 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.407 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 4.4 p -55.62 -48.05 75.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.587 -0.696 . . . . 0.0 110.216 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 7.7 p30 -69.93 -33.29 71.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.0 OUTLIER -59.75 -41.33 90.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 108.741 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -79.54 -30.38 41.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.516 0.674 . . . . 0.0 109.422 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.699 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -64.97 -32.82 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.533 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -80.83 -27.83 36.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.503 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 21' ' ' THR . 2.0 ttt180 -94.3 6.39 48.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.299 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -74.16 -41.95 5.38 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.587 -0.695 . . . . 0.0 110.958 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -74.8 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.479 1.252 . . . . 0.0 110.941 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.19 24.84 0.2 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 7.6 m -94.95 141.42 23.25 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 120.995 -1.297 . . . . 0.0 110.255 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -73.7 119.74 6.07 Favored 'Trans proline' 0 C--N 1.285 -2.797 0 O-C-N 124.648 1.867 . . . . 0.0 108.793 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -35.13 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.225 0.536 . . . . 0.0 110.849 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.85 -45.58 93.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.848 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -70.85 -36.09 72.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 110.51 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.2 m -74.44 -23.46 58.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.689 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.667 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -96.0 -12.57 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.997 . . . . 0.0 109.761 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.1 m -95.13 -21.64 18.38 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -99.58 -20.46 16.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.497 ' HG1' ' CG ' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -111.55 -7.28 14.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.56 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 104.18 -34.48 5.75 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.686 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.667 ' C ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -46.15 174.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.027 -1.278 . . . . 0.0 110.42 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 32' ' ' CYS . 28.3 pt -158.32 145.74 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.772 ' O ' HG23 ' A' ' 35' ' ' ILE . 4.8 mp -106.41 140.48 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 110.138 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.024 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.2 pp -160.98 134.1 4.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 110.186 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.98 70.81 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.918 1.483 . . . . 0.0 110.448 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' HD13 ' A' ' 35' ' ' ILE . . . 168.87 138.27 2.44 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.48 15.35 5.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -81.9 10.29 6.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.524 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -40.57 163.53 0.09 OUTLIER Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.874 -0.516 . . . . 0.0 110.264 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 42.7 Cg_endo -69.8 169.28 19.34 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.068 1.562 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.69 61.83 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 43.4 p-10 -112.0 -19.86 12.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.03 -1.276 . . . . 0.0 109.519 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 16.2 m-85 -123.27 17.94 9.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.614 -0.678 . . . . 0.0 109.444 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.4 32.55 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.489 -0.757 . . . . 0.0 110.338 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 17.7 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.337 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.84 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.929 HG21 ' CE1' ' A' ' 13' ' ' PHE . 94.2 m -127.58 160.71 30.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.5 m -148.05 156.98 43.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 85.9 m -147.53 130.52 7.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 6' ' ' SER . 49.6 Cg_endo -77.74 25.26 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.977 1.514 . . . . 0.0 112.79 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER 174.25 164.95 0.21 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.254 -1.528 . . . . 0.0 111.059 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' SER . 56.4 mt -65.46 -30.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.508 -0.745 . . . . 0.0 109.328 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 64.8 t -66.74 -50.79 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.925 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -55.24 -66.15 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -51.75 -22.52 3.63 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.593 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 2.1 t -80.24 -63.33 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.565 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 10.3 p30 -61.65 -37.04 82.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.929 ' CE1' HG21 ' A' ' 2' ' ' THR . 0.2 OUTLIER -59.87 -44.92 93.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.942 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 1.5 p30 -69.46 -27.83 65.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.186 -0.946 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -23.25 28.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.664 ' SG ' HG21 ' A' ' 21' ' ' THR . 5.3 t -92.78 -22.93 19.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.697 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -91.1 5.23 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.556 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -65.89 -46.47 65.05 Favored Pre-proline 0 C--N 1.306 -1.29 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.4 Cg_endo -74.8 -71.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.614 1.323 . . . . 0.0 110.581 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.1 27.31 0.09 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.664 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.7 m -84.23 141.35 39.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.064 -1.256 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.6 Cg_endo -74.17 124.73 9.25 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 O-C-N 124.546 1.814 . . . . 0.0 108.242 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.821 ' OE2' HG23 ' A' ' 2' ' ' THR . 0.0 OUTLIER -39.98 -23.37 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.8 -0.563 . . . . 0.0 110.209 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.19 -51.23 68.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.089 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -29.09 66.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 110.576 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.676 ' O ' HG22 ' A' ' 30' ' ' THR . 27.8 m -78.63 -44.92 22.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.039 -1.038 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.889 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -68.89 -13.29 62.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.927 -1.108 . . . . 0.0 109.648 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.561 HG22 ' N ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -77.84 -47.03 19.8 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.537 0.684 . . . . 0.0 109.663 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' N ' HG22 ' A' ' 28' ' ' THR . 4.6 t80 -94.89 -41.03 9.4 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.616 0.722 . . . . 0.0 110.064 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -68.25 -31.87 71.65 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.438 -0.789 . . . . 0.0 110.357 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 124.26 -47.41 1.02 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.561 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.889 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 66.5 m -44.17 169.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.041 -1.27 . . . . 0.0 110.193 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.9 148.8 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.136 -0.977 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 24' ' ' ALA . 1.9 mp -80.39 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.587 HD13 ' SG ' ' A' ' 40' ' ' CYS . 1.1 pp -134.97 133.16 20.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.79 6.66 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.95 1.5 . . . . 0.0 110.388 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.23 -138.9 5.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.9 -48.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.995 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -102.65 2.06 35.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.012 . . . . 0.0 110.42 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.587 ' SG ' HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER 47.48 177.73 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.862 -0.524 . . . . 0.0 111.168 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.16 -157.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.032 1.543 . . . . 0.0 110.188 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.76 -8.54 54.23 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -19.33 14.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.246 . . . . 0.0 110.145 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 16.6 m-85 -114.25 10.27 17.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.11 31.38 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 23.2 t-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.757 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 t -92.82 171.32 9.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 33' ' ' ILE . 1.1 m -147.16 106.07 3.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.045 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 10' ' ' ARG . 1.2 m -99.58 144.07 27.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.917 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.8 Cg_endo -70.86 -3.35 12.56 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.951 1.5 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.483 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER 172.43 175.09 0.1 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.803 -1.186 . . . . 0.0 110.559 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 7' ' ' ILE . 30.9 mm -57.7 -36.08 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 110.05 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.49 -62.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -61.63 -54.24 45.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.944 . . . . 0.0 108.992 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.69 -52.63 4.84 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.302 -0.874 . . . . 0.0 109.555 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -64.45 -32.73 74.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.064 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.565 ' HB2' ' HA ' ' A' ' 9' ' ' ALA . 1.2 m-20 -59.85 -71.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.683 0.754 . . . . 0.0 109.83 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.649 ' CE2' ' CB ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -47.62 -33.64 6.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.562 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -70.35 -26.11 63.59 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.827 0.822 . . . . 0.0 109.165 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -70.95 -25.02 25.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.68 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.52 -22.64 26.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -74.05 -10.1 59.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.554 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.6 mt -72.4 -55.73 4.53 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.11 -34.14 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.732 1.385 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.6 7.9 1.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.68 HG21 ' SG ' ' A' ' 16' ' ' CYS . 32.9 m -65.26 131.61 95.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 120.91 -1.347 . . . . 0.0 110.363 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 40.3 Cg_endo -72.23 116.99 4.92 Favored 'Trans proline' 0 C--N 1.288 -2.647 0 O-C-N 124.431 1.753 . . . . 0.0 108.738 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 26.4 pt-20 -33.03 -31.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.433 0.635 . . . . 0.0 110.896 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.53 -43.08 99.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 110.734 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -72.15 -45.29 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.905 -1.122 . . . . 0.0 111.368 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -84.37 -15.45 46.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 0.0 111.763 -178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -75.99 -39.12 56.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.465 -1.397 . . . . 0.0 108.631 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -30.18 63.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.182 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 1.7 t80 -90.89 -48.36 7.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.805 . . . . 0.0 110.357 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 26' ' ' CYS . 1.2 t -66.67 -12.83 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.569 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.95 -43.95 1.61 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.447 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' GLY . 1.5 t -46.77 175.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -1.203 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.471 HD11 ' SG ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER -140.39 156.72 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.112 -0.992 . . . . 0.0 109.808 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 27' ' ' ALA . 73.5 mt -137.25 141.26 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.815 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.692 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -147.52 156.3 45.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 0.0 109.804 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.82 68.85 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.815 1.429 . . . . 0.0 110.046 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 149.11 4.97 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.37 32.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -1.006 . . . . 0.0 110.419 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' CYS . 1.5 t -84.06 14.35 4.26 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 110.768 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' THR . 62.4 m -36.19 154.75 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 122.095 -0.378 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 49.0 Cg_endo -73.97 -176.72 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.943 1.496 . . . . 0.0 110.33 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.23 4.87 82.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.96 -22.5 12.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -1.201 . . . . 0.0 109.872 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -117.87 14.93 14.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 109.838 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.12 29.21 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.824 . . . . 0.0 110.551 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' HB3' ' N ' ' A' ' 6' ' ' SER . 1.2 t-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.127 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.843 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.806 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 1.3 m -124.61 161.1 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -152.56 145.24 24.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.633 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -134.12 161.08 65.9 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.3 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 46.7 Cg_endo -73.59 -0.98 10.06 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.112 1.585 . . . . 0.0 111.607 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -176.17 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.669 -1.27 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -75.07 -31.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.968 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.2 t -65.61 -44.48 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -62.74 -70.22 0.22 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 109.049 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.84 -26.87 0.15 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.1 m -72.37 -61.78 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.621 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 36.3 p30 -58.14 -21.18 45.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.998 -1.064 . . . . 0.0 109.802 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.806 ' CZ ' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -72.47 -45.13 60.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.662 0.744 . . . . 0.0 109.101 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -73.56 -20.13 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.79 . . . . 0.0 109.048 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.24 -25.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.452 0.644 . . . . 0.0 109.653 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -84.57 -25.88 28.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.783 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 15.5 ttt180 -88.32 7.32 32.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.758 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.593 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -61.07 -43.69 91.67 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.454 -0.778 . . . . 0.0 110.829 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -76.98 -21.41 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.611 1.322 . . . . 0.0 110.834 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.49 12.99 1.93 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.222 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.548 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.7 m -65.63 144.8 99.01 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.063 -1.257 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.96 118.82 5.57 Favored 'Trans proline' 0 C--N 1.287 -2.693 0 O-C-N 124.614 1.849 . . . . 0.0 108.859 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 22' ' ' PRO . 75.2 mt-10 -36.34 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.145 0.498 . . . . 0.0 110.562 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.69 -38.85 89.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.195 -0.94 . . . . 0.0 109.953 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -30.88 32.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.049 -1.032 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.547 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 69.4 m -80.05 -14.44 58.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.05 . . . . 0.0 110.361 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.648 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -99.85 -27.47 13.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.371 1.081 . . . . 0.0 109.555 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -78.74 -23.58 45.33 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.798 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.8 t80 -102.28 -32.21 10.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.283 -0.885 . . . . 0.0 109.792 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.621 ' HG1' ' CG ' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -91.09 -5.11 55.62 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.03 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 105.64 -38.75 3.14 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.728 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.648 ' C ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -50.01 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.969 -1.312 . . . . 0.0 110.196 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.563 HG23 ' C ' ' A' ' 32' ' ' CYS . 1.2 pp -156.82 163.22 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.871 -1.143 . . . . 0.0 110.499 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' ILE . 7.4 mm -100.79 165.92 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.078 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.926 HG23 ' O ' ' A' ' 34' ' ' ILE . 1.3 pt -171.56 170.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 109.646 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.5 Cg_endo -69.75 -16.84 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.865 1.455 . . . . 0.0 110.139 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.746 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 105.03 141.04 10.6 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 74.6 -6.84 1.83 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.686 -0.891 . . . . 0.0 111.323 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' THR . 0.6 OUTLIER -96.78 10.87 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.497 ' SG ' HD11 ' A' ' 35' ' ' ILE . 52.0 m -62.32 130.1 92.87 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 110.112 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 43.7 Cg_endo -70.38 -165.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.817 1.43 . . . . 0.0 110.717 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.98 -14.01 55.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 43' ' ' ASP . 37.2 p-10 -98.18 -20.22 17.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -1.208 . . . . 0.0 109.498 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 11.9 m-85 -119.49 23.34 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.804 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -88.93 21.64 3.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 4.8 m120 . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.836 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.682 HG21 ' HE1' ' A' ' 13' ' ' PHE . 9.4 t -138.75 173.93 11.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.1 m -152.38 110.83 3.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.889 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.499 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 19.4 m -99.46 162.94 19.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.0 Cg_endo -71.41 -7.84 22.11 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 7' ' ' ILE . 9.0 t 175.14 -171.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.8 -1.187 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.2 mm -70.72 -33.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.1 t -55.54 -61.41 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.589 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -56.99 -66.46 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.64 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.499 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -41.99 -37.7 1.42 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.368 -0.833 . . . . 0.0 110.386 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 t -66.81 -49.71 64.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.949 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.481 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 12.2 m-20 -57.14 -59.34 5.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.682 ' HE1' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -50.09 -38.88 40.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.39 -0.819 . . . . 0.0 109.573 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 3.3 m-20 -68.4 -32.79 73.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.905 0.859 . . . . 0.0 108.866 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.49 -18.33 23.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.803 0.811 . . . . 0.0 108.966 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.874 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.89 -26.93 22.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.779 -0.575 . . . . 0.0 110.723 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.32 -9.17 58.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.532 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.2 mt -73.19 -56.55 3.23 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.606 -0.684 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.0 Cg_endo -70.26 -85.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.959 1.505 . . . . 0.0 110.825 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.58 27.32 0.22 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.874 HG21 ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -89.8 127.71 53.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.294 -1.121 . . . . 0.0 110.843 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.6 Cg_endo -71.86 121.29 7.49 Favored 'Trans proline' 0 C--N 1.286 -2.715 0 O-C-N 124.302 1.685 . . . . 0.0 108.78 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.627 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 8.5 pt-20 -34.03 -28.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.158 0.504 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.18 -43.5 74.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.01 -1.056 . . . . 0.0 110.887 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -69.61 -35.51 75.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 111.661 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -92.74 -14.59 27.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.658 -1.276 . . . . 0.0 111.196 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -82.02 -32.17 30.65 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.692 1.234 . . . . 0.0 107.925 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -79.19 -28.83 42.68 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.917 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -88.0 -33.69 18.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.468 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 26' ' ' CYS . 2.1 t -86.97 -12.15 48.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.085 . . . . 0.0 110.761 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 113.66 -46.26 1.2 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' ALA . 16.6 t -45.93 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -1.206 . . . . 0.0 110.036 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.74 153.18 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.901 ' O ' HG23 ' A' ' 35' ' ' ILE . 5.7 mm -90.28 163.68 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.256 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.901 HG23 ' O ' ' A' ' 34' ' ' ILE . 2.1 pt -167.7 156.82 8.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.44 -0.787 . . . . 0.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.16 -28.75 8.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.14 1.6 . . . . 0.0 109.918 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.32 -141.74 4.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.47 33.26 3.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -1.087 . . . . 0.0 110.033 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -79.45 9.03 5.24 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.676 -0.64 . . . . 0.0 111.133 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -43.45 165.87 0.11 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.69 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.629 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.3 Cg_endo -70.04 179.56 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.911 1.479 . . . . 0.0 111.187 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.61 -10.91 85.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 2.1 t0 -95.54 -19.93 19.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.672 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.563 ' CD2' ' CG ' ' A' ' 41' ' ' PRO . 11.3 m-85 -117.78 11.99 13.75 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.525 -0.734 . . . . 0.0 109.933 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.89 30.8 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.374 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.848 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 3' ' ' CYS . 47.3 m -79.37 169.43 18.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.088 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' N ' HG22 ' A' ' 2' ' ' THR . 88.1 m -147.67 128.39 14.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 110.648 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 89.8 m -126.52 141.26 39.6 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 109.923 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.8 Cg_endo -72.0 -6.69 19.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.99 1.521 . . . . 0.0 111.488 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 10.9 p 176.41 161.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 34.3 mt -45.88 -29.88 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.892 . . . . 0.0 109.456 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.7 t -52.19 -62.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.9 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -67.03 -53.35 32.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.153 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -43.63 -33.37 1.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 33.0 t -70.8 -49.44 46.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.311 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.495 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 7.3 m-20 -63.82 -56.86 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 1.1 t80 -40.95 -42.06 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 109.8 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -83.82 -24.26 31.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.919 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -72.25 -31.41 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.802 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.707 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.84 -27.14 23.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -86.5 -2.08 58.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.274 -0.892 . . . . 0.0 109.757 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.4 mt -77.1 -45.19 2.81 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.343 -0.848 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -71.75 -81.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.523 1.275 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.93 29.09 0.59 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.39 -1.386 . . . . 0.0 109.984 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.707 HG21 ' SG ' ' A' ' 16' ' ' CYS . 1.9 m -101.01 142.61 24.97 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.921 -1.341 . . . . 0.0 110.444 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.5 Cg_endo -74.93 126.1 9.79 Favored 'Trans proline' 0 C--N 1.286 -2.73 0 O-C-N 124.622 1.854 . . . . 0.0 108.555 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -34.23 -27.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.947 0.403 . . . . 0.0 111.532 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.56 -48.31 82.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.912 -1.117 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -70.17 -39.1 75.48 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.176 -0.953 . . . . 0.0 110.203 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 59.0 m -61.22 -30.48 70.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.625 -0.672 . . . . 0.0 111.826 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.895 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -95.89 -11.3 26.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -26.79 30.76 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -89.64 -42.68 11.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.393 0.616 . . . . 0.0 109.95 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 27' ' ' ALA . 2.4 t -85.51 -13.74 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.949 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 109.11 -42.01 2.07 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.084 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.9 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 74.9 m -41.31 154.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.267 -1.137 . . . . 0.0 110.198 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.2 pt -142.61 147.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.016 -1.053 . . . . 0.0 110.627 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 HG12 ' OE2' ' A' ' 23' ' ' GLU . 3.0 mt -101.49 139.05 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.422 -0.799 . . . . 0.0 109.949 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -130.15 171.07 9.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.501 -179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 50.1 Cg_endo -76.79 6.25 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.079 1.568 . . . . 0.0 110.875 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.04 -142.97 13.61 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.11 16.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -1.043 . . . . 0.0 111.705 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -130.81 5.32 4.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' THR . 68.2 m 53.07 165.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.84 0 O-C-N 121.753 -0.592 . . . . 0.0 110.531 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.963 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 49.5 Cg_endo -74.51 -158.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.873 1.46 . . . . 0.0 110.187 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.11 -18.42 24.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 44' ' ' TYR . 21.5 p30 -96.04 -21.76 17.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.131 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.54 ' CG ' ' OD1' ' A' ' 43' ' ' ASP . 2.4 m-85 -121.9 26.6 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.963 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.75 30.74 0.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.4 -0.812 . . . . 0.0 110.595 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.09 179.796 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.544 HG21 ' CE1' ' A' ' 13' ' ' PHE . 97.7 m -111.38 149.69 30.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m -155.16 105.83 2.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 35.0 m -99.05 150.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.123 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 44.5 Cg_endo -69.36 -3.11 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 111.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.49 175.93 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.23 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.469 HG13 ' OD1' ' A' ' 46' ' ' ASN . 1.8 mp -67.09 -35.2 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.84 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 8' ' ' VAL . 3.2 t -68.32 -47.92 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.855 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.95 69.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.57 -42.91 33.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.478 -0.764 . . . . 0.0 109.196 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 21.5 p -57.93 -49.89 75.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.767 . . . . 0.0 109.907 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 3.1 m120 -66.66 -53.6 32.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.6 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 20.8 t80 -41.49 -45.9 3.35 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.519 0.676 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -74.14 -26.3 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -82.51 -25.27 33.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.891 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 21' ' ' THR . 8.0 tpt180 -85.09 -1.91 57.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -0.878 . . . . 0.0 109.295 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.641 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -70.67 -49.11 15.51 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.491 -0.756 . . . . 0.0 110.473 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 39.7 Cg_endo -69.12 -81.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.663 1.349 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.73 32.17 0.38 Allowed Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.729 HG21 ' SG ' ' A' ' 16' ' ' CYS . 3.6 m -101.1 137.22 19.65 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 121.147 -1.208 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.3 Cg_endo -73.08 124.62 9.7 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.481 1.779 . . . . 0.0 108.279 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 22' ' ' PRO . 71.0 mt-10 -31.84 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.269 0.557 . . . . 0.0 111.141 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -55.81 -52.1 65.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 110.062 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.2 OUTLIER -71.43 -26.71 62.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.609 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.6 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 61.6 m -71.54 -25.25 62.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -99.86 -17.39 17.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.082 -1.012 . . . . 0.0 109.357 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -81.24 -28.96 34.59 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -93.34 -37.18 12.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.379 -0.825 . . . . 0.0 109.904 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 27' ' ' ALA . 1.2 t -88.23 -9.49 52.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 103.99 -40.46 2.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.861 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 41.9 t -42.58 159.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -1.201 . . . . 0.0 110.218 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 3' ' ' CYS . 2.5 pp -143.28 144.46 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 110.944 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.0 142.17 17.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.55 -0.719 . . . . 0.0 109.59 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.05 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -145.94 136.56 12.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.74 62.45 7.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.967 1.509 . . . . 0.0 110.044 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 35' ' ' ILE . . . -176.63 137.41 3.58 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 15.01 4.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.596 -0.943 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -84.85 12.27 7.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.301 -0.874 . . . . 0.0 110.62 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.2 m -35.48 140.77 0.32 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 122.096 -0.377 . . . . 0.0 110.648 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' CG ' ' CD1' ' A' ' 44' ' ' TYR . 47.2 Cg_endo -72.27 -171.54 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.539 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.65 -0.56 69.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -108.09 -8.9 15.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' CD1' ' CG ' ' A' ' 41' ' ' PRO . 23.1 m-30 -119.7 5.44 11.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.58 30.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.437 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.832 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.549 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -136.61 176.98 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.195 . . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 40.4 m -154.19 144.56 22.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.569 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 11.4 m -144.97 141.82 17.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 40.5 Cg_endo -65.43 -8.61 19.47 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.098 1.578 . . . . 0.0 112.533 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 2.7 p 173.0 -170.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.446 -1.408 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 11' ' ' SER . 29.6 mm -65.38 -40.93 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.816 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 74.9 t -53.26 -56.9 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.415 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.911 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -62.36 -66.6 0.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.285 -0.884 . . . . 0.0 109.005 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' CD ' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -40.76 -48.77 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.541 -0.725 . . . . 0.0 110.344 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 15' ' ' VAL . 47.7 t -49.99 -60.6 2.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.963 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 42.3 m-20 -51.73 -62.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.651 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' C ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.71 -41.94 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.248 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -76.48 -19.66 57.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 109.329 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -83.31 -27.97 7.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.536 -0.728 . . . . 0.0 109.343 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.697 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.02 -19.81 36.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -5.83 59.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.593 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -63.91 -48.95 77.56 Favored Pre-proline 0 C--N 1.305 -1.362 0 O-C-N 121.48 -0.763 . . . . 0.0 111.03 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -71.63 -25.79 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.602 1.317 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.66 11.18 2.73 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.076 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.697 HG21 ' SG ' ' A' ' 16' ' ' CYS . 3.7 m -70.32 145.81 93.68 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.094 -1.239 . . . . 0.0 110.125 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 41.9 Cg_endo -75.32 122.91 7.34 Favored 'Trans proline' 0 C--N 1.286 -2.754 0 O-C-N 124.556 1.819 . . . . 0.0 108.559 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 11.2 pt-20 -35.32 -26.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.044 0.45 . . . . 0.0 111.279 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.42 -50.32 74.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.957 -1.089 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -18.98 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.061 -1.025 . . . . 0.0 110.131 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 48.3 m -80.89 -29.53 35.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.549 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.634 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -91.6 -12.37 34.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.71 -33.88 30.9 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -42.47 19.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.53 -0.731 . . . . 0.0 110.024 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 32' ' ' CYS . 4.1 t -84.21 -5.25 59.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.796 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 96.72 -30.29 9.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.911 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 23.3 m -48.47 177.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.251 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 pt -141.63 168.17 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 110.498 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 35' ' ' ILE . 7.4 mm -102.21 178.23 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.008 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.553 HG23 ' CB ' ' A' ' 1' ' ' THR . 0.9 OUTLIER -170.31 135.98 1.21 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.123 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.92 -28.16 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.942 1.496 . . . . 0.0 110.648 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -124.92 -141.34 5.65 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.23 25.82 4.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.995 . . . . 0.0 110.328 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -78.48 7.21 7.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.504 -0.748 . . . . 0.0 110.879 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -41.87 163.33 0.12 Allowed Pre-proline 0 C--N 1.293 -1.871 0 O-C-N 121.627 -0.671 . . . . 0.0 110.183 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.1 Cg_endo -73.03 -164.7 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.805 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.11 -8.05 34.45 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.9 OUTLIER -95.4 -19.5 19.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.698 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.426 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 10.5 m-85 -119.12 17.86 13.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.512 -0.743 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.87 28.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.121 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.512 ' O ' ' CD ' ' A' ' 10' ' ' ARG . 7.8 t-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.142 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.463 ' OG1' HG13 ' A' ' 34' ' ' ILE . 7.2 t -126.77 167.22 16.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.853 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -157.68 112.02 2.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.638 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 16.8 m -94.75 164.09 20.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.88 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 45.3 Cg_endo -70.63 -4.87 15.48 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.018 1.536 . . . . 0.0 111.333 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 11.5 p -178.24 171.67 1.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.964 -1.085 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.459 HG12 ' OD1' ' A' ' 46' ' ' ASN . 41.3 mm -64.16 -34.49 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.413 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 87.1 t -68.14 -50.81 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' A' ' 5' ' ' PRO . . . -52.21 -34.32 44.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -79.98 -32.02 39.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.13 -46.15 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.585 -0.697 . . . . 0.0 109.682 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 4.0 m-20 -71.16 -47.34 58.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.308 -0.87 . . . . 0.0 109.085 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -51.57 -31.64 25.38 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.734 0.778 . . . . 0.0 109.507 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -81.84 -22.29 37.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -32.66 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.742 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.52 -28.08 28.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.522 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -88.03 5.13 42.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.445 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -75.45 -48.22 4.1 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.468 -0.77 . . . . 0.0 110.517 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -73.67 -84.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.732 1.385 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.44 29.66 0.63 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.742 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.1 m -91.32 142.01 26.69 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 120.729 -1.454 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.7 Cg_endo -72.56 125.63 10.79 Favored 'Trans proline' 0 C--N 1.283 -2.882 0 O-C-N 124.547 1.814 . . . . 0.0 108.594 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mt-10 -32.87 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.173 0.511 . . . . 0.0 111.259 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.15 -51.25 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.11 -32.72 74.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.016 . . . . 0.0 110.102 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 33.5 m -72.56 -36.72 68.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.948 . . . . 0.0 110.206 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.032 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -89.67 4.5 49.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.743 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -91.74 -40.17 11.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -86.18 -28.5 23.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.704 HG23 ' H ' ' A' ' 32' ' ' CYS . 2.1 t -93.23 -21.12 19.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.99 . . . . 0.0 110.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 104.49 -37.93 3.53 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.196 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 1.032 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 39.3 t -41.52 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -1.163 . . . . 0.0 110.466 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.36 148.18 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 0.0 110.394 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.7 mp -108.69 161.2 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.511 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 19.3 pt -151.15 167.32 13.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.947 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 41.5 Cg_endo -68.78 -20.88 39.18 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.771 1.406 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' ' CG2' ' A' ' 1' ' ' THR . . . 119.51 128.45 3.73 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.662 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.57 -89.57 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.885 -0.774 . . . . 0.0 109.366 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -156.42 2.51 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.024 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 39' ' ' THR . 71.2 m 53.05 160.04 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 110.901 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 51.4 Cg_endo -80.0 -157.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.62 1.326 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.26 -10.58 27.39 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 44' ' ' TYR . 19.0 p30 -104.74 -17.57 14.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -1.159 . . . . 0.0 109.96 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 10.4 m-85 -116.58 16.89 15.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.68 30.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 110.508 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.459 ' OD1' HG12 ' A' ' 7' ' ' ILE . 1.7 t-20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.835 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.816 HG23 HG12 ' A' ' 34' ' ' ILE . 3.3 m -94.41 160.69 14.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 2' ' ' THR . 66.1 m -151.71 111.99 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.558 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 88.0 m -111.01 144.42 30.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.728 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -74.42 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.044 1.549 . . . . 0.0 111.271 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -159.44 165.74 32.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.851 -1.156 . . . . 0.0 110.725 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -31.62 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 11.3 t -73.74 -53.79 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.932 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -42.35 -37.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.237 -0.914 . . . . 0.0 110.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -83.69 -37.85 22.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.411 -0.806 . . . . 0.0 109.182 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 6.2 m -54.39 -32.86 58.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.504 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 2.1 m120 -81.39 -50.12 9.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.035 . . . . 0.0 109.545 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.665 ' CZ ' HG21 ' A' ' 2' ' ' THR . 0.0 OUTLIER -54.35 -39.79 67.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.22 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.618 ' OD1' ' N ' ' A' ' 15' ' ' VAL . 4.7 p-10 -75.54 -24.52 56.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 t -80.41 -25.49 11.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.601 0.715 . . . . 0.0 109.346 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -83.19 -25.55 31.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 110.025 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' THR . 28.1 ttt180 -92.45 6.33 47.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.597 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -63.12 -43.88 82.52 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -75.32 -72.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.54 1.284 . . . . 0.0 110.685 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.59 26.4 0.14 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 16' ' ' CYS . 9.5 m -83.04 142.0 44.04 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 121.125 -1.22 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -74.03 119.3 5.78 Favored 'Trans proline' 0 C--N 1.285 -2.782 0 O-C-N 124.616 1.851 . . . . 0.0 108.686 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.614 ' HB2' HD13 ' A' ' 34' ' ' ILE . 11.1 pt-20 -34.82 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -60.74 -43.6 97.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -73.63 -37.33 65.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 110.371 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 64.3 m -73.0 -20.03 61.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -98.39 -18.18 18.43 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.272 1.035 . . . . 0.0 109.511 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -83.83 -26.33 29.62 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.032 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.15 -43.83 9.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.519 0.676 . . . . 0.0 109.847 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.2 t -81.26 -10.52 59.57 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.426 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 103.07 -39.75 2.68 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.563 ' H ' HG23 ' A' ' 30' ' ' THR . 48.9 m -40.4 160.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.285 -1.126 . . . . 0.0 110.632 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' C ' HG13 ' A' ' 34' ' ' ILE . 7.4 pt -127.83 158.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.98 -1.075 . . . . 0.0 109.777 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 2' ' ' THR . 64.2 mt -137.22 139.72 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 110.72 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.611 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.74 137.08 12.25 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.51 66.33 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.925 1.487 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.06 -139.68 2.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.47 24.33 0.08 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.602 -0.94 . . . . 0.0 109.937 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.31 11.31 24.06 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.757 0.789 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.69 151.22 4.34 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.774 -0.579 . . . . 0.0 110.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.6 -172.21 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.993 1.523 . . . . 0.0 110.48 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.2 55.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' A' ' 44' ' ' TYR . 4.4 p30 -116.07 -20.23 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.819 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' OD2' ' A' ' 43' ' ' ASP . 19.5 m-85 -115.38 4.59 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.419 -0.801 . . . . 0.0 109.747 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.87 32.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.875 . . . . 0.0 110.175 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.092 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.843 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.711 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.962 HG23 HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -134.98 117.57 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.456 . . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 134.48 55.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.904 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 24.1 m -105.18 152.03 39.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -73.06 -4.99 16.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 111.087 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.509 ' CA ' ' HB3' ' A' ' 46' ' ' ASN . 3.3 p -152.39 145.11 24.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -49.7 -39.22 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 109.214 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.33 -50.4 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.707 . . . . 0.0 109.776 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -51.25 -21.86 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.428 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -93.55 -36.27 12.49 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -47.42 81.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.278 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 25.0 p-10 -75.43 -36.09 60.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.906 ' CE1' HG21 ' A' ' 2' ' ' THR . 8.2 t80 -56.94 -42.92 80.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.409 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -75.86 -18.3 59.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.334 -0.853 . . . . 0.0 108.942 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -77.11 -23.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.467 0.651 . . . . 0.0 109.725 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.534 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.3 t -93.29 -21.51 19.54 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.523 -0.736 . . . . 0.0 110.52 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 6.3 ttt-85 -90.59 6.96 41.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.643 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -79.64 -41.78 1.5 Allowed Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.432 -0.792 . . . . 0.0 111.441 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -72.75 -18.07 25.35 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.379 1.199 . . . . 0.0 110.84 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.48 17.55 1.93 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.056 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 9.1 m -82.58 144.45 49.13 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.017 -1.284 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 40.3 Cg_endo -72.74 119.71 6.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 O-C-N 124.643 1.865 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' HD2' ' A' ' 17' ' ' ARG . 12.1 pt-20 -37.27 -25.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.104 0.478 . . . . 0.0 110.838 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -64.65 -43.2 94.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 109.924 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -76.63 -21.26 55.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.092 -1.005 . . . . 0.0 110.241 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 30' ' ' THR . 73.2 m -87.15 -11.96 48.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.31 -19.91 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.284 1.04 . . . . 0.0 109.12 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -91.07 -22.53 20.69 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.09 -27.65 14.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.206 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -99.98 -13.55 19.04 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.552 -0.718 . . . . 0.0 110.27 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.67 -37.86 3.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.991 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ALA . 6.2 t -46.96 176.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.636 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 44' ' ' TYR . 23.4 pt -138.39 154.88 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.943 -1.098 . . . . 0.0 110.455 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.962 HD13 HG23 ' A' ' 2' ' ' THR . 14.5 mm -102.82 168.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.017 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 34' ' ' ILE . 23.6 pt -158.24 144.23 12.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.347 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.6 -15.82 27.22 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.027 1.54 . . . . 0.0 110.029 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.72 -140.64 11.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -175.67 25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.397 -1.061 . . . . 0.0 110.839 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' O ' ' A' ' 40' ' ' CYS . 9.5 t -94.79 -15.87 23.45 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 39' ' ' THR . 54.3 m 53.13 122.99 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.676 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 42.7 Cg_endo -70.96 -170.72 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.518 1.273 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -13.16 64.81 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -97.76 -18.58 18.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -1.218 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 33' ' ' ILE . 9.6 m-85 -118.81 18.16 13.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -88.71 32.33 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.087 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' HB3' ' CA ' ' A' ' 6' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.12 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.844 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.406 HG23 ' CE2' ' A' ' 13' ' ' PHE . 4.4 m -126.99 131.21 51.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.882 ' SG ' HD11 ' A' ' 35' ' ' ILE . 10.9 m -119.02 123.69 45.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 84.1 m -136.3 150.94 72.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 43.0 Cg_endo -68.87 -8.53 23.74 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.694 1.365 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.498 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 3.1 m -174.58 160.27 3.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.013 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 7.7 mt -50.74 -42.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.611 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.7 t -56.13 -58.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 109.899 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -45.98 -47.81 16.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -68.43 -40.58 81.12 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.21 -52.63 34.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.758 . . . . 0.0 109.824 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.76 -56.54 20.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.19 -37.84 10.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.525 -0.735 . . . . 0.0 110.018 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -83.1 -22.13 33.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 11' ' ' SER . 1.2 t -87.76 -20.59 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.671 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.9 OUTLIER -85.46 -31.95 22.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.563 -0.711 . . . . 0.0 110.187 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 26.8 ttt-85 -88.73 7.37 34.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.164 -0.96 . . . . 0.0 109.279 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.609 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -63.65 -46.42 82.92 Favored Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.497 -0.752 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -73.87 -71.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.55 1.289 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.35 24.03 0.14 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.921 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.537 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 10.0 m -82.99 142.36 44.54 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 120.932 -1.334 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -73.87 118.38 5.41 Favored 'Trans proline' 0 C--N 1.286 -2.757 0 O-C-N 124.606 1.845 . . . . 0.0 108.542 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 18.6 pt-20 -36.37 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.039 0.447 . . . . 0.0 111.046 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.52 -42.53 99.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.028 -1.045 . . . . 0.0 109.67 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -73.18 -41.58 63.7 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.179 -0.951 . . . . 0.0 110.545 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.7 m -66.75 -24.24 66.19 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 111.061 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -97.74 -7.85 29.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.0 109.467 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.3 -24.74 19.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.9 t80 -95.52 -32.73 12.71 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 32' ' ' CYS . 0.8 OUTLIER -95.24 -10.48 30.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 110.179 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 100.34 -38.82 2.96 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.843 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 20.3 m -43.13 166.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.112 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.509 HG23 ' C ' ' A' ' 32' ' ' CYS . 2.1 pp -150.43 148.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.053 -1.029 . . . . 0.0 110.297 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -108.22 146.83 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 0.0 110.263 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.882 HD11 ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -130.81 174.83 4.21 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.258 -0.901 . . . . 0.0 110.114 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 35' ' ' ILE . 42.4 Cg_endo -70.93 -32.59 13.45 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.55 . . . . 0.0 110.525 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 140.53 134.28 3.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . 174.81 -80.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.612 -0.934 . . . . 0.0 109.735 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -174.32 18.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.61 -0.681 . . . . 0.0 111.315 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.3 m 56.14 166.05 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.439 -0.788 . . . . 0.0 109.363 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 45.8 Cg_endo -72.59 -158.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.933 1.491 . . . . 0.0 109.924 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.68 -29.76 3.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -81.57 -21.16 38.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.928 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 43' ' ' ASP . 2.8 m-85 -119.23 33.67 5.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.88 29.67 0.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.839 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 163.46 26.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.721 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 33' ' ' ILE . 5.9 p -158.24 144.18 17.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -125.9 147.88 60.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.287 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 46.9 Cg_endo -73.01 -0.61 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.008 1.531 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -156.22 157.11 35.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.093 -1.004 . . . . 0.0 110.413 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 mp -61.73 -33.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.926 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 5.3 t -70.01 -56.31 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.54 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -42.68 -36.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -81.61 -35.09 30.48 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -55.83 -42.27 75.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 109.565 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 15' ' ' VAL . 2.5 m120 -73.83 -52.87 11.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 0.0 109.297 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' C ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -42.81 -36.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.47 -0.769 . . . . 0.0 109.453 179.398 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -73.42 -31.5 63.87 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.84 0.829 . . . . 0.0 109.182 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -71.52 -22.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.553 0.692 . . . . 0.0 109.338 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.935 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -80.74 -34.02 34.71 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.615 -0.678 . . . . 0.0 110.716 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -74.52 -6.38 48.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 2.1 mt -71.7 -57.67 4.06 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.471 -0.768 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -71.28 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.007 1.53 . . . . 0.0 110.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.93 23.08 0.24 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.935 HG21 ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -84.0 125.39 72.88 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.221 -1.164 . . . . 0.0 110.997 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 38.7 Cg_endo -70.82 121.87 8.3 Favored 'Trans proline' 0 C--N 1.288 -2.651 0 O-C-N 124.286 1.677 . . . . 0.0 108.801 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.3 pt-20 -34.23 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.413 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.4 -40.35 77.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.374 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -65.61 -43.78 88.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 110.645 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.568 ' O ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -85.63 -23.81 27.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.071 -1.018 . . . . 0.0 111.427 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 32' ' ' CYS . . . -71.86 -27.17 62.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.764 -1.21 . . . . 0.0 108.711 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -80.28 -32.76 38.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.247 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -94.01 -35.26 12.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.448 -0.782 . . . . 0.0 110.56 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 26' ' ' CYS . 1.0 OUTLIER -82.3 -11.73 58.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.552 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 19.13 23.27 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.573 ' C ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.5 -179.32 3.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -1.169 . . . . 0.0 110.005 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.6 HD11 ' SG ' ' A' ' 40' ' ' CYS . 45.1 pt -154.78 144.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.061 -1.024 . . . . 0.0 110.178 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.3 mp -95.97 142.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.444 -0.785 . . . . 0.0 110.114 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.697 HD12 ' HB3' ' A' ' 38' ' ' ALA . 8.5 pt -147.74 153.85 43.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.842 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.86 58.84 4.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.975 1.513 . . . . 0.0 110.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.763 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 76.66 132.36 0.47 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . 163.38 -28.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.818 -0.813 . . . . 0.0 109.668 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.692 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 69.69 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.716 0.769 . . . . 0.0 110.378 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 57.71 178.3 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 110.383 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 40' ' ' CYS . 45.5 Cg_endo -70.8 -168.1 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.99 1.521 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.6 2.43 87.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -103.96 -28.83 11.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -1.159 . . . . 0.0 109.653 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' O ' ' HB2' ' A' ' 3' ' ' CYS . 14.8 m-85 -103.45 1.8 32.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.5 -0.75 . . . . 0.0 110.038 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.11 29.76 0.47 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 0.0 110.718 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 5.0 m-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.075 -0.965 . . . . 0.0 109.982 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.842 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 1.07 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -86.59 156.82 19.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.798 . . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 2' ' ' THR . 56.1 m -153.33 122.85 6.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 74.9 m -132.7 139.66 35.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.36 -2.6 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.883 1.465 . . . . 0.0 111.091 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -160.95 149.23 16.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.474 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 7' ' ' ILE . 49.1 mt -51.54 -32.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.727 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 9' ' ' ALA . 50.5 t -69.71 -55.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.738 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -43.12 -36.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.846 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -82.5 -44.14 16.32 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.35 -0.844 . . . . 0.0 108.91 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -39.44 41.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 2.5 m120 -68.58 -50.78 49.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 108.95 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 1.07 ' CE2' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -47.31 -42.31 20.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.58 -0.7 . . . . 0.0 109.407 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -78.0 -16.57 58.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.612 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -83.16 -25.4 8.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.591 -0.693 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.691 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.08 -26.97 22.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.545 -0.722 . . . . 0.0 110.386 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 21' ' ' THR . 4.4 ttt180 -91.02 9.97 28.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.326 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -73.11 -45.05 8.2 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.546 -0.721 . . . . 0.0 110.529 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.7 Cg_endo -75.81 -81.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.665 1.35 . . . . 0.0 110.776 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -150.86 36.43 0.9 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.996 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.691 HG21 ' SG ' ' A' ' 16' ' ' CYS . 12.0 m -106.46 134.44 19.8 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.921 -1.341 . . . . 0.0 110.403 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -71.18 119.86 6.59 Favored 'Trans proline' 0 C--N 1.286 -2.734 0 O-C-N 124.476 1.777 . . . . 0.0 109.051 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 10.3 mt-10 -28.91 -35.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.707 0.765 . . . . 0.0 111.116 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.7 -48.18 78.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.299 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -74.34 -19.39 60.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.014 . . . . 0.0 110.372 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 84.3 m -84.99 -19.31 32.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.248 -0.908 . . . . 0.0 110.742 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -96.47 -24.33 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.38 1.086 . . . . 0.0 109.208 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -85.3 -21.54 28.94 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.861 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -93.3 -30.95 14.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.619 -0.675 . . . . 0.0 109.639 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.1 t -95.43 -11.91 26.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 114.46 -39.36 2.83 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.367 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 66.2 m -48.24 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.333 -1.098 . . . . 0.0 111.028 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.492 ' CG2' ' C ' ' A' ' 32' ' ' CYS . 5.3 pt -151.68 157.58 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 24' ' ' ALA . 35.9 mt -135.32 142.36 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.478 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -138.79 163.92 43.27 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 46.6 Cg_endo -73.7 54.44 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.993 1.523 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 90.13 137.36 6.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 39' ' ' THR . . . 175.02 -28.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.959 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 73.64 -1.61 3.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.801 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' O ' ' A' ' 39' ' ' THR . 3.3 m 47.47 171.77 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.332 0.587 . . . . 0.0 111.915 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 44' ' ' TYR . 54.2 Cg_endo -75.04 -158.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.872 1.459 . . . . 0.0 110.098 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 7.65 59.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 -23.22 10.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 109.642 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.488 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 19.4 m-85 -110.48 9.17 23.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 110.066 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.95 30.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.847 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.844 HG21 ' CE1' ' A' ' 13' ' ' PHE . 86.0 m -135.65 131.9 36.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.463 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.3 m -132.13 99.68 4.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 109.883 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 37.2 m -97.06 159.98 30.13 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 42.1 Cg_endo -67.64 -9.19 24.62 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.97 1.511 . . . . 0.0 112.28 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 170.91 175.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.54 -1.35 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 11' ' ' SER . 27.0 mm -55.58 -40.16 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.483 -0.761 . . . . 0.0 109.797 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 11' ' ' SER . 78.9 t -54.44 -64.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.53 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -49.21 -65.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.206 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -44.48 -25.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.404 -0.81 . . . . 0.0 110.144 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 0.3 OUTLIER -69.04 -52.05 32.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.027 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.4 m-80 -70.45 -51.87 26.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.844 ' CE1' HG21 ' A' ' 2' ' ' THR . 38.1 t80 -42.31 -46.29 4.52 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.528 -0.733 . . . . 0.0 110.297 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -77.09 -20.57 55.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 109.622 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -81.24 -26.23 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 109.725 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -86.31 -22.82 26.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.173 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 21' ' ' THR . 16.2 tpt180 -89.28 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.742 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.642 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -68.34 -43.86 34.15 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.527 -0.733 . . . . 0.0 110.646 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -72.91 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.488 1.257 . . . . 0.0 110.857 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.64 28.75 0.18 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.696 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.4 m -96.2 142.27 24.32 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.2 Cg_endo -74.82 124.99 9.12 Favored 'Trans proline' 0 C--N 1.286 -2.741 0 O-C-N 124.622 1.854 . . . . 0.0 108.37 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 22' ' ' PRO . 81.6 mt-10 -33.29 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.125 0.488 . . . . 0.0 111.297 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.26 -49.55 76.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.021 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.61 -27.75 64.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.983 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -76.06 -32.82 59.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.446 -0.784 . . . . 0.0 110.572 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -94.13 -3.1 51.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 109.738 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -86.23 -36.81 19.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -88.21 -40.05 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.97 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.708 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.6 t -80.02 -16.95 54.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 110.239 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 101.6 -37.12 3.79 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.893 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 42.4 t -42.41 159.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -1.208 . . . . 0.0 110.195 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 3' ' ' CYS . 1.1 pp -137.05 145.61 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 1' ' ' THR . 4.0 mp -107.35 153.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.418 -0.801 . . . . 0.0 109.976 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.42 155.99 60.66 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.081 -1.012 . . . . 0.0 110.554 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.44 -1.27 11.1 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.083 1.57 . . . . 0.0 110.061 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.97 -141.83 3.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.96 47.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.986 . . . . 0.0 109.749 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.44 8.87 27.63 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.493 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 28.6 p -48.12 162.93 0.31 Allowed Pre-proline 0 C--N 1.291 -1.949 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.187 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 44.3 Cg_endo -69.78 162.18 43.06 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.839 1.442 . . . . 0.0 111.33 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 -8.33 78.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 10.8 m-20 -90.65 -21.33 21.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.239 . . . . 0.0 109.067 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' CD1' ' HG2' ' A' ' 41' ' ' PRO . 9.2 m-85 -119.61 10.58 11.79 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.519 0.676 . . . . 0.0 109.493 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.62 31.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 110.28 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.27 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.85 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.968 HG23 ' CE2' ' A' ' 13' ' ' PHE . 1.5 m -97.77 144.37 27.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 1.6 m -145.75 115.01 7.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.256 -0.903 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 1.7 m -106.28 158.46 32.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 48.3 Cg_endo -76.17 -21.89 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.193 1.628 . . . . 0.0 111.174 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 p -140.75 172.1 13.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.007 -1.058 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -69.92 -32.01 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.875 . . . . 0.0 110.019 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -64.3 -34.64 78.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -42.77 81.28 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -63.44 -45.77 89.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.753 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 15' ' ' VAL . 2.3 m120 -65.66 -53.18 44.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.968 ' CE2' HG23 ' A' ' 2' ' ' THR . 1.0 OUTLIER -44.65 -48.45 10.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.944 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.62 -14.43 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 0.0 109.637 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -84.58 -20.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 109.89 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.8 t -92.77 -22.41 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 0.0 110.567 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 5.0 mtp180 -85.38 0.6 51.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 109.597 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.62 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -67.82 -47.96 42.27 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 41.5 Cg_endo -69.45 -17.76 38.84 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.449 1.236 . . . . 0.0 110.836 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 19.99 3.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.568 HG21 ' SG ' ' A' ' 16' ' ' CYS . 6.3 m -77.27 145.85 73.4 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.361 -1.082 . . . . 0.0 110.295 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.0 Cg_endo -75.38 120.78 6.09 Favored 'Trans proline' 0 C--N 1.286 -2.744 0 O-C-N 124.593 1.839 . . . . 0.0 108.403 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.539 ' HG3' HG21 ' A' ' 34' ' ' ILE . 14.6 pm0 -35.68 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.973 0.416 . . . . 0.0 111.221 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.71 -52.13 66.82 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -42.94 97.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 109.759 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 27.8 m -70.22 -16.58 63.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -92.18 -7.19 49.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.241 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.0 -34.33 18.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -83.49 -39.69 20.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.429 -0.794 . . . . 0.0 109.632 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.473 HG21 ' CA ' ' A' ' 13' ' ' PHE 0.271 23.8 p -75.54 -26.62 58.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.45 -0.781 . . . . 0.0 110.429 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.23 14.26 64.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.498 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 33.2 m -93.86 -174.56 3.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -1.091 . . . . 0.0 110.389 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -144.62 151.86 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 27' ' ' ALA . 2.8 mp -111.2 138.89 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.398 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -125.36 171.77 7.11 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 44.5 Cg_endo -71.44 -26.35 20.39 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.99 1.521 . . . . 0.0 111.884 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.989 ' O ' HD13 ' A' ' 35' ' ' ILE . . . -151.28 -141.64 3.38 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.493 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.63 29.56 1.29 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.672 -0.899 . . . . 0.0 110.592 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.81 7.42 7.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 35' ' ' ILE . 55.7 m -51.15 151.13 5.09 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 121.587 -0.696 . . . . 0.0 110.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 50.1 Cg_endo -75.57 -159.66 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.883 1.465 . . . . 0.0 110.339 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 -13.04 25.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 3.9 m-20 -96.89 -16.15 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.922 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 15.4 m-85 -116.81 19.75 14.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 110.16 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.51 30.88 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.263 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.853 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.809 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.536 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 7.3 t -81.05 165.34 21.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 12.6 m -156.85 109.7 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 110.406 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.614 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -121.62 163.2 32.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 110.288 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.4 Cg_endo -72.04 -7.1 20.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.052 1.554 . . . . 0.0 111.063 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 5' ' ' PRO . 1.8 m -158.53 154.03 26.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.014 -1.054 . . . . 0.0 110.798 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 mt -61.75 -28.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.799 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.6 t -65.9 -48.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.614 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -58.83 -49.4 77.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.8 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -36.75 76.97 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.43 -39.89 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.672 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.497 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 2.4 m120 -72.75 -51.57 18.62 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.026 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -44.2 -50.37 8.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.529 -0.732 . . . . 0.0 109.568 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.69 -39.9 95.46 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 1.2 t -58.02 -25.81 27.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.615 0.721 . . . . 0.0 109.06 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.4 OUTLIER -86.01 -16.04 39.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.768 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 21' ' ' THR . 14.1 tpt180 -84.43 -7.21 59.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 109.355 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -56.07 -50.94 84.48 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.364 -0.835 . . . . 0.0 111.142 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.72 -25.7 23.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.604 1.318 . . . . 0.0 110.713 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.46 17.69 2.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.589 HG21 ' SG ' ' A' ' 16' ' ' CYS . 6.3 m -68.09 144.17 96.71 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.186 -1.185 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.5 Cg_endo -74.1 122.13 7.39 Favored 'Trans proline' 0 C--N 1.283 -2.886 0 O-C-N 124.517 1.798 . . . . 0.0 108.757 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -32.04 -31.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.138 0.494 . . . . 0.0 111.054 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.01 -47.59 77.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.134 -0.978 . . . . 0.0 109.371 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -68.66 -41.44 79.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.405 -0.809 . . . . 0.0 110.414 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 16.3 m -70.38 -25.0 63.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.344 -0.848 . . . . 0.0 110.809 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.887 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -96.02 -2.06 47.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.064 . . . . 0.0 109.685 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -101.98 -22.92 14.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -93.47 -29.05 15.75 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 32' ' ' CYS . 0.6 OUTLIER -102.91 -21.23 14.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.838 -0.539 . . . . 0.0 110.13 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 109.67 -35.0 5.14 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.481 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.887 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.2 m -41.38 160.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.119 -1.224 . . . . 0.0 110.542 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.2 pt -133.24 145.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.883 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 1' ' ' THR . 2.7 mp -110.42 147.37 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 110.825 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.37 147.57 31.45 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.561 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.03 69.57 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.851 1.448 . . . . 0.0 110.292 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.92 145.95 4.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.42 25.38 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.98 . . . . 0.0 110.523 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -84.99 14.13 5.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 110.625 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.6 m -38.79 161.57 0.07 OUTLIER Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.989 -0.444 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.1 Cg_endo -70.69 -161.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.884 1.465 . . . . 0.0 110.902 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.61 -5.25 26.11 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 1.3 t0 -93.63 -31.4 14.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -1.232 . . . . 0.0 110.039 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.539 ' CE2' ' HB3' ' A' ' 43' ' ' ASP . 2.3 m-85 -114.49 23.13 13.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.634 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.91 32.12 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.85 . . . . 0.0 110.509 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.687 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.621 HG23 ' CE1' ' A' ' 13' ' ' PHE . 97.2 m -89.14 133.48 34.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.097 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.568 ' SG ' HD12 ' A' ' 35' ' ' ILE . 41.4 m -137.69 93.49 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 109.985 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 29.0 m -105.45 161.75 21.83 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.393 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.6 Cg_endo -70.08 -10.2 27.75 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.173 1.617 . . . . 0.0 111.605 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 172.57 -169.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.257 . . . . 0.0 111.005 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 11' ' ' SER . 11.2 mm -65.76 -33.4 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.106 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.7 t -53.7 -66.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.818 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -60.32 -58.6 7.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.888 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -40.54 -37.06 0.65 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.533 -0.729 . . . . 0.0 110.318 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 6.2 t -76.12 -36.22 58.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' CB ' ' OG1' ' A' ' 30' ' ' THR . 68.7 m-20 -69.13 -63.01 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.621 ' CE1' HG23 ' A' ' 2' ' ' THR . 0.7 OUTLIER -47.41 -34.62 7.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 13.3 m-20 -78.14 -14.3 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -96.66 -19.57 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.442 -0.786 . . . . 0.0 110.034 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -91.28 -23.69 20.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.412 -0.805 . . . . 0.0 110.868 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 21' ' ' THR . 26.4 tpt180 -88.95 -8.21 54.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.499 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.1 mt -60.8 -45.17 96.8 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.488 -0.757 . . . . 0.0 110.75 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.1 Cg_endo -73.65 -76.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.635 1.334 . . . . 0.0 110.895 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.11 25.91 0.11 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.65 HG21 ' SG ' ' A' ' 16' ' ' CYS . 4.1 m -91.34 141.33 26.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.134 -1.215 . . . . 0.0 110.261 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.91 122.96 8.08 Favored 'Trans proline' 0 C--N 1.285 -2.773 0 O-C-N 124.557 1.819 . . . . 0.0 108.5 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' OE1' HG21 ' A' ' 34' ' ' ILE . 1.8 pt-20 -34.74 -28.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.052 0.453 . . . . 0.0 110.986 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.26 -47.47 85.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.09 -1.006 . . . . 0.0 109.524 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -20.34 60.44 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.316 -0.865 . . . . 0.0 109.837 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -86.95 -24.94 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -100.17 -3.52 31.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.305 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -97.18 -29.02 13.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -90.04 -33.57 16.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.2 t -93.19 -19.74 21.15 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.353 -0.842 . . . . 0.0 110.354 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 108.87 -42.16 2.03 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.405 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.811 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 43.1 t -43.79 166.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.31 . . . . 0.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' HG3' ' A' ' 41' ' ' PRO . 1.4 pt -145.59 146.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.571 HG21 ' OE1' ' A' ' 23' ' ' GLU . 2.9 mp -108.21 156.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.418 -0.801 . . . . 0.0 109.562 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.837 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -142.03 145.2 35.06 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.145 -0.972 . . . . 0.0 110.282 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.35 62.01 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.11 1.584 . . . . 0.0 110.518 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.91 -139.36 2.78 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -148.21 12.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.976 . . . . 0.0 110.481 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 106.33 13.52 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.251 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 76.0 m -74.83 164.46 61.23 Favored Pre-proline 0 C--N 1.291 -1.956 0 O-C-N 121.859 -0.526 . . . . 0.0 109.66 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.624 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.0 Cg_endo -74.06 -165.44 0.26 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.944 1.497 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.69 -25.22 10.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.508 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 2.4 m-20 -85.62 -23.47 27.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -1.183 . . . . 0.0 109.666 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.508 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 2.8 m-85 -121.59 35.72 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.367 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -84.25 29.22 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.444 -0.785 . . . . 0.0 110.87 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 8.1 t-20 . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.846 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.755 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.757 HG21 ' CD1' ' A' ' 13' ' ' PHE . 4.3 m -87.97 157.84 18.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -155.45 111.14 3.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 111.093 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.66 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -113.69 150.2 42.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 51.5 Cg_endo -78.63 30.86 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.75 1.395 . . . . 0.0 112.046 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.561 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 7.5 t -178.21 155.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 110.928 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.447 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 13.4 mt -65.53 -25.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.499 -0.751 . . . . 0.0 109.792 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 4.1 t -80.78 -54.03 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.803 . . . . 0.0 109.884 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.66 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -53.81 -48.13 70.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 109.495 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -68.51 -27.12 65.84 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.535 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.1 t -74.62 -45.23 46.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.152 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.54 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 9.9 m-20 -52.17 -48.67 64.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.464 -0.773 . . . . 0.0 108.967 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.757 ' CD1' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -52.96 -41.39 64.49 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.534 0.683 . . . . 0.0 109.629 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -75.04 -11.98 60.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.64 -23.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.587 -0.695 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.0 t -89.92 -17.11 28.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.64 0.99 55.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.899 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -55.41 -44.61 99.73 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.483 -0.76 . . . . 0.0 110.957 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.7 Cg_endo -76.62 -22.88 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.678 1.357 . . . . 0.0 110.852 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.58 15.2 2.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.583 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.3 m -65.3 145.16 99.11 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.975 -1.309 . . . . 0.0 110.293 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 42.3 Cg_endo -74.95 119.07 5.5 Favored 'Trans proline' 0 C--N 1.287 -2.685 0 O-C-N 124.613 1.849 . . . . 0.0 108.696 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 6.3 pt-20 -35.54 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.246 0.546 . . . . 0.0 110.528 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.18 -40.46 81.55 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.119 -0.988 . . . . 0.0 109.572 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -33.54 43.61 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 36.2 m -83.45 -17.88 40.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 111.155 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.82 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -100.85 -11.68 19.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 109.68 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.6 m -93.64 -25.47 17.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.85 -29.35 13.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.246 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -95.71 -16.59 21.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.439 -0.788 . . . . 0.0 110.36 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 110.95 -42.16 2.04 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.761 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.82 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 73.0 m -40.5 149.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.165 -1.197 . . . . 0.0 110.438 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 33' ' ' ILE . 18.2 pt -129.77 148.38 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.417 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.512 ' CD1' ' HG3' ' A' ' 23' ' ' GLU . 3.3 mp -113.29 151.34 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.764 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -145.79 162.69 34.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.8 Cg_endo -74.03 -3.82 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.83 1.437 . . . . 0.0 110.838 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.19 -142.65 12.54 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.94 7.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.469 -1.018 . . . . 0.0 111.233 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' CYS . 1.4 t -130.23 -2.63 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.798 -1.189 . . . . 0.0 111.101 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.609 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 9.0 p 37.64 -163.25 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 122.064 -0.398 . . . . 0.0 110.391 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.609 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 54.9 Cg_endo -79.24 176.98 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 122.84 0.916 . . . . 0.0 111.253 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.05 -2.34 66.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.41 -28.08 14.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 5.3 m-85 -114.36 23.69 12.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.31 -0.869 . . . . 0.0 109.544 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.493 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . -84.99 30.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.561 ' HB3' ' N ' ' A' ' 6' ' ' SER . 1.4 m-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.038 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.852 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.779 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.6 m -111.37 154.07 25.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -144.93 86.58 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.455 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 33.7 m -109.74 132.56 21.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.434 ' C ' ' OG ' ' A' ' 6' ' ' SER . 50.3 Cg_endo -76.18 47.57 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.862 1.454 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 179.47 121.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.084 -1.01 . . . . 0.0 109.903 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' OD1' ' A' ' 46' ' ' ASN . 43.6 mm -45.59 -32.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.007 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG12 ' OD1' ' A' ' 12' ' ' ASN . 31.0 t -79.3 -50.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.847 . . . . 0.0 109.951 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.421 ' CB ' ' OG ' ' A' ' 6' ' ' SER . . . -46.25 -31.1 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.901 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.35 -42.52 36.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.44 -0.787 . . . . 0.0 109.653 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.555 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -63.95 -53.85 43.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.388 -0.82 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' OD1' HG12 ' A' ' 8' ' ' VAL . 6.7 m120 -50.54 -50.54 53.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 1.1 t80 -51.06 -37.67 46.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -76.57 -15.18 59.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -23.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.641 -0.662 . . . . 0.0 109.739 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -89.05 -18.71 26.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.403 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -90.51 -5.67 55.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.627 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -64.51 -42.24 64.32 Favored Pre-proline 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 111.003 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 44.9 Cg_endo -74.15 -26.63 12.53 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.456 1.24 . . . . 0.0 110.604 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.65 10.96 1.98 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.236 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 16' ' ' CYS . 8.6 m -70.39 143.99 91.31 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.019 -1.283 . . . . 0.0 110.352 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -74.94 120.03 5.91 Favored 'Trans proline' 0 C--N 1.285 -2.811 0 O-C-N 124.627 1.856 . . . . 0.0 108.989 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 1.012 ' OE1' HD13 ' A' ' 34' ' ' ILE . 1.7 pp20? -32.74 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.957 0.408 . . . . 0.0 111.413 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.48 -40.67 95.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 0.0 109.396 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -73.66 -37.39 65.31 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 23.8 m -75.28 -19.84 59.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.894 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -95.7 -6.64 39.41 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.076 0.941 . . . . 0.0 109.524 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -29.21 19.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.29 -35.23 17.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.676 -0.64 . . . . 0.0 109.489 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 27' ' ' ALA 0.261 16.8 p -80.35 -23.62 40.42 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.396 -0.815 . . . . 0.0 110.284 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 23.45 47.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.693 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -116.85 175.1 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -1.029 . . . . 0.0 109.937 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 pp -132.95 148.0 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.012 HD13 ' OE1' ' A' ' 23' ' ' GLU . 3.3 mp -105.68 161.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.247 -0.908 . . . . 0.0 110.114 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.478 HG23 ' C ' ' A' ' 34' ' ' ILE . 48.6 pt -148.72 163.39 26.11 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 110.436 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.7 Cg_endo -70.12 -38.03 7.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.014 1.534 . . . . 0.0 110.198 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.54 130.77 1.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 39' ' ' THR . . . -174.2 17.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.603 -0.94 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 66.86 4.29 3.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 110.89 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.516 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER 56.14 142.61 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.778 -0.576 . . . . 0.0 110.867 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.9 Cg_endo -74.6 173.68 13.92 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.631 1.332 . . . . 0.0 110.054 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.23 -4.11 88.79 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.425 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 37.3 m-20 -102.0 -26.11 13.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -1.201 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 4.8 m-85 -118.12 21.14 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.8 30.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.455 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.998 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.778 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 t -113.27 169.4 8.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.497 ' O ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -157.54 102.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.133 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.85 159.34 41.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.136 -0.978 . . . . 0.0 110.49 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 49.4 Cg_endo -77.83 6.51 4.5 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.178 1.62 . . . . 0.0 111.246 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 5' ' ' PRO . 8.7 m -170.56 168.35 7.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.086 . . . . 0.0 110.815 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.614 ' N ' HD13 ' A' ' 7' ' ' ILE . 4.0 mm -68.76 -30.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.513 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 9' ' ' ALA . 10.4 t -80.89 -48.46 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.529 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -44.18 -36.71 2.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.184 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -78.0 -39.28 42.75 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.407 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 4.4 p -55.62 -48.05 75.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.587 -0.696 . . . . 0.0 110.216 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 7.7 p30 -69.93 -33.29 71.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.0 OUTLIER -59.75 -41.33 90.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 108.741 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -79.54 -30.38 41.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.516 0.674 . . . . 0.0 109.422 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.699 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -64.97 -32.82 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.533 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -80.83 -27.83 36.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.503 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 21' ' ' THR . 2.0 ttt180 -94.3 6.39 48.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.299 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -74.16 -41.95 5.38 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.587 -0.695 . . . . 0.0 110.958 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -74.8 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.479 1.252 . . . . 0.0 110.941 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.19 24.84 0.2 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 7.6 m -94.95 141.42 23.25 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 120.995 -1.297 . . . . 0.0 110.255 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -73.7 119.74 6.07 Favored 'Trans proline' 0 C--N 1.285 -2.797 0 O-C-N 124.648 1.867 . . . . 0.0 108.793 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -35.13 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.225 0.536 . . . . 0.0 110.849 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.85 -45.58 93.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.848 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -70.85 -36.09 72.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 110.51 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.2 m -74.44 -23.46 58.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.689 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.667 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -96.0 -12.57 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.997 . . . . 0.0 109.761 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.1 m -95.13 -21.64 18.38 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -99.58 -20.46 16.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.497 ' HG1' ' CG ' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -111.55 -7.28 14.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.56 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 104.18 -34.48 5.75 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.686 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.667 ' C ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -46.15 174.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.027 -1.278 . . . . 0.0 110.42 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 32' ' ' CYS . 28.3 pt -158.32 145.74 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.772 ' O ' HG23 ' A' ' 35' ' ' ILE . 4.8 mp -106.41 140.48 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 110.138 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.024 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.2 pp -160.98 134.1 4.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 110.186 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.98 70.81 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.918 1.483 . . . . 0.0 110.448 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' HD13 ' A' ' 35' ' ' ILE . . . 168.87 138.27 2.44 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.48 15.35 5.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -81.9 10.29 6.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.524 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -40.57 163.53 0.09 OUTLIER Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.874 -0.516 . . . . 0.0 110.264 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 42.7 Cg_endo -69.8 169.28 19.34 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.068 1.562 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.69 61.83 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 43.4 p-10 -112.0 -19.86 12.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.03 -1.276 . . . . 0.0 109.519 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 16.2 m-85 -123.27 17.94 9.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.614 -0.678 . . . . 0.0 109.444 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.4 32.55 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.489 -0.757 . . . . 0.0 110.338 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 17.7 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.337 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.84 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.929 HG21 ' CE1' ' A' ' 13' ' ' PHE . 94.2 m -127.58 160.71 30.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.5 m -148.05 156.98 43.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 85.9 m -147.53 130.52 7.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 6' ' ' SER . 49.6 Cg_endo -77.74 25.26 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.977 1.514 . . . . 0.0 112.79 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER 174.25 164.95 0.21 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.254 -1.528 . . . . 0.0 111.059 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' SER . 56.4 mt -65.46 -30.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.508 -0.745 . . . . 0.0 109.328 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 64.8 t -66.74 -50.79 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.925 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -55.24 -66.15 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -51.75 -22.52 3.63 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.593 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 2.1 t -80.24 -63.33 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.565 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 10.3 p30 -61.65 -37.04 82.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.929 ' CE1' HG21 ' A' ' 2' ' ' THR . 0.2 OUTLIER -59.87 -44.92 93.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.942 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 1.5 p30 -69.46 -27.83 65.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.186 -0.946 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -23.25 28.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.664 ' SG ' HG21 ' A' ' 21' ' ' THR . 5.3 t -92.78 -22.93 19.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.697 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -91.1 5.23 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.556 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -65.89 -46.47 65.05 Favored Pre-proline 0 C--N 1.306 -1.29 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.4 Cg_endo -74.8 -71.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.614 1.323 . . . . 0.0 110.581 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.1 27.31 0.09 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.664 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.7 m -84.23 141.35 39.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.064 -1.256 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.6 Cg_endo -74.17 124.73 9.25 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 O-C-N 124.546 1.814 . . . . 0.0 108.242 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.821 ' OE2' HG23 ' A' ' 2' ' ' THR . 0.0 OUTLIER -39.98 -23.37 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.8 -0.563 . . . . 0.0 110.209 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.19 -51.23 68.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.089 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -29.09 66.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 110.576 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.676 ' O ' HG22 ' A' ' 30' ' ' THR . 27.8 m -78.63 -44.92 22.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.039 -1.038 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.889 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -68.89 -13.29 62.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.927 -1.108 . . . . 0.0 109.648 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.561 HG22 ' N ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -77.84 -47.03 19.8 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.537 0.684 . . . . 0.0 109.663 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' N ' HG22 ' A' ' 28' ' ' THR . 4.6 t80 -94.89 -41.03 9.4 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.616 0.722 . . . . 0.0 110.064 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -68.25 -31.87 71.65 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.438 -0.789 . . . . 0.0 110.357 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 124.26 -47.41 1.02 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.561 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.889 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 66.5 m -44.17 169.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.041 -1.27 . . . . 0.0 110.193 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.9 148.8 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.136 -0.977 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 24' ' ' ALA . 1.9 mp -80.39 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.587 HD13 ' SG ' ' A' ' 40' ' ' CYS . 1.1 pp -134.97 133.16 20.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.79 6.66 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.95 1.5 . . . . 0.0 110.388 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.23 -138.9 5.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.9 -48.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.995 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -102.65 2.06 35.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.012 . . . . 0.0 110.42 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.587 ' SG ' HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER 47.48 177.73 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.862 -0.524 . . . . 0.0 111.168 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.16 -157.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.032 1.543 . . . . 0.0 110.188 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.76 -8.54 54.23 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -19.33 14.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.246 . . . . 0.0 110.145 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 16.6 m-85 -114.25 10.27 17.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.11 31.38 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 23.2 t-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.757 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 t -92.82 171.32 9.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 33' ' ' ILE . 1.1 m -147.16 106.07 3.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.045 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 10' ' ' ARG . 1.2 m -99.58 144.07 27.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.917 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.8 Cg_endo -70.86 -3.35 12.56 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.951 1.5 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.483 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER 172.43 175.09 0.1 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.803 -1.186 . . . . 0.0 110.559 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 7' ' ' ILE . 30.9 mm -57.7 -36.08 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 110.05 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.49 -62.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -61.63 -54.24 45.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.944 . . . . 0.0 108.992 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.69 -52.63 4.84 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.302 -0.874 . . . . 0.0 109.555 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -64.45 -32.73 74.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.064 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.565 ' HB2' ' HA ' ' A' ' 9' ' ' ALA . 1.2 m-20 -59.85 -71.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.683 0.754 . . . . 0.0 109.83 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.649 ' CE2' ' CB ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -47.62 -33.64 6.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.562 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -70.35 -26.11 63.59 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.827 0.822 . . . . 0.0 109.165 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -70.95 -25.02 25.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.68 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.52 -22.64 26.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -74.05 -10.1 59.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.554 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.6 mt -72.4 -55.73 4.53 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.11 -34.14 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.732 1.385 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.6 7.9 1.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.68 HG21 ' SG ' ' A' ' 16' ' ' CYS . 32.9 m -65.26 131.61 95.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 120.91 -1.347 . . . . 0.0 110.363 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 40.3 Cg_endo -72.23 116.99 4.92 Favored 'Trans proline' 0 C--N 1.288 -2.647 0 O-C-N 124.431 1.753 . . . . 0.0 108.738 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 26.4 pt-20 -33.03 -31.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.433 0.635 . . . . 0.0 110.896 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.53 -43.08 99.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 110.734 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -72.15 -45.29 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.905 -1.122 . . . . 0.0 111.368 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -84.37 -15.45 46.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 0.0 111.763 -178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -75.99 -39.12 56.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.465 -1.397 . . . . 0.0 108.631 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -30.18 63.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.182 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 1.7 t80 -90.89 -48.36 7.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.805 . . . . 0.0 110.357 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 26' ' ' CYS . 1.2 t -66.67 -12.83 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.569 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.95 -43.95 1.61 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.447 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' GLY . 1.5 t -46.77 175.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -1.203 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.471 HD11 ' SG ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER -140.39 156.72 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.112 -0.992 . . . . 0.0 109.808 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 27' ' ' ALA . 73.5 mt -137.25 141.26 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.815 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.692 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -147.52 156.3 45.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 0.0 109.804 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.82 68.85 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.815 1.429 . . . . 0.0 110.046 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 149.11 4.97 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.37 32.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -1.006 . . . . 0.0 110.419 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' CYS . 1.5 t -84.06 14.35 4.26 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 110.768 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' THR . 62.4 m -36.19 154.75 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 122.095 -0.378 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 49.0 Cg_endo -73.97 -176.72 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.943 1.496 . . . . 0.0 110.33 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.23 4.87 82.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.96 -22.5 12.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -1.201 . . . . 0.0 109.872 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -117.87 14.93 14.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 109.838 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.12 29.21 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.824 . . . . 0.0 110.551 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' HB3' ' N ' ' A' ' 6' ' ' SER . 1.2 t-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.127 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.843 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.806 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 1.3 m -124.61 161.1 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -152.56 145.24 24.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.633 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -134.12 161.08 65.9 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.3 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 46.7 Cg_endo -73.59 -0.98 10.06 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.112 1.585 . . . . 0.0 111.607 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -176.17 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.669 -1.27 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -75.07 -31.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.968 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.2 t -65.61 -44.48 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -62.74 -70.22 0.22 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 109.049 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.84 -26.87 0.15 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.1 m -72.37 -61.78 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.621 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 36.3 p30 -58.14 -21.18 45.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.998 -1.064 . . . . 0.0 109.802 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.806 ' CZ ' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -72.47 -45.13 60.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.662 0.744 . . . . 0.0 109.101 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -73.56 -20.13 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.79 . . . . 0.0 109.048 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.24 -25.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.452 0.644 . . . . 0.0 109.653 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -84.57 -25.88 28.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.783 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 15.5 ttt180 -88.32 7.32 32.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.758 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.593 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -61.07 -43.69 91.67 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.454 -0.778 . . . . 0.0 110.829 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -76.98 -21.41 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.611 1.322 . . . . 0.0 110.834 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.49 12.99 1.93 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.222 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.548 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.7 m -65.63 144.8 99.01 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.063 -1.257 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.96 118.82 5.57 Favored 'Trans proline' 0 C--N 1.287 -2.693 0 O-C-N 124.614 1.849 . . . . 0.0 108.859 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 22' ' ' PRO . 75.2 mt-10 -36.34 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.145 0.498 . . . . 0.0 110.562 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.69 -38.85 89.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.195 -0.94 . . . . 0.0 109.953 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -30.88 32.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.049 -1.032 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.547 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 69.4 m -80.05 -14.44 58.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.05 . . . . 0.0 110.361 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.648 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -99.85 -27.47 13.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.371 1.081 . . . . 0.0 109.555 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -78.74 -23.58 45.33 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.798 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.8 t80 -102.28 -32.21 10.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.283 -0.885 . . . . 0.0 109.792 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.621 ' HG1' ' CG ' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -91.09 -5.11 55.62 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.03 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 105.64 -38.75 3.14 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.728 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.648 ' C ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -50.01 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.969 -1.312 . . . . 0.0 110.196 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.563 HG23 ' C ' ' A' ' 32' ' ' CYS . 1.2 pp -156.82 163.22 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.871 -1.143 . . . . 0.0 110.499 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' ILE . 7.4 mm -100.79 165.92 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.078 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.926 HG23 ' O ' ' A' ' 34' ' ' ILE . 1.3 pt -171.56 170.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 109.646 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.5 Cg_endo -69.75 -16.84 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.865 1.455 . . . . 0.0 110.139 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.746 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 105.03 141.04 10.6 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 74.6 -6.84 1.83 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.686 -0.891 . . . . 0.0 111.323 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' THR . 0.6 OUTLIER -96.78 10.87 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' SG ' HD11 ' A' ' 35' ' ' ILE . 52.0 m -62.32 130.1 92.87 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 110.112 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 43.7 Cg_endo -70.38 -165.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.817 1.43 . . . . 0.0 110.717 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.98 -14.01 55.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 43' ' ' ASP . 37.2 p-10 -98.18 -20.22 17.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -1.208 . . . . 0.0 109.498 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 11.9 m-85 -119.49 23.34 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.804 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -88.93 21.64 3.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 4.8 m120 . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.836 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.682 HG21 ' HE1' ' A' ' 13' ' ' PHE . 9.4 t -138.75 173.93 11.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.1 m -152.38 110.83 3.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.889 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.499 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 19.4 m -99.46 162.94 19.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.0 Cg_endo -71.41 -7.84 22.11 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 7' ' ' ILE . 9.0 t 175.14 -171.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.8 -1.187 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.2 mm -70.72 -33.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.1 t -55.54 -61.41 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.589 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -56.99 -66.46 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.64 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.499 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -41.99 -37.7 1.42 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.368 -0.833 . . . . 0.0 110.386 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 t -66.81 -49.71 64.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.949 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.481 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 12.2 m-20 -57.14 -59.34 5.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.682 ' HE1' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -50.09 -38.88 40.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.39 -0.819 . . . . 0.0 109.573 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 3.3 m-20 -68.4 -32.79 73.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.905 0.859 . . . . 0.0 108.866 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.49 -18.33 23.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.803 0.811 . . . . 0.0 108.966 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.874 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.89 -26.93 22.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.779 -0.575 . . . . 0.0 110.723 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.32 -9.17 58.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.532 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.2 mt -73.19 -56.55 3.23 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.606 -0.684 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.0 Cg_endo -70.26 -85.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.959 1.505 . . . . 0.0 110.825 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.58 27.32 0.22 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.874 HG21 ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -89.8 127.71 53.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.294 -1.121 . . . . 0.0 110.843 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.6 Cg_endo -71.86 121.29 7.49 Favored 'Trans proline' 0 C--N 1.286 -2.715 0 O-C-N 124.302 1.685 . . . . 0.0 108.78 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.627 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 8.5 pt-20 -34.03 -28.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.158 0.504 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.18 -43.5 74.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.01 -1.056 . . . . 0.0 110.887 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -69.61 -35.51 75.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 111.661 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -92.74 -14.59 27.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.658 -1.276 . . . . 0.0 111.196 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -82.02 -32.17 30.65 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.692 1.234 . . . . 0.0 107.925 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -79.19 -28.83 42.68 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.917 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -88.0 -33.69 18.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.468 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 26' ' ' CYS . 2.1 t -86.97 -12.15 48.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.085 . . . . 0.0 110.761 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 113.66 -46.26 1.2 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' ALA . 16.6 t -45.93 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -1.206 . . . . 0.0 110.036 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.74 153.18 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.901 ' O ' HG23 ' A' ' 35' ' ' ILE . 5.7 mm -90.28 163.68 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.256 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.901 HG23 ' O ' ' A' ' 34' ' ' ILE . 2.1 pt -167.7 156.82 8.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.44 -0.787 . . . . 0.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.16 -28.75 8.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.14 1.6 . . . . 0.0 109.918 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.32 -141.74 4.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.47 33.26 3.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -1.087 . . . . 0.0 110.033 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -79.45 9.03 5.24 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.676 -0.64 . . . . 0.0 111.133 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -43.45 165.87 0.11 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.69 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.629 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.3 Cg_endo -70.04 179.56 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.911 1.479 . . . . 0.0 111.187 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.61 -10.91 85.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 2.1 t0 -95.54 -19.93 19.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.672 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.563 ' CD2' ' CG ' ' A' ' 41' ' ' PRO . 11.3 m-85 -117.78 11.99 13.75 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.525 -0.734 . . . . 0.0 109.933 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.89 30.8 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.374 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.848 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 3' ' ' CYS . 47.3 m -79.37 169.43 18.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.088 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.48 ' N ' HG22 ' A' ' 2' ' ' THR . 88.1 m -147.67 128.39 14.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 110.648 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 89.8 m -126.52 141.26 39.6 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 109.923 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.8 Cg_endo -72.0 -6.69 19.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.99 1.521 . . . . 0.0 111.488 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 10.9 p 176.41 161.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 34.3 mt -45.88 -29.88 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.892 . . . . 0.0 109.456 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.7 t -52.19 -62.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.9 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -67.03 -53.35 32.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.153 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -43.63 -33.37 1.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 33.0 t -70.8 -49.44 46.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.311 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.495 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 7.3 m-20 -63.82 -56.86 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 1.1 t80 -40.95 -42.06 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 109.8 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -83.82 -24.26 31.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.919 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -72.25 -31.41 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.802 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.707 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.84 -27.14 23.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -86.5 -2.08 58.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.274 -0.892 . . . . 0.0 109.757 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.4 mt -77.1 -45.19 2.81 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.343 -0.848 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -71.75 -81.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.523 1.275 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.93 29.09 0.59 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.39 -1.386 . . . . 0.0 109.984 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.707 HG21 ' SG ' ' A' ' 16' ' ' CYS . 1.9 m -101.01 142.61 24.97 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.921 -1.341 . . . . 0.0 110.444 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.5 Cg_endo -74.93 126.1 9.79 Favored 'Trans proline' 0 C--N 1.286 -2.73 0 O-C-N 124.622 1.854 . . . . 0.0 108.555 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -34.23 -27.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.947 0.403 . . . . 0.0 111.532 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.56 -48.31 82.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.912 -1.117 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -70.17 -39.1 75.48 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.176 -0.953 . . . . 0.0 110.203 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 59.0 m -61.22 -30.48 70.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.625 -0.672 . . . . 0.0 111.826 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.895 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -95.89 -11.3 26.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -26.79 30.76 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -89.64 -42.68 11.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.393 0.616 . . . . 0.0 109.95 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 27' ' ' ALA . 2.4 t -85.51 -13.74 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.949 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 109.11 -42.01 2.07 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.084 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.9 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 74.9 m -41.31 154.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.267 -1.137 . . . . 0.0 110.198 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.2 pt -142.61 147.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.016 -1.053 . . . . 0.0 110.627 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 HG12 ' OE2' ' A' ' 23' ' ' GLU . 3.0 mt -101.49 139.05 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.422 -0.799 . . . . 0.0 109.949 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -130.15 171.07 9.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.501 -179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 50.1 Cg_endo -76.79 6.25 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.079 1.568 . . . . 0.0 110.875 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.04 -142.97 13.61 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.11 16.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -1.043 . . . . 0.0 111.705 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -130.81 5.32 4.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' THR . 68.2 m 53.07 165.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.84 0 O-C-N 121.753 -0.592 . . . . 0.0 110.531 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.963 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 49.5 Cg_endo -74.51 -158.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.873 1.46 . . . . 0.0 110.187 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.11 -18.42 24.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 44' ' ' TYR . 21.5 p30 -96.04 -21.76 17.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.131 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.54 ' CG ' ' OD1' ' A' ' 43' ' ' ASP . 2.4 m-85 -121.9 26.6 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.963 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.75 30.74 0.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.4 -0.812 . . . . 0.0 110.595 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.09 179.796 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.544 HG21 ' CE1' ' A' ' 13' ' ' PHE . 97.7 m -111.38 149.69 30.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m -155.16 105.83 2.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 35.0 m -99.05 150.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.123 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 44.5 Cg_endo -69.36 -3.11 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 111.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.49 175.93 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.23 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.469 HG13 ' OD1' ' A' ' 46' ' ' ASN . 1.8 mp -67.09 -35.2 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.84 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 8' ' ' VAL . 3.2 t -68.32 -47.92 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.855 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.95 69.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.57 -42.91 33.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.478 -0.764 . . . . 0.0 109.196 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 21.5 p -57.93 -49.89 75.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.767 . . . . 0.0 109.907 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 3.1 m120 -66.66 -53.6 32.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.6 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 20.8 t80 -41.49 -45.9 3.35 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.519 0.676 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -74.14 -26.3 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -82.51 -25.27 33.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.891 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 21' ' ' THR . 8.0 tpt180 -85.09 -1.91 57.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -0.878 . . . . 0.0 109.295 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.641 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -70.67 -49.11 15.51 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.491 -0.756 . . . . 0.0 110.473 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 39.7 Cg_endo -69.12 -81.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.663 1.349 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.73 32.17 0.38 Allowed Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.729 HG21 ' SG ' ' A' ' 16' ' ' CYS . 3.6 m -101.1 137.22 19.65 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 121.147 -1.208 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.3 Cg_endo -73.08 124.62 9.7 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.481 1.779 . . . . 0.0 108.279 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 22' ' ' PRO . 71.0 mt-10 -31.84 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.269 0.557 . . . . 0.0 111.141 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -55.81 -52.1 65.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 110.062 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.2 OUTLIER -71.43 -26.71 62.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.609 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.6 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 61.6 m -71.54 -25.25 62.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -99.86 -17.39 17.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.082 -1.012 . . . . 0.0 109.357 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -81.24 -28.96 34.59 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -93.34 -37.18 12.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.379 -0.825 . . . . 0.0 109.904 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 27' ' ' ALA . 1.2 t -88.23 -9.49 52.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 103.99 -40.46 2.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.861 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 41.9 t -42.58 159.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -1.201 . . . . 0.0 110.218 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 3' ' ' CYS . 2.5 pp -143.28 144.46 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 110.944 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.0 142.17 17.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.55 -0.719 . . . . 0.0 109.59 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.05 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -145.94 136.56 12.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.74 62.45 7.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.967 1.509 . . . . 0.0 110.044 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 35' ' ' ILE . . . -176.63 137.41 3.58 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 15.01 4.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.596 -0.943 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -84.85 12.27 7.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.301 -0.874 . . . . 0.0 110.62 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.2 m -35.48 140.77 0.32 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 122.096 -0.377 . . . . 0.0 110.648 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' CG ' ' CD1' ' A' ' 44' ' ' TYR . 47.2 Cg_endo -72.27 -171.54 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.539 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.65 -0.56 69.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -108.09 -8.9 15.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' CD1' ' CG ' ' A' ' 41' ' ' PRO . 23.1 m-30 -119.7 5.44 11.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.58 30.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.437 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.832 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.549 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -136.61 176.98 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.195 . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 40.4 m -154.19 144.56 22.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.569 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 11.4 m -144.97 141.82 17.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 40.5 Cg_endo -65.43 -8.61 19.47 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.098 1.578 . . . . 0.0 112.533 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 2.7 p 173.0 -170.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.446 -1.408 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 11' ' ' SER . 29.6 mm -65.38 -40.93 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.816 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 74.9 t -53.26 -56.9 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.415 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.911 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -62.36 -66.6 0.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.285 -0.884 . . . . 0.0 109.005 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' CD ' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -40.76 -48.77 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.541 -0.725 . . . . 0.0 110.344 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 15' ' ' VAL . 47.7 t -49.99 -60.6 2.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.963 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 42.3 m-20 -51.73 -62.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.651 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' C ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.71 -41.94 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.248 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -76.48 -19.66 57.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 109.329 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -83.31 -27.97 7.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.536 -0.728 . . . . 0.0 109.343 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.697 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.02 -19.81 36.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -5.83 59.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.593 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -63.91 -48.95 77.56 Favored Pre-proline 0 C--N 1.305 -1.362 0 O-C-N 121.48 -0.763 . . . . 0.0 111.03 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -71.63 -25.79 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.602 1.317 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.66 11.18 2.73 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.076 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.697 HG21 ' SG ' ' A' ' 16' ' ' CYS . 3.7 m -70.32 145.81 93.68 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.094 -1.239 . . . . 0.0 110.125 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 41.9 Cg_endo -75.32 122.91 7.34 Favored 'Trans proline' 0 C--N 1.286 -2.754 0 O-C-N 124.556 1.819 . . . . 0.0 108.559 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 11.2 pt-20 -35.32 -26.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.044 0.45 . . . . 0.0 111.279 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.42 -50.32 74.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.957 -1.089 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -18.98 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.061 -1.025 . . . . 0.0 110.131 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 48.3 m -80.89 -29.53 35.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.549 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.634 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -91.6 -12.37 34.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.71 -33.88 30.9 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -42.47 19.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.53 -0.731 . . . . 0.0 110.024 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 32' ' ' CYS . 4.1 t -84.21 -5.25 59.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.796 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 96.72 -30.29 9.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.911 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 23.3 m -48.47 177.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.251 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 pt -141.63 168.17 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 110.498 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 35' ' ' ILE . 7.4 mm -102.21 178.23 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.008 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.553 HG23 ' CB ' ' A' ' 1' ' ' THR . 0.9 OUTLIER -170.31 135.98 1.21 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.123 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.92 -28.16 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.942 1.496 . . . . 0.0 110.648 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -124.92 -141.34 5.65 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.23 25.82 4.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.995 . . . . 0.0 110.328 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -78.48 7.21 7.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.504 -0.748 . . . . 0.0 110.879 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -41.87 163.33 0.12 Allowed Pre-proline 0 C--N 1.293 -1.871 0 O-C-N 121.627 -0.671 . . . . 0.0 110.183 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.1 Cg_endo -73.03 -164.7 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.805 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.11 -8.05 34.45 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.9 OUTLIER -95.4 -19.5 19.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.698 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.426 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 10.5 m-85 -119.12 17.86 13.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.512 -0.743 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.87 28.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.121 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' O ' ' CD ' ' A' ' 10' ' ' ARG . 7.8 t-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.142 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.849 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.463 ' OG1' HG13 ' A' ' 34' ' ' ILE . 7.2 t -126.77 167.22 16.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.853 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -157.68 112.02 2.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.638 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 16.8 m -94.75 164.09 20.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.88 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 45.3 Cg_endo -70.63 -4.87 15.48 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.018 1.536 . . . . 0.0 111.333 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 11.5 p -178.24 171.67 1.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.964 -1.085 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.459 HG12 ' OD1' ' A' ' 46' ' ' ASN . 41.3 mm -64.16 -34.49 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.413 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 87.1 t -68.14 -50.81 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' A' ' 5' ' ' PRO . . . -52.21 -34.32 44.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -79.98 -32.02 39.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.13 -46.15 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.585 -0.697 . . . . 0.0 109.682 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 4.0 m-20 -71.16 -47.34 58.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.308 -0.87 . . . . 0.0 109.085 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -51.57 -31.64 25.38 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.734 0.778 . . . . 0.0 109.507 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -81.84 -22.29 37.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -32.66 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.742 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.52 -28.08 28.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.522 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -88.03 5.13 42.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.445 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -75.45 -48.22 4.1 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.468 -0.77 . . . . 0.0 110.517 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -73.67 -84.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.732 1.385 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.44 29.66 0.63 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.742 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.1 m -91.32 142.01 26.69 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 120.729 -1.454 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.7 Cg_endo -72.56 125.63 10.79 Favored 'Trans proline' 0 C--N 1.283 -2.882 0 O-C-N 124.547 1.814 . . . . 0.0 108.594 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mt-10 -32.87 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.173 0.511 . . . . 0.0 111.259 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.15 -51.25 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.11 -32.72 74.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.016 . . . . 0.0 110.102 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 33.5 m -72.56 -36.72 68.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.948 . . . . 0.0 110.206 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.032 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -89.67 4.5 49.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.743 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -91.74 -40.17 11.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -86.18 -28.5 23.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.704 HG23 ' H ' ' A' ' 32' ' ' CYS . 2.1 t -93.23 -21.12 19.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.99 . . . . 0.0 110.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 104.49 -37.93 3.53 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.196 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 1.032 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 39.3 t -41.52 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -1.163 . . . . 0.0 110.466 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.36 148.18 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 0.0 110.394 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.7 mp -108.69 161.2 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.511 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 19.3 pt -151.15 167.32 13.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.947 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 41.5 Cg_endo -68.78 -20.88 39.18 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.771 1.406 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' ' CG2' ' A' ' 1' ' ' THR . . . 119.51 128.45 3.73 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.662 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.57 -89.57 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.885 -0.774 . . . . 0.0 109.366 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -156.42 2.51 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.024 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 39' ' ' THR . 71.2 m 53.05 160.04 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 110.901 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 51.4 Cg_endo -80.0 -157.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.62 1.326 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.26 -10.58 27.39 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 44' ' ' TYR . 19.0 p30 -104.74 -17.57 14.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -1.159 . . . . 0.0 109.96 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 10.4 m-85 -116.58 16.89 15.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.68 30.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 110.508 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.459 ' OD1' HG12 ' A' ' 7' ' ' ILE . 1.7 t-20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.835 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.816 HG23 HG12 ' A' ' 34' ' ' ILE . 3.3 m -94.41 160.69 14.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 2' ' ' THR . 66.1 m -151.71 111.99 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.558 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 88.0 m -111.01 144.42 30.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.728 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -74.42 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.044 1.549 . . . . 0.0 111.271 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -159.44 165.74 32.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.851 -1.156 . . . . 0.0 110.725 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -31.62 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 11.3 t -73.74 -53.79 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.932 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -42.35 -37.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.237 -0.914 . . . . 0.0 110.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -83.69 -37.85 22.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.411 -0.806 . . . . 0.0 109.182 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 6.2 m -54.39 -32.86 58.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.504 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 2.1 m120 -81.39 -50.12 9.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.035 . . . . 0.0 109.545 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.665 ' CZ ' HG21 ' A' ' 2' ' ' THR . 0.0 OUTLIER -54.35 -39.79 67.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.22 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.618 ' OD1' ' N ' ' A' ' 15' ' ' VAL . 4.7 p-10 -75.54 -24.52 56.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 t -80.41 -25.49 11.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.601 0.715 . . . . 0.0 109.346 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -83.19 -25.55 31.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 110.025 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' THR . 28.1 ttt180 -92.45 6.33 47.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.597 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -63.12 -43.88 82.52 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -75.32 -72.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.54 1.284 . . . . 0.0 110.685 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.59 26.4 0.14 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 16' ' ' CYS . 9.5 m -83.04 142.0 44.04 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 121.125 -1.22 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -74.03 119.3 5.78 Favored 'Trans proline' 0 C--N 1.285 -2.782 0 O-C-N 124.616 1.851 . . . . 0.0 108.686 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.614 ' HB2' HD13 ' A' ' 34' ' ' ILE . 11.1 pt-20 -34.82 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -60.74 -43.6 97.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -73.63 -37.33 65.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 110.371 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 64.3 m -73.0 -20.03 61.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -98.39 -18.18 18.43 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.272 1.035 . . . . 0.0 109.511 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -83.83 -26.33 29.62 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.15 -43.83 9.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.519 0.676 . . . . 0.0 109.847 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.2 t -81.26 -10.52 59.57 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.426 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 103.07 -39.75 2.68 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.563 ' H ' HG23 ' A' ' 30' ' ' THR . 48.9 m -40.4 160.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.285 -1.126 . . . . 0.0 110.632 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' C ' HG13 ' A' ' 34' ' ' ILE . 7.4 pt -127.83 158.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.98 -1.075 . . . . 0.0 109.777 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 2' ' ' THR . 64.2 mt -137.22 139.72 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 110.72 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.611 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.74 137.08 12.25 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.51 66.33 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.925 1.487 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.06 -139.68 2.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.47 24.33 0.08 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.602 -0.94 . . . . 0.0 109.937 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.31 11.31 24.06 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.757 0.789 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.69 151.22 4.34 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.774 -0.579 . . . . 0.0 110.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.6 -172.21 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.993 1.523 . . . . 0.0 110.48 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.2 55.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' A' ' 44' ' ' TYR . 4.4 p30 -116.07 -20.23 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.819 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' OD2' ' A' ' 43' ' ' ASP . 19.5 m-85 -115.38 4.59 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.419 -0.801 . . . . 0.0 109.747 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.87 32.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.875 . . . . 0.0 110.175 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.092 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.843 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.711 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.962 HG23 HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -134.98 117.57 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.456 . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 134.48 55.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.904 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 24.1 m -105.18 152.03 39.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -73.06 -4.99 16.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 111.087 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.509 ' CA ' ' HB3' ' A' ' 46' ' ' ASN . 3.3 p -152.39 145.11 24.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -49.7 -39.22 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 109.214 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.33 -50.4 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.707 . . . . 0.0 109.776 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -51.25 -21.86 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.428 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -93.55 -36.27 12.49 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -47.42 81.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.278 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 25.0 p-10 -75.43 -36.09 60.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.906 ' CE1' HG21 ' A' ' 2' ' ' THR . 8.2 t80 -56.94 -42.92 80.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.409 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -75.86 -18.3 59.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.334 -0.853 . . . . 0.0 108.942 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -77.11 -23.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.467 0.651 . . . . 0.0 109.725 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.534 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.3 t -93.29 -21.51 19.54 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.523 -0.736 . . . . 0.0 110.52 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 6.3 ttt-85 -90.59 6.96 41.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.643 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -79.64 -41.78 1.5 Allowed Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.432 -0.792 . . . . 0.0 111.441 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -72.75 -18.07 25.35 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.379 1.199 . . . . 0.0 110.84 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.48 17.55 1.93 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.056 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 9.1 m -82.58 144.45 49.13 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.017 -1.284 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 40.3 Cg_endo -72.74 119.71 6.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 O-C-N 124.643 1.865 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' HD2' ' A' ' 17' ' ' ARG . 12.1 pt-20 -37.27 -25.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.104 0.478 . . . . 0.0 110.838 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -64.65 -43.2 94.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 109.924 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -76.63 -21.26 55.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.092 -1.005 . . . . 0.0 110.241 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 30' ' ' THR . 73.2 m -87.15 -11.96 48.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.31 -19.91 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.284 1.04 . . . . 0.0 109.12 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -91.07 -22.53 20.69 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.09 -27.65 14.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.206 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -99.98 -13.55 19.04 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.552 -0.718 . . . . 0.0 110.27 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.67 -37.86 3.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.991 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ALA . 6.2 t -46.96 176.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.636 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 44' ' ' TYR . 23.4 pt -138.39 154.88 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.943 -1.098 . . . . 0.0 110.455 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.962 HD13 HG23 ' A' ' 2' ' ' THR . 14.5 mm -102.82 168.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.017 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 34' ' ' ILE . 23.6 pt -158.24 144.23 12.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.347 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.6 -15.82 27.22 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.027 1.54 . . . . 0.0 110.029 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.72 -140.64 11.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -175.67 25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.397 -1.061 . . . . 0.0 110.839 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' O ' ' A' ' 40' ' ' CYS . 9.5 t -94.79 -15.87 23.45 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 39' ' ' THR . 54.3 m 53.13 122.99 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.676 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 42.7 Cg_endo -70.96 -170.72 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.518 1.273 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -13.16 64.81 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -97.76 -18.58 18.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -1.218 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 33' ' ' ILE . 9.6 m-85 -118.81 18.16 13.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -88.71 32.33 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.087 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' HB3' ' CA ' ' A' ' 6' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.12 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.844 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.406 HG23 ' CE2' ' A' ' 13' ' ' PHE . 4.4 m -126.99 131.21 51.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.882 ' SG ' HD11 ' A' ' 35' ' ' ILE . 10.9 m -119.02 123.69 45.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 84.1 m -136.3 150.94 72.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 43.0 Cg_endo -68.87 -8.53 23.74 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.694 1.365 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.498 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 3.1 m -174.58 160.27 3.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.013 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 7.7 mt -50.74 -42.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.611 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.7 t -56.13 -58.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 109.899 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -45.98 -47.81 16.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -68.43 -40.58 81.12 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.21 -52.63 34.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.758 . . . . 0.0 109.824 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.76 -56.54 20.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.19 -37.84 10.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.525 -0.735 . . . . 0.0 110.018 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -83.1 -22.13 33.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 11' ' ' SER . 1.2 t -87.76 -20.59 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.671 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.9 OUTLIER -85.46 -31.95 22.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.563 -0.711 . . . . 0.0 110.187 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 26.8 ttt-85 -88.73 7.37 34.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.164 -0.96 . . . . 0.0 109.279 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.609 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -63.65 -46.42 82.92 Favored Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.497 -0.752 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -73.87 -71.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.55 1.289 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.35 24.03 0.14 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.921 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.537 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 10.0 m -82.99 142.36 44.54 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 120.932 -1.334 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -73.87 118.38 5.41 Favored 'Trans proline' 0 C--N 1.286 -2.757 0 O-C-N 124.606 1.845 . . . . 0.0 108.542 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 18.6 pt-20 -36.37 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.039 0.447 . . . . 0.0 111.046 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.52 -42.53 99.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.028 -1.045 . . . . 0.0 109.67 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -73.18 -41.58 63.7 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.179 -0.951 . . . . 0.0 110.545 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.7 m -66.75 -24.24 66.19 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 111.061 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -97.74 -7.85 29.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.0 109.467 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.3 -24.74 19.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.9 t80 -95.52 -32.73 12.71 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 32' ' ' CYS . 0.8 OUTLIER -95.24 -10.48 30.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 110.179 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 100.34 -38.82 2.96 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.843 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 20.3 m -43.13 166.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.112 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.509 HG23 ' C ' ' A' ' 32' ' ' CYS . 2.1 pp -150.43 148.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.053 -1.029 . . . . 0.0 110.297 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -108.22 146.83 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 0.0 110.263 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.882 HD11 ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -130.81 174.83 4.21 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.258 -0.901 . . . . 0.0 110.114 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 35' ' ' ILE . 42.4 Cg_endo -70.93 -32.59 13.45 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.55 . . . . 0.0 110.525 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 140.53 134.28 3.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . 174.81 -80.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.612 -0.934 . . . . 0.0 109.735 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -174.32 18.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.61 -0.681 . . . . 0.0 111.315 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.3 m 56.14 166.05 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.439 -0.788 . . . . 0.0 109.363 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 45.8 Cg_endo -72.59 -158.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.933 1.491 . . . . 0.0 109.924 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.68 -29.76 3.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -81.57 -21.16 38.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.928 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 43' ' ' ASP . 2.8 m-85 -119.23 33.67 5.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.88 29.67 0.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.839 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 163.46 26.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.721 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 33' ' ' ILE . 5.9 p -158.24 144.18 17.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -125.9 147.88 60.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.287 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 46.9 Cg_endo -73.01 -0.61 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.008 1.531 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -156.22 157.11 35.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.093 -1.004 . . . . 0.0 110.413 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 mp -61.73 -33.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.926 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 5.3 t -70.01 -56.31 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.54 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -42.68 -36.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -81.61 -35.09 30.48 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -55.83 -42.27 75.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 109.565 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 15' ' ' VAL . 2.5 m120 -73.83 -52.87 11.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 0.0 109.297 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' C ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -42.81 -36.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.47 -0.769 . . . . 0.0 109.453 179.398 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -73.42 -31.5 63.87 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.84 0.829 . . . . 0.0 109.182 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -71.52 -22.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.553 0.692 . . . . 0.0 109.338 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.935 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -80.74 -34.02 34.71 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.615 -0.678 . . . . 0.0 110.716 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -74.52 -6.38 48.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 2.1 mt -71.7 -57.67 4.06 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.471 -0.768 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -71.28 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.007 1.53 . . . . 0.0 110.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.93 23.08 0.24 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.935 HG21 ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -84.0 125.39 72.88 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.221 -1.164 . . . . 0.0 110.997 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 38.7 Cg_endo -70.82 121.87 8.3 Favored 'Trans proline' 0 C--N 1.288 -2.651 0 O-C-N 124.286 1.677 . . . . 0.0 108.801 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.3 pt-20 -34.23 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.413 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.4 -40.35 77.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.374 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -65.61 -43.78 88.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 110.645 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.568 ' O ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -85.63 -23.81 27.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.071 -1.018 . . . . 0.0 111.427 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 32' ' ' CYS . . . -71.86 -27.17 62.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.764 -1.21 . . . . 0.0 108.711 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -80.28 -32.76 38.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.247 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -94.01 -35.26 12.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.448 -0.782 . . . . 0.0 110.56 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 26' ' ' CYS . 1.0 OUTLIER -82.3 -11.73 58.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.552 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 19.13 23.27 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.573 ' C ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.5 -179.32 3.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -1.169 . . . . 0.0 110.005 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.6 HD11 ' SG ' ' A' ' 40' ' ' CYS . 45.1 pt -154.78 144.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.061 -1.024 . . . . 0.0 110.178 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.3 mp -95.97 142.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.444 -0.785 . . . . 0.0 110.114 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.697 HD12 ' HB3' ' A' ' 38' ' ' ALA . 8.5 pt -147.74 153.85 43.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.842 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.86 58.84 4.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.975 1.513 . . . . 0.0 110.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.763 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 76.66 132.36 0.47 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . 163.38 -28.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.818 -0.813 . . . . 0.0 109.668 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.692 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 69.69 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.716 0.769 . . . . 0.0 110.378 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 57.71 178.3 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 110.383 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 40' ' ' CYS . 45.5 Cg_endo -70.8 -168.1 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.99 1.521 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.6 2.43 87.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -103.96 -28.83 11.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -1.159 . . . . 0.0 109.653 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' O ' ' HB2' ' A' ' 3' ' ' CYS . 14.8 m-85 -103.45 1.8 32.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.5 -0.75 . . . . 0.0 110.038 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.11 29.76 0.47 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 0.0 110.718 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 5.0 m-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.075 -0.965 . . . . 0.0 109.982 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.842 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 1.07 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -86.59 156.82 19.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.798 . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 2' ' ' THR . 56.1 m -153.33 122.85 6.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 74.9 m -132.7 139.66 35.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.36 -2.6 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.883 1.465 . . . . 0.0 111.091 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -160.95 149.23 16.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.474 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 7' ' ' ILE . 49.1 mt -51.54 -32.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.727 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 9' ' ' ALA . 50.5 t -69.71 -55.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.738 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -43.12 -36.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.846 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -82.5 -44.14 16.32 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.35 -0.844 . . . . 0.0 108.91 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -39.44 41.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 2.5 m120 -68.58 -50.78 49.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 108.95 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 1.07 ' CE2' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -47.31 -42.31 20.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.58 -0.7 . . . . 0.0 109.407 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -78.0 -16.57 58.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.612 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -83.16 -25.4 8.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.591 -0.693 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.691 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.08 -26.97 22.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.545 -0.722 . . . . 0.0 110.386 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 21' ' ' THR . 4.4 ttt180 -91.02 9.97 28.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.326 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -73.11 -45.05 8.2 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.546 -0.721 . . . . 0.0 110.529 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.7 Cg_endo -75.81 -81.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.665 1.35 . . . . 0.0 110.776 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -150.86 36.43 0.9 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.996 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.691 HG21 ' SG ' ' A' ' 16' ' ' CYS . 12.0 m -106.46 134.44 19.8 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.921 -1.341 . . . . 0.0 110.403 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -71.18 119.86 6.59 Favored 'Trans proline' 0 C--N 1.286 -2.734 0 O-C-N 124.476 1.777 . . . . 0.0 109.051 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 10.3 mt-10 -28.91 -35.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.707 0.765 . . . . 0.0 111.116 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.7 -48.18 78.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.299 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -74.34 -19.39 60.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.014 . . . . 0.0 110.372 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 84.3 m -84.99 -19.31 32.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.248 -0.908 . . . . 0.0 110.742 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -96.47 -24.33 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.38 1.086 . . . . 0.0 109.208 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -85.3 -21.54 28.94 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.861 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -93.3 -30.95 14.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.619 -0.675 . . . . 0.0 109.639 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.1 t -95.43 -11.91 26.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 114.46 -39.36 2.83 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.367 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 66.2 m -48.24 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.333 -1.098 . . . . 0.0 111.028 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.492 ' CG2' ' C ' ' A' ' 32' ' ' CYS . 5.3 pt -151.68 157.58 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 24' ' ' ALA . 35.9 mt -135.32 142.36 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.478 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -138.79 163.92 43.27 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 46.6 Cg_endo -73.7 54.44 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.993 1.523 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 90.13 137.36 6.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 39' ' ' THR . . . 175.02 -28.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.959 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 73.64 -1.61 3.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.801 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' O ' ' A' ' 39' ' ' THR . 3.3 m 47.47 171.77 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.332 0.587 . . . . 0.0 111.915 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 44' ' ' TYR . 54.2 Cg_endo -75.04 -158.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.872 1.459 . . . . 0.0 110.098 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 7.65 59.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 -23.22 10.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 109.642 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.488 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 19.4 m-85 -110.48 9.17 23.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 110.066 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.95 30.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.847 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.844 HG21 ' CE1' ' A' ' 13' ' ' PHE . 86.0 m -135.65 131.9 36.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.463 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.3 m -132.13 99.68 4.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 109.883 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 37.2 m -97.06 159.98 30.13 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 42.1 Cg_endo -67.64 -9.19 24.62 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.97 1.511 . . . . 0.0 112.28 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 170.91 175.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.54 -1.35 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 11' ' ' SER . 27.0 mm -55.58 -40.16 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.483 -0.761 . . . . 0.0 109.797 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 11' ' ' SER . 78.9 t -54.44 -64.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.53 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -49.21 -65.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.206 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -44.48 -25.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.404 -0.81 . . . . 0.0 110.144 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 0.3 OUTLIER -69.04 -52.05 32.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.027 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.4 m-80 -70.45 -51.87 26.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.844 ' CE1' HG21 ' A' ' 2' ' ' THR . 38.1 t80 -42.31 -46.29 4.52 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.528 -0.733 . . . . 0.0 110.297 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -77.09 -20.57 55.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 109.622 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -81.24 -26.23 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 109.725 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -86.31 -22.82 26.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.173 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 21' ' ' THR . 16.2 tpt180 -89.28 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.742 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.642 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -68.34 -43.86 34.15 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.527 -0.733 . . . . 0.0 110.646 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -72.91 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.488 1.257 . . . . 0.0 110.857 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.64 28.75 0.18 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.696 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.4 m -96.2 142.27 24.32 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.2 Cg_endo -74.82 124.99 9.12 Favored 'Trans proline' 0 C--N 1.286 -2.741 0 O-C-N 124.622 1.854 . . . . 0.0 108.37 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 22' ' ' PRO . 81.6 mt-10 -33.29 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.125 0.488 . . . . 0.0 111.297 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.26 -49.55 76.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.021 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.61 -27.75 64.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.983 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -76.06 -32.82 59.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.446 -0.784 . . . . 0.0 110.572 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -94.13 -3.1 51.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 109.738 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -86.23 -36.81 19.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -88.21 -40.05 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.97 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.708 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.6 t -80.02 -16.95 54.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 110.239 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 101.6 -37.12 3.79 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.893 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 42.4 t -42.41 159.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -1.208 . . . . 0.0 110.195 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 3' ' ' CYS . 1.1 pp -137.05 145.61 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 1' ' ' THR . 4.0 mp -107.35 153.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.418 -0.801 . . . . 0.0 109.976 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.42 155.99 60.66 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.081 -1.012 . . . . 0.0 110.554 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.44 -1.27 11.1 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.083 1.57 . . . . 0.0 110.061 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.97 -141.83 3.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.96 47.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.986 . . . . 0.0 109.749 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.44 8.87 27.63 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.493 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 28.6 p -48.12 162.93 0.31 Allowed Pre-proline 0 C--N 1.291 -1.949 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.187 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 44.3 Cg_endo -69.78 162.18 43.06 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.839 1.442 . . . . 0.0 111.33 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 -8.33 78.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 10.8 m-20 -90.65 -21.33 21.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.239 . . . . 0.0 109.067 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' CD1' ' HG2' ' A' ' 41' ' ' PRO . 9.2 m-85 -119.61 10.58 11.79 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.519 0.676 . . . . 0.0 109.493 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.62 31.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 110.28 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.27 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.85 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.968 HG23 ' CE2' ' A' ' 13' ' ' PHE . 1.5 m -97.77 144.37 27.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 1.6 m -145.75 115.01 7.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.256 -0.903 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 1.7 m -106.28 158.46 32.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 48.3 Cg_endo -76.17 -21.89 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.193 1.628 . . . . 0.0 111.174 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 p -140.75 172.1 13.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.007 -1.058 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -69.92 -32.01 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.875 . . . . 0.0 110.019 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -64.3 -34.64 78.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -42.77 81.28 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -63.44 -45.77 89.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.753 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 15' ' ' VAL . 2.3 m120 -65.66 -53.18 44.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.968 ' CE2' HG23 ' A' ' 2' ' ' THR . 1.0 OUTLIER -44.65 -48.45 10.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.944 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.62 -14.43 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 0.0 109.637 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -84.58 -20.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 109.89 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.8 t -92.77 -22.41 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 0.0 110.567 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 5.0 mtp180 -85.38 0.6 51.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 109.597 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.62 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -67.82 -47.96 42.27 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 41.5 Cg_endo -69.45 -17.76 38.84 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.449 1.236 . . . . 0.0 110.836 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 19.99 3.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.568 HG21 ' SG ' ' A' ' 16' ' ' CYS . 6.3 m -77.27 145.85 73.4 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.361 -1.082 . . . . 0.0 110.295 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.0 Cg_endo -75.38 120.78 6.09 Favored 'Trans proline' 0 C--N 1.286 -2.744 0 O-C-N 124.593 1.839 . . . . 0.0 108.403 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.539 ' HG3' HG21 ' A' ' 34' ' ' ILE . 14.6 pm0 -35.68 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.973 0.416 . . . . 0.0 111.221 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.71 -52.13 66.82 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -42.94 97.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 109.759 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 27.8 m -70.22 -16.58 63.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -92.18 -7.19 49.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.241 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.0 -34.33 18.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -83.49 -39.69 20.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.429 -0.794 . . . . 0.0 109.632 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.473 HG21 ' CA ' ' A' ' 13' ' ' PHE 0.271 23.8 p -75.54 -26.62 58.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.45 -0.781 . . . . 0.0 110.429 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.23 14.26 64.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.498 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 33.2 m -93.86 -174.56 3.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -1.091 . . . . 0.0 110.389 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -144.62 151.86 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 27' ' ' ALA . 2.8 mp -111.2 138.89 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.398 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -125.36 171.77 7.11 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 44.5 Cg_endo -71.44 -26.35 20.39 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.99 1.521 . . . . 0.0 111.884 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.989 ' O ' HD13 ' A' ' 35' ' ' ILE . . . -151.28 -141.64 3.38 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.493 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.63 29.56 1.29 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.672 -0.899 . . . . 0.0 110.592 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.81 7.42 7.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 35' ' ' ILE . 55.7 m -51.15 151.13 5.09 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 121.587 -0.696 . . . . 0.0 110.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 50.1 Cg_endo -75.57 -159.66 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.883 1.465 . . . . 0.0 110.339 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 -13.04 25.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 3.9 m-20 -96.89 -16.15 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.922 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 15.4 m-85 -116.81 19.75 14.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 110.16 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.51 30.88 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.263 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.853 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.809 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.536 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 7.3 t -81.05 165.34 21.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 12.6 m -156.85 109.7 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 110.406 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.614 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -121.62 163.2 32.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 110.288 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.4 Cg_endo -72.04 -7.1 20.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.052 1.554 . . . . 0.0 111.063 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 5' ' ' PRO . 1.8 m -158.53 154.03 26.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.014 -1.054 . . . . 0.0 110.798 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 mt -61.75 -28.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.799 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.6 t -65.9 -48.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.614 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -58.83 -49.4 77.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.8 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -36.75 76.97 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.43 -39.89 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.672 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.497 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 2.4 m120 -72.75 -51.57 18.62 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.026 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -44.2 -50.37 8.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.529 -0.732 . . . . 0.0 109.568 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.69 -39.9 95.46 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 1.2 t -58.02 -25.81 27.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.615 0.721 . . . . 0.0 109.06 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.4 OUTLIER -86.01 -16.04 39.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.768 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 21' ' ' THR . 14.1 tpt180 -84.43 -7.21 59.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 109.355 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -56.07 -50.94 84.48 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.364 -0.835 . . . . 0.0 111.142 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.72 -25.7 23.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.604 1.318 . . . . 0.0 110.713 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.46 17.69 2.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.589 HG21 ' SG ' ' A' ' 16' ' ' CYS . 6.3 m -68.09 144.17 96.71 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.186 -1.185 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.5 Cg_endo -74.1 122.13 7.39 Favored 'Trans proline' 0 C--N 1.283 -2.886 0 O-C-N 124.517 1.798 . . . . 0.0 108.757 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -32.04 -31.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.138 0.494 . . . . 0.0 111.054 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.01 -47.59 77.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.134 -0.978 . . . . 0.0 109.371 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -68.66 -41.44 79.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.405 -0.809 . . . . 0.0 110.414 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 16.3 m -70.38 -25.0 63.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.344 -0.848 . . . . 0.0 110.809 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.887 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -96.02 -2.06 47.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.064 . . . . 0.0 109.685 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -101.98 -22.92 14.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -93.47 -29.05 15.75 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 32' ' ' CYS . 0.6 OUTLIER -102.91 -21.23 14.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.838 -0.539 . . . . 0.0 110.13 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 109.67 -35.0 5.14 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.481 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.887 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.2 m -41.38 160.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.119 -1.224 . . . . 0.0 110.542 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.2 pt -133.24 145.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.883 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 1' ' ' THR . 2.7 mp -110.42 147.37 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 110.825 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.37 147.57 31.45 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.561 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.03 69.57 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.851 1.448 . . . . 0.0 110.292 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.92 145.95 4.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.42 25.38 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.98 . . . . 0.0 110.523 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -84.99 14.13 5.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 110.625 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.6 m -38.79 161.57 0.07 OUTLIER Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.989 -0.444 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.1 Cg_endo -70.69 -161.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.884 1.465 . . . . 0.0 110.902 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.61 -5.25 26.11 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 1.3 t0 -93.63 -31.4 14.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -1.232 . . . . 0.0 110.039 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.539 ' CE2' ' HB3' ' A' ' 43' ' ' ASP . 2.3 m-85 -114.49 23.13 13.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.634 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.91 32.12 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.85 . . . . 0.0 110.509 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.849 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.687 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.621 HG23 ' CE1' ' A' ' 13' ' ' PHE . 97.2 m -89.14 133.48 34.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.097 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.568 ' SG ' HD12 ' A' ' 35' ' ' ILE . 41.4 m -137.69 93.49 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 109.985 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 29.0 m -105.45 161.75 21.83 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.393 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.6 Cg_endo -70.08 -10.2 27.75 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.173 1.617 . . . . 0.0 111.605 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 172.57 -169.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.257 . . . . 0.0 111.005 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 11' ' ' SER . 11.2 mm -65.76 -33.4 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.106 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.7 t -53.7 -66.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.818 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -60.32 -58.6 7.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.888 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -40.54 -37.06 0.65 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.533 -0.729 . . . . 0.0 110.318 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 6.2 t -76.12 -36.22 58.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' CB ' ' OG1' ' A' ' 30' ' ' THR . 68.7 m-20 -69.13 -63.01 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.621 ' CE1' HG23 ' A' ' 2' ' ' THR . 0.7 OUTLIER -47.41 -34.62 7.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 13.3 m-20 -78.14 -14.3 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -96.66 -19.57 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.442 -0.786 . . . . 0.0 110.034 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -91.28 -23.69 20.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.412 -0.805 . . . . 0.0 110.868 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 21' ' ' THR . 26.4 tpt180 -88.95 -8.21 54.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.499 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.1 mt -60.8 -45.17 96.8 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.488 -0.757 . . . . 0.0 110.75 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.1 Cg_endo -73.65 -76.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.635 1.334 . . . . 0.0 110.895 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.11 25.91 0.11 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.65 HG21 ' SG ' ' A' ' 16' ' ' CYS . 4.1 m -91.34 141.33 26.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.134 -1.215 . . . . 0.0 110.261 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.91 122.96 8.08 Favored 'Trans proline' 0 C--N 1.285 -2.773 0 O-C-N 124.557 1.819 . . . . 0.0 108.5 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' OE1' HG21 ' A' ' 34' ' ' ILE . 1.8 pt-20 -34.74 -28.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.052 0.453 . . . . 0.0 110.986 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.26 -47.47 85.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.09 -1.006 . . . . 0.0 109.524 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -20.34 60.44 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.316 -0.865 . . . . 0.0 109.837 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -86.95 -24.94 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -100.17 -3.52 31.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.305 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -97.18 -29.02 13.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -90.04 -33.57 16.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.2 t -93.19 -19.74 21.15 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.353 -0.842 . . . . 0.0 110.354 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 108.87 -42.16 2.03 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.405 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.811 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 43.1 t -43.79 166.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.31 . . . . 0.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' HG3' ' A' ' 41' ' ' PRO . 1.4 pt -145.59 146.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.571 HG21 ' OE1' ' A' ' 23' ' ' GLU . 2.9 mp -108.21 156.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.418 -0.801 . . . . 0.0 109.562 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -142.03 145.2 35.06 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.145 -0.972 . . . . 0.0 110.282 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.35 62.01 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.11 1.584 . . . . 0.0 110.518 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.91 -139.36 2.78 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -148.21 12.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.976 . . . . 0.0 110.481 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 106.33 13.52 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.251 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 76.0 m -74.83 164.46 61.23 Favored Pre-proline 0 C--N 1.291 -1.956 0 O-C-N 121.859 -0.526 . . . . 0.0 109.66 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.624 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.0 Cg_endo -74.06 -165.44 0.26 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.944 1.497 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.69 -25.22 10.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.508 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 2.4 m-20 -85.62 -23.47 27.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -1.183 . . . . 0.0 109.666 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.508 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 2.8 m-85 -121.59 35.72 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.367 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -84.25 29.22 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.444 -0.785 . . . . 0.0 110.87 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.846 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.755 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.757 HG21 ' CD1' ' A' ' 13' ' ' PHE . 4.3 m -87.97 157.84 18.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -155.45 111.14 3.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 111.093 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.66 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -113.69 150.2 42.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 51.5 Cg_endo -78.63 30.86 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.75 1.395 . . . . 0.0 112.046 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.561 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 7.5 t -178.21 155.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 110.928 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.447 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 13.4 mt -65.53 -25.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.499 -0.751 . . . . 0.0 109.792 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 4.1 t -80.78 -54.03 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.803 . . . . 0.0 109.884 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.66 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -53.81 -48.13 70.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 109.495 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -68.51 -27.12 65.84 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.535 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.1 t -74.62 -45.23 46.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.152 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.54 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 9.9 m-20 -52.17 -48.67 64.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.464 -0.773 . . . . 0.0 108.967 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.757 ' CD1' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -52.96 -41.39 64.49 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.534 0.683 . . . . 0.0 109.629 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -75.04 -11.98 60.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.64 -23.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.587 -0.695 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.0 t -89.92 -17.11 28.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.64 0.99 55.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.899 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -55.41 -44.61 99.73 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.483 -0.76 . . . . 0.0 110.957 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.7 Cg_endo -76.62 -22.88 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.678 1.357 . . . . 0.0 110.852 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.58 15.2 2.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.583 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.3 m -65.3 145.16 99.11 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.975 -1.309 . . . . 0.0 110.293 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 42.3 Cg_endo -74.95 119.07 5.5 Favored 'Trans proline' 0 C--N 1.287 -2.685 0 O-C-N 124.613 1.849 . . . . 0.0 108.696 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 6.3 pt-20 -35.54 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.246 0.546 . . . . 0.0 110.528 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.18 -40.46 81.55 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.119 -0.988 . . . . 0.0 109.572 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -33.54 43.61 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 36.2 m -83.45 -17.88 40.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 111.155 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.82 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -100.85 -11.68 19.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 109.68 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.6 m -93.64 -25.47 17.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.85 -29.35 13.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.246 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -95.71 -16.59 21.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.439 -0.788 . . . . 0.0 110.36 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 110.95 -42.16 2.04 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.761 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.82 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 73.0 m -40.5 149.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.165 -1.197 . . . . 0.0 110.438 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 33' ' ' ILE . 18.2 pt -129.77 148.38 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.417 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.512 ' CD1' ' HG3' ' A' ' 23' ' ' GLU . 3.3 mp -113.29 151.34 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.764 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -145.79 162.69 34.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.8 Cg_endo -74.03 -3.82 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.83 1.437 . . . . 0.0 110.838 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.19 -142.65 12.54 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.94 7.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.469 -1.018 . . . . 0.0 111.233 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' CYS . 1.4 t -130.23 -2.63 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.798 -1.189 . . . . 0.0 111.101 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.609 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 9.0 p 37.64 -163.25 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 122.064 -0.398 . . . . 0.0 110.391 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.609 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 54.9 Cg_endo -79.24 176.98 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 122.84 0.916 . . . . 0.0 111.253 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.05 -2.34 66.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.41 -28.08 14.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 5.3 m-85 -114.36 23.69 12.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.31 -0.869 . . . . 0.0 109.544 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.493 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . -84.99 30.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.561 ' HB3' ' N ' ' A' ' 6' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.852 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.779 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.6 m -111.37 154.07 25.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -144.93 86.58 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.455 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 33.7 m -109.74 132.56 21.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' C ' ' OG ' ' A' ' 6' ' ' SER . 50.3 Cg_endo -76.18 47.57 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.862 1.454 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 179.47 121.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.084 -1.01 . . . . 0.0 109.903 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' OD1' ' A' ' 46' ' ' ASN . 43.6 mm -45.59 -32.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.007 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.745 HG12 HD21 ' A' ' 12' ' ' ASN . 31.0 t -79.3 -50.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.847 . . . . 0.0 109.951 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.421 ' CB ' ' OG ' ' A' ' 6' ' ' SER . . . -46.25 -31.1 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.901 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.35 -42.52 36.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.44 -0.787 . . . . 0.0 109.653 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.555 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -63.95 -53.85 43.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.388 -0.82 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.745 HD21 HG12 ' A' ' 8' ' ' VAL . 36.2 m-20 -50.54 -50.54 53.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 1.1 t80 -51.06 -37.67 46.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -76.57 -15.18 59.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -23.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.641 -0.662 . . . . 0.0 109.739 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -89.05 -18.71 26.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.403 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -90.51 -5.67 55.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.627 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -64.51 -42.24 64.32 Favored Pre-proline 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 111.003 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 44.9 Cg_endo -74.15 -26.63 12.53 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.456 1.24 . . . . 0.0 110.604 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.65 10.96 1.98 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.236 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 16' ' ' CYS . 8.6 m -70.39 143.99 91.31 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.019 -1.283 . . . . 0.0 110.352 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -74.94 120.03 5.91 Favored 'Trans proline' 0 C--N 1.285 -2.811 0 O-C-N 124.627 1.856 . . . . 0.0 108.989 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 1.012 ' OE1' HD13 ' A' ' 34' ' ' ILE . 1.7 pp20? -32.74 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.957 0.408 . . . . 0.0 111.413 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.48 -40.67 95.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 0.0 109.396 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -73.66 -37.39 65.31 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 23.8 m -75.28 -19.84 59.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.894 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -95.7 -6.64 39.41 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.076 0.941 . . . . 0.0 109.524 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -29.21 19.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.29 -35.23 17.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.676 -0.64 . . . . 0.0 109.489 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 27' ' ' ALA 0.261 16.8 p -80.35 -23.62 40.42 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.396 -0.815 . . . . 0.0 110.284 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 23.45 47.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.693 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -116.85 175.1 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -1.029 . . . . 0.0 109.937 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 pp -132.95 148.0 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.012 HD13 ' OE1' ' A' ' 23' ' ' GLU . 3.3 mp -105.68 161.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.247 -0.908 . . . . 0.0 110.114 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.478 HG23 ' C ' ' A' ' 34' ' ' ILE . 48.6 pt -148.72 163.39 26.11 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 110.436 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.7 Cg_endo -70.12 -38.03 7.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.014 1.534 . . . . 0.0 110.198 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.54 130.77 1.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 39' ' ' THR . . . -174.2 17.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.603 -0.94 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 66.86 4.29 3.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 110.89 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.516 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER 56.14 142.61 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.778 -0.576 . . . . 0.0 110.867 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.9 Cg_endo -74.6 173.68 13.92 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.631 1.332 . . . . 0.0 110.054 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.23 -4.11 88.79 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.425 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 37.3 m-20 -102.0 -26.11 13.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -1.201 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 4.8 m-85 -118.12 21.14 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.8 30.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.455 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.998 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.838 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.778 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 t -113.27 169.4 8.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.497 ' O ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -157.54 102.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.133 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.85 159.34 41.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.136 -0.978 . . . . 0.0 110.49 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 49.4 Cg_endo -77.83 6.51 4.5 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.178 1.62 . . . . 0.0 111.246 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 5' ' ' PRO . 8.7 m -170.56 168.35 7.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.086 . . . . 0.0 110.815 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.614 ' N ' HD13 ' A' ' 7' ' ' ILE . 4.0 mm -68.76 -30.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.513 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 9' ' ' ALA . 10.4 t -80.89 -48.46 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.529 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -44.18 -36.71 2.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.184 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -78.0 -39.28 42.75 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.407 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 4.4 p -55.62 -48.05 75.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.587 -0.696 . . . . 0.0 110.216 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 7.7 p30 -69.93 -33.29 71.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.0 OUTLIER -59.75 -41.33 90.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 108.741 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -79.54 -30.38 41.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.516 0.674 . . . . 0.0 109.422 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.699 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -64.97 -32.82 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.533 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -80.83 -27.83 36.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.503 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 21' ' ' THR . 2.0 ttt180 -94.3 6.39 48.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.299 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -74.16 -41.95 5.38 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.587 -0.695 . . . . 0.0 110.958 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -74.8 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.479 1.252 . . . . 0.0 110.941 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.19 24.84 0.2 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 7.6 m -94.95 141.42 23.25 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 120.995 -1.297 . . . . 0.0 110.255 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -73.7 119.74 6.07 Favored 'Trans proline' 0 C--N 1.285 -2.797 0 O-C-N 124.648 1.867 . . . . 0.0 108.793 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -35.13 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.225 0.536 . . . . 0.0 110.849 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.85 -45.58 93.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.848 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -70.85 -36.09 72.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 110.51 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.2 m -74.44 -23.46 58.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.689 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.667 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -96.0 -12.57 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.997 . . . . 0.0 109.761 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.1 m -95.13 -21.64 18.38 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -99.58 -20.46 16.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.497 ' HG1' ' CG ' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -111.55 -7.28 14.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.56 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 104.18 -34.48 5.75 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.686 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.667 ' C ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -46.15 174.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.027 -1.278 . . . . 0.0 110.42 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 32' ' ' CYS . 28.3 pt -158.32 145.74 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.772 ' O ' HG23 ' A' ' 35' ' ' ILE . 4.8 mp -106.41 140.48 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 110.138 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.024 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.2 pp -160.98 134.1 4.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 110.186 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.98 70.81 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.918 1.483 . . . . 0.0 110.448 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' HD13 ' A' ' 35' ' ' ILE . . . 168.87 138.27 2.44 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.48 15.35 5.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -81.9 10.29 6.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.524 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -40.57 163.53 0.09 OUTLIER Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.874 -0.516 . . . . 0.0 110.264 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 42.7 Cg_endo -69.8 169.28 19.34 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.068 1.562 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.69 61.83 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 43.4 p-10 -112.0 -19.86 12.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.03 -1.276 . . . . 0.0 109.519 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 16.2 m-85 -123.27 17.94 9.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.614 -0.678 . . . . 0.0 109.444 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.4 32.55 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.489 -0.757 . . . . 0.0 110.338 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 17.7 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.337 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.84 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.929 HG21 ' CE1' ' A' ' 13' ' ' PHE . 94.2 m -127.58 160.71 30.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.5 m -148.05 156.98 43.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 85.9 m -147.53 130.52 7.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 6' ' ' SER . 49.6 Cg_endo -77.74 25.26 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.977 1.514 . . . . 0.0 112.79 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER 174.25 164.95 0.21 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.254 -1.528 . . . . 0.0 111.059 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' SER . 56.4 mt -65.46 -30.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.508 -0.745 . . . . 0.0 109.328 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 64.8 t -66.74 -50.79 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.925 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -55.24 -66.15 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -51.75 -22.52 3.63 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.593 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 2.1 t -80.24 -63.33 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.565 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 10.3 p30 -61.65 -37.04 82.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.929 ' CE1' HG21 ' A' ' 2' ' ' THR . 0.2 OUTLIER -59.87 -44.92 93.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.942 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 1.5 p30 -69.46 -27.83 65.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.186 -0.946 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -23.25 28.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.664 ' SG ' HG21 ' A' ' 21' ' ' THR . 5.3 t -92.78 -22.93 19.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.697 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -91.1 5.23 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.556 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -65.89 -46.47 65.05 Favored Pre-proline 0 C--N 1.306 -1.29 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.4 Cg_endo -74.8 -71.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.614 1.323 . . . . 0.0 110.581 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.1 27.31 0.09 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.664 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.7 m -84.23 141.35 39.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.064 -1.256 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.6 Cg_endo -74.17 124.73 9.25 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 O-C-N 124.546 1.814 . . . . 0.0 108.242 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.821 ' OE2' HG23 ' A' ' 2' ' ' THR . 0.0 OUTLIER -39.98 -23.37 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.8 -0.563 . . . . 0.0 110.209 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.19 -51.23 68.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.089 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -29.09 66.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 110.576 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.676 ' O ' HG22 ' A' ' 30' ' ' THR . 27.8 m -78.63 -44.92 22.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.039 -1.038 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.889 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -68.89 -13.29 62.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.927 -1.108 . . . . 0.0 109.648 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.561 HG22 ' N ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -77.84 -47.03 19.8 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.537 0.684 . . . . 0.0 109.663 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' N ' HG22 ' A' ' 28' ' ' THR . 4.6 t80 -94.89 -41.03 9.4 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.616 0.722 . . . . 0.0 110.064 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -68.25 -31.87 71.65 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.438 -0.789 . . . . 0.0 110.357 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 124.26 -47.41 1.02 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.561 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.889 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 66.5 m -44.17 169.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.041 -1.27 . . . . 0.0 110.193 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.9 148.8 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.136 -0.977 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 24' ' ' ALA . 1.9 mp -80.39 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.587 HD13 ' SG ' ' A' ' 40' ' ' CYS . 1.1 pp -134.97 133.16 20.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.79 6.66 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.95 1.5 . . . . 0.0 110.388 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.23 -138.9 5.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.9 -48.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.995 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -102.65 2.06 35.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.012 . . . . 0.0 110.42 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.587 ' SG ' HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER 47.48 177.73 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.862 -0.524 . . . . 0.0 111.168 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.16 -157.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.032 1.543 . . . . 0.0 110.188 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.76 -8.54 54.23 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -19.33 14.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.246 . . . . 0.0 110.145 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 16.6 m-85 -114.25 10.27 17.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.11 31.38 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.429 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.9 t30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.838 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.757 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 t -92.82 171.32 9.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 33' ' ' ILE . 1.1 m -147.16 106.07 3.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.045 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 10' ' ' ARG . 1.2 m -99.58 144.07 27.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.917 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.8 Cg_endo -70.86 -3.35 12.56 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.951 1.5 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.483 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER 172.43 175.09 0.1 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.803 -1.186 . . . . 0.0 110.559 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 7' ' ' ILE . 30.9 mm -57.7 -36.08 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 110.05 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.49 -62.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -61.63 -54.24 45.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.944 . . . . 0.0 108.992 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.69 -52.63 4.84 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.302 -0.874 . . . . 0.0 109.555 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -64.45 -32.73 74.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.064 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.565 ' HB2' ' HA ' ' A' ' 9' ' ' ALA . 1.2 m-20 -59.85 -71.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.683 0.754 . . . . 0.0 109.83 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.649 ' CE2' ' CB ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -47.62 -33.64 6.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.562 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -70.35 -26.11 63.59 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.827 0.822 . . . . 0.0 109.165 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -70.95 -25.02 25.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.68 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.52 -22.64 26.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -74.05 -10.1 59.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.554 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.6 mt -72.4 -55.73 4.53 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.11 -34.14 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.732 1.385 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.6 7.9 1.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.68 HG21 ' SG ' ' A' ' 16' ' ' CYS . 32.9 m -65.26 131.61 95.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 120.91 -1.347 . . . . 0.0 110.363 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 40.3 Cg_endo -72.23 116.99 4.92 Favored 'Trans proline' 0 C--N 1.288 -2.647 0 O-C-N 124.431 1.753 . . . . 0.0 108.738 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 26.4 pt-20 -33.03 -31.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.433 0.635 . . . . 0.0 110.896 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.53 -43.08 99.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 110.734 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -72.15 -45.29 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.905 -1.122 . . . . 0.0 111.368 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -84.37 -15.45 46.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 0.0 111.763 -178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -75.99 -39.12 56.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.465 -1.397 . . . . 0.0 108.631 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -30.18 63.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.182 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 1.7 t80 -90.89 -48.36 7.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.805 . . . . 0.0 110.357 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 26' ' ' CYS . 1.2 t -66.67 -12.83 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.569 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.95 -43.95 1.61 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.447 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' GLY . 1.5 t -46.77 175.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -1.203 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.471 HD11 ' SG ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER -140.39 156.72 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.112 -0.992 . . . . 0.0 109.808 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 27' ' ' ALA . 73.5 mt -137.25 141.26 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.815 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.692 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -147.52 156.3 45.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 0.0 109.804 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.82 68.85 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.815 1.429 . . . . 0.0 110.046 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 149.11 4.97 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.37 32.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -1.006 . . . . 0.0 110.419 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' CYS . 1.5 t -84.06 14.35 4.26 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 110.768 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' THR . 62.4 m -36.19 154.75 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 122.095 -0.378 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 49.0 Cg_endo -73.97 -176.72 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.943 1.496 . . . . 0.0 110.33 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.23 4.87 82.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.96 -22.5 12.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -1.201 . . . . 0.0 109.872 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -117.87 14.93 14.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 109.838 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.12 29.21 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.824 . . . . 0.0 110.551 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' HB3' ' N ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.127 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.843 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.806 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 1.3 m -124.61 161.1 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -152.56 145.24 24.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.633 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -134.12 161.08 65.9 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.3 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 46.7 Cg_endo -73.59 -0.98 10.06 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.112 1.585 . . . . 0.0 111.607 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -176.17 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.669 -1.27 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -75.07 -31.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.968 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.2 t -65.61 -44.48 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -62.74 -70.22 0.22 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 109.049 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.84 -26.87 0.15 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.1 m -72.37 -61.78 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.621 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 36.3 p30 -58.14 -21.18 45.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.998 -1.064 . . . . 0.0 109.802 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.806 ' CZ ' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -72.47 -45.13 60.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.662 0.744 . . . . 0.0 109.101 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -73.56 -20.13 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.79 . . . . 0.0 109.048 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.24 -25.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.452 0.644 . . . . 0.0 109.653 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -84.57 -25.88 28.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.783 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 15.5 ttt180 -88.32 7.32 32.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.758 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.593 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -61.07 -43.69 91.67 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.454 -0.778 . . . . 0.0 110.829 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -76.98 -21.41 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.611 1.322 . . . . 0.0 110.834 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.49 12.99 1.93 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.222 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.548 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.7 m -65.63 144.8 99.01 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.063 -1.257 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.96 118.82 5.57 Favored 'Trans proline' 0 C--N 1.287 -2.693 0 O-C-N 124.614 1.849 . . . . 0.0 108.859 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 22' ' ' PRO . 75.2 mt-10 -36.34 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.145 0.498 . . . . 0.0 110.562 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.69 -38.85 89.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.195 -0.94 . . . . 0.0 109.953 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -30.88 32.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.049 -1.032 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.547 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 69.4 m -80.05 -14.44 58.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.05 . . . . 0.0 110.361 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.648 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -99.85 -27.47 13.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.371 1.081 . . . . 0.0 109.555 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -78.74 -23.58 45.33 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.798 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.8 t80 -102.28 -32.21 10.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.283 -0.885 . . . . 0.0 109.792 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.621 ' HG1' ' CG ' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -91.09 -5.11 55.62 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.03 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 105.64 -38.75 3.14 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.728 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.648 ' C ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -50.01 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.969 -1.312 . . . . 0.0 110.196 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.563 HG23 ' C ' ' A' ' 32' ' ' CYS . 1.2 pp -156.82 163.22 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.871 -1.143 . . . . 0.0 110.499 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' ILE . 7.4 mm -100.79 165.92 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.078 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.926 HG23 ' O ' ' A' ' 34' ' ' ILE . 1.3 pt -171.56 170.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 109.646 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.5 Cg_endo -69.75 -16.84 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.865 1.455 . . . . 0.0 110.139 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.746 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 105.03 141.04 10.6 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 74.6 -6.84 1.83 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.686 -0.891 . . . . 0.0 111.323 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' THR . 0.6 OUTLIER -96.78 10.87 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.497 ' SG ' HD11 ' A' ' 35' ' ' ILE . 52.0 m -62.32 130.1 92.87 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 110.112 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 43.7 Cg_endo -70.38 -165.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.817 1.43 . . . . 0.0 110.717 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.98 -14.01 55.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.492 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 37.2 p-10 -98.18 -20.22 17.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -1.208 . . . . 0.0 109.498 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 11.9 m-85 -119.49 23.34 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.804 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -88.93 21.64 3.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 4.8 m120 . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.836 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.682 HG21 ' HE1' ' A' ' 13' ' ' PHE . 9.4 t -138.75 173.93 11.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.1 m -152.38 110.83 3.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.889 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.499 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 19.4 m -99.46 162.94 19.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.0 Cg_endo -71.41 -7.84 22.11 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.531 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 9.0 t 175.14 -171.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.8 -1.187 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.2 mm -70.72 -33.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.1 t -55.54 -61.41 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.589 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -56.99 -66.46 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.64 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.499 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -41.99 -37.7 1.42 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.368 -0.833 . . . . 0.0 110.386 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 t -66.81 -49.71 64.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.949 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.481 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 12.2 m-20 -57.14 -59.34 5.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.682 ' HE1' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -50.09 -38.88 40.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.39 -0.819 . . . . 0.0 109.573 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 3.3 m-20 -68.4 -32.79 73.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.905 0.859 . . . . 0.0 108.866 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.49 -18.33 23.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.803 0.811 . . . . 0.0 108.966 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.874 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.89 -26.93 22.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.779 -0.575 . . . . 0.0 110.723 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.32 -9.17 58.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.532 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.2 mt -73.19 -56.55 3.23 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.606 -0.684 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.0 Cg_endo -70.26 -85.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.959 1.505 . . . . 0.0 110.825 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.58 27.32 0.22 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.874 HG21 ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -89.8 127.71 53.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.294 -1.121 . . . . 0.0 110.843 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.6 Cg_endo -71.86 121.29 7.49 Favored 'Trans proline' 0 C--N 1.286 -2.715 0 O-C-N 124.302 1.685 . . . . 0.0 108.78 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.627 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 8.5 pt-20 -34.03 -28.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.158 0.504 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.18 -43.5 74.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.01 -1.056 . . . . 0.0 110.887 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -69.61 -35.51 75.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 111.661 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -92.74 -14.59 27.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.658 -1.276 . . . . 0.0 111.196 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -82.02 -32.17 30.65 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.692 1.234 . . . . 0.0 107.925 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -79.19 -28.83 42.68 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.917 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -88.0 -33.69 18.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.468 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 26' ' ' CYS . 2.1 t -86.97 -12.15 48.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.085 . . . . 0.0 110.761 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 113.66 -46.26 1.2 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' ALA . 16.6 t -45.93 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -1.206 . . . . 0.0 110.036 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.74 153.18 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.901 ' O ' HG23 ' A' ' 35' ' ' ILE . 5.7 mm -90.28 163.68 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.256 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.901 HG23 ' O ' ' A' ' 34' ' ' ILE . 2.1 pt -167.7 156.82 8.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.44 -0.787 . . . . 0.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.16 -28.75 8.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.14 1.6 . . . . 0.0 109.918 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.32 -141.74 4.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.47 33.26 3.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -1.087 . . . . 0.0 110.033 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -79.45 9.03 5.24 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.676 -0.64 . . . . 0.0 111.133 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -43.45 165.87 0.11 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.69 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.629 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.3 Cg_endo -70.04 179.56 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.911 1.479 . . . . 0.0 111.187 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.61 -10.91 85.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 2.1 t0 -95.54 -19.93 19.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.672 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.563 ' CD2' ' CG ' ' A' ' 41' ' ' PRO . 11.3 m-85 -117.78 11.99 13.75 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.525 -0.734 . . . . 0.0 109.933 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.89 30.8 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.2 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.848 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 3' ' ' CYS . 47.3 m -79.37 169.43 18.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.088 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' N ' HG22 ' A' ' 2' ' ' THR . 88.1 m -147.67 128.39 14.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 110.648 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 89.8 m -126.52 141.26 39.6 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 109.923 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.8 Cg_endo -72.0 -6.69 19.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.99 1.521 . . . . 0.0 111.488 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 10.9 p 176.41 161.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 34.3 mt -45.88 -29.88 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.892 . . . . 0.0 109.456 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.7 t -52.19 -62.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.9 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -67.03 -53.35 32.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.153 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -43.63 -33.37 1.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 33.0 t -70.8 -49.44 46.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.311 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.495 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 7.3 m-20 -63.82 -56.86 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 1.1 t80 -40.95 -42.06 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 109.8 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -83.82 -24.26 31.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.919 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -72.25 -31.41 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.802 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.707 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.84 -27.14 23.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -86.5 -2.08 58.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.274 -0.892 . . . . 0.0 109.757 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.4 mt -77.1 -45.19 2.81 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.343 -0.848 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -71.75 -81.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.523 1.275 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.93 29.09 0.59 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.39 -1.386 . . . . 0.0 109.984 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.707 HG21 ' SG ' ' A' ' 16' ' ' CYS . 1.9 m -101.01 142.61 24.97 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.921 -1.341 . . . . 0.0 110.444 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.5 Cg_endo -74.93 126.1 9.79 Favored 'Trans proline' 0 C--N 1.286 -2.73 0 O-C-N 124.622 1.854 . . . . 0.0 108.555 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -34.23 -27.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.947 0.403 . . . . 0.0 111.532 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.56 -48.31 82.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.912 -1.117 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -70.17 -39.1 75.48 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.176 -0.953 . . . . 0.0 110.203 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 59.0 m -61.22 -30.48 70.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.625 -0.672 . . . . 0.0 111.826 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.895 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -95.89 -11.3 26.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -26.79 30.76 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -89.64 -42.68 11.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.393 0.616 . . . . 0.0 109.95 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 27' ' ' ALA . 2.4 t -85.51 -13.74 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.949 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 109.11 -42.01 2.07 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.084 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.9 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 74.9 m -41.31 154.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.267 -1.137 . . . . 0.0 110.198 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.2 pt -142.61 147.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.016 -1.053 . . . . 0.0 110.627 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 HG12 ' OE2' ' A' ' 23' ' ' GLU . 3.0 mt -101.49 139.05 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.422 -0.799 . . . . 0.0 109.949 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -130.15 171.07 9.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.501 -179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 50.1 Cg_endo -76.79 6.25 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.079 1.568 . . . . 0.0 110.875 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.04 -142.97 13.61 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.11 16.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -1.043 . . . . 0.0 111.705 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -130.81 5.32 4.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' THR . 68.2 m 53.07 165.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.84 0 O-C-N 121.753 -0.592 . . . . 0.0 110.531 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.963 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 49.5 Cg_endo -74.51 -158.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.873 1.46 . . . . 0.0 110.187 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.11 -18.42 24.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 44' ' ' TYR . 21.5 p30 -96.04 -21.76 17.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.131 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.54 ' CG ' ' OD1' ' A' ' 43' ' ' ASP . 2.4 m-85 -121.9 26.6 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.963 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.75 30.74 0.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.4 -0.812 . . . . 0.0 110.595 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.09 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.849 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.544 HG21 ' CE1' ' A' ' 13' ' ' PHE . 97.7 m -111.38 149.69 30.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m -155.16 105.83 2.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 35.0 m -99.05 150.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.123 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 44.5 Cg_endo -69.36 -3.11 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 111.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.49 175.93 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.23 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.469 HG13 ' OD1' ' A' ' 46' ' ' ASN . 1.8 mp -67.09 -35.2 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.84 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.792 HG12 HD21 ' A' ' 12' ' ' ASN . 3.2 t -68.32 -47.92 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.855 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.95 69.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.57 -42.91 33.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.478 -0.764 . . . . 0.0 109.196 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 21.5 p -57.93 -49.89 75.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.767 . . . . 0.0 109.907 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.792 HD21 HG12 ' A' ' 8' ' ' VAL . 6.8 m-20 -66.66 -53.6 32.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.6 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 20.8 t80 -41.49 -45.9 3.35 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.519 0.676 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -74.14 -26.3 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -82.51 -25.27 33.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.891 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 21' ' ' THR . 8.0 tpt180 -85.09 -1.91 57.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -0.878 . . . . 0.0 109.295 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.641 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -70.67 -49.11 15.51 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.491 -0.756 . . . . 0.0 110.473 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 39.7 Cg_endo -69.12 -81.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.663 1.349 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.73 32.17 0.38 Allowed Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.729 HG21 ' SG ' ' A' ' 16' ' ' CYS . 3.6 m -101.1 137.22 19.65 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 121.147 -1.208 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.3 Cg_endo -73.08 124.62 9.7 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.481 1.779 . . . . 0.0 108.279 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 22' ' ' PRO . 71.0 mt-10 -31.84 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.269 0.557 . . . . 0.0 111.141 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -55.81 -52.1 65.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 110.062 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.2 OUTLIER -71.43 -26.71 62.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.609 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.6 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 61.6 m -71.54 -25.25 62.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -99.86 -17.39 17.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.082 -1.012 . . . . 0.0 109.357 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -81.24 -28.96 34.59 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -93.34 -37.18 12.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.379 -0.825 . . . . 0.0 109.904 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 27' ' ' ALA . 1.2 t -88.23 -9.49 52.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 103.99 -40.46 2.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.861 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 41.9 t -42.58 159.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -1.201 . . . . 0.0 110.218 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 3' ' ' CYS . 2.5 pp -143.28 144.46 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 110.944 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.0 142.17 17.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.55 -0.719 . . . . 0.0 109.59 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.05 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -145.94 136.56 12.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.74 62.45 7.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.967 1.509 . . . . 0.0 110.044 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 35' ' ' ILE . . . -176.63 137.41 3.58 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 15.01 4.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.596 -0.943 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -84.85 12.27 7.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.301 -0.874 . . . . 0.0 110.62 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.2 m -35.48 140.77 0.32 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 122.096 -0.377 . . . . 0.0 110.648 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' CG ' ' CD1' ' A' ' 44' ' ' TYR . 47.2 Cg_endo -72.27 -171.54 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.539 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.65 -0.56 69.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -108.09 -8.9 15.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' CD1' ' CG ' ' A' ' 41' ' ' PRO . 23.1 m-30 -119.7 5.44 11.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.58 30.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.437 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.832 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.549 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -136.61 176.98 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.195 . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 40.4 m -154.19 144.56 22.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.569 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 11.4 m -144.97 141.82 17.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 40.5 Cg_endo -65.43 -8.61 19.47 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.098 1.578 . . . . 0.0 112.533 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.496 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 2.7 p 173.0 -170.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.446 -1.408 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 11' ' ' SER . 29.6 mm -65.38 -40.93 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.816 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 74.9 t -53.26 -56.9 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.415 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.911 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -62.36 -66.6 0.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.285 -0.884 . . . . 0.0 109.005 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' CD ' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -40.76 -48.77 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.541 -0.725 . . . . 0.0 110.344 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 15' ' ' VAL . 47.7 t -49.99 -60.6 2.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.963 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 42.3 m-20 -51.73 -62.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.651 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.71 -41.94 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.248 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -76.48 -19.66 57.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 109.329 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -83.31 -27.97 7.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.536 -0.728 . . . . 0.0 109.343 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.697 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.02 -19.81 36.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -5.83 59.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.593 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -63.91 -48.95 77.56 Favored Pre-proline 0 C--N 1.305 -1.362 0 O-C-N 121.48 -0.763 . . . . 0.0 111.03 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -71.63 -25.79 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.602 1.317 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.66 11.18 2.73 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.076 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.697 HG21 ' SG ' ' A' ' 16' ' ' CYS . 3.7 m -70.32 145.81 93.68 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.094 -1.239 . . . . 0.0 110.125 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 41.9 Cg_endo -75.32 122.91 7.34 Favored 'Trans proline' 0 C--N 1.286 -2.754 0 O-C-N 124.556 1.819 . . . . 0.0 108.559 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 11.2 pt-20 -35.32 -26.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.044 0.45 . . . . 0.0 111.279 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.42 -50.32 74.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.957 -1.089 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -18.98 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.061 -1.025 . . . . 0.0 110.131 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 48.3 m -80.89 -29.53 35.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.549 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.634 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -91.6 -12.37 34.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.71 -33.88 30.9 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -42.47 19.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.53 -0.731 . . . . 0.0 110.024 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 32' ' ' CYS . 4.1 t -84.21 -5.25 59.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.796 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 96.72 -30.29 9.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.911 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 23.3 m -48.47 177.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.251 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 pt -141.63 168.17 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 110.498 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 35' ' ' ILE . 7.4 mm -102.21 178.23 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.008 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.553 HG23 ' CB ' ' A' ' 1' ' ' THR . 0.9 OUTLIER -170.31 135.98 1.21 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.123 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.92 -28.16 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.942 1.496 . . . . 0.0 110.648 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -124.92 -141.34 5.65 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.23 25.82 4.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.995 . . . . 0.0 110.328 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -78.48 7.21 7.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.504 -0.748 . . . . 0.0 110.879 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -41.87 163.33 0.12 Allowed Pre-proline 0 C--N 1.293 -1.871 0 O-C-N 121.627 -0.671 . . . . 0.0 110.183 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.1 Cg_endo -73.03 -164.7 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.805 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.11 -8.05 34.45 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.9 OUTLIER -95.4 -19.5 19.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.698 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.426 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 10.5 m-85 -119.12 17.86 13.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.512 -0.743 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.87 28.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.121 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.512 ' O ' ' CD ' ' A' ' 10' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.142 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.849 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.463 ' OG1' HG13 ' A' ' 34' ' ' ILE . 7.2 t -126.77 167.22 16.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.853 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -157.68 112.02 2.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.638 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 16.8 m -94.75 164.09 20.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.88 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 45.3 Cg_endo -70.63 -4.87 15.48 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.018 1.536 . . . . 0.0 111.333 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 11.5 p -178.24 171.67 1.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.964 -1.085 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.459 HG12 ' OD1' ' A' ' 46' ' ' ASN . 41.3 mm -64.16 -34.49 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.413 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 87.1 t -68.14 -50.81 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' A' ' 5' ' ' PRO . . . -52.21 -34.32 44.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -79.98 -32.02 39.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.13 -46.15 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.585 -0.697 . . . . 0.0 109.682 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 4.0 m-20 -71.16 -47.34 58.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.308 -0.87 . . . . 0.0 109.085 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -51.57 -31.64 25.38 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.734 0.778 . . . . 0.0 109.507 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -81.84 -22.29 37.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -32.66 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.742 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.52 -28.08 28.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.522 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -88.03 5.13 42.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.445 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -75.45 -48.22 4.1 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.468 -0.77 . . . . 0.0 110.517 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -73.67 -84.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.732 1.385 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.44 29.66 0.63 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.742 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.1 m -91.32 142.01 26.69 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 120.729 -1.454 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.7 Cg_endo -72.56 125.63 10.79 Favored 'Trans proline' 0 C--N 1.283 -2.882 0 O-C-N 124.547 1.814 . . . . 0.0 108.594 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mt-10 -32.87 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.173 0.511 . . . . 0.0 111.259 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.15 -51.25 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.11 -32.72 74.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.016 . . . . 0.0 110.102 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 33.5 m -72.56 -36.72 68.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.948 . . . . 0.0 110.206 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.032 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -89.67 4.5 49.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.743 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -91.74 -40.17 11.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -86.18 -28.5 23.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.704 HG23 ' H ' ' A' ' 32' ' ' CYS . 2.1 t -93.23 -21.12 19.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.99 . . . . 0.0 110.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 104.49 -37.93 3.53 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.196 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 1.032 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 39.3 t -41.52 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -1.163 . . . . 0.0 110.466 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.36 148.18 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 0.0 110.394 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.7 mp -108.69 161.2 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.511 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 19.3 pt -151.15 167.32 13.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.947 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 41.5 Cg_endo -68.78 -20.88 39.18 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.771 1.406 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' ' CG2' ' A' ' 1' ' ' THR . . . 119.51 128.45 3.73 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.662 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.57 -89.57 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.885 -0.774 . . . . 0.0 109.366 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -156.42 2.51 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.024 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 39' ' ' THR . 71.2 m 53.05 160.04 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 110.901 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 51.4 Cg_endo -80.0 -157.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.62 1.326 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.26 -10.58 27.39 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 44' ' ' TYR . 19.0 p30 -104.74 -17.57 14.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -1.159 . . . . 0.0 109.96 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 10.4 m-85 -116.58 16.89 15.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.68 30.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 110.508 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.459 ' OD1' HG12 ' A' ' 7' ' ' ILE . 1.7 t-20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.835 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.816 HG23 HG12 ' A' ' 34' ' ' ILE . 3.3 m -94.41 160.69 14.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 2' ' ' THR . 66.1 m -151.71 111.99 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.558 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 88.0 m -111.01 144.42 30.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.728 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -74.42 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.044 1.549 . . . . 0.0 111.271 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -159.44 165.74 32.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.851 -1.156 . . . . 0.0 110.725 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -31.62 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.514 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 11.3 t -73.74 -53.79 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.932 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -42.35 -37.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.237 -0.914 . . . . 0.0 110.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -83.69 -37.85 22.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.411 -0.806 . . . . 0.0 109.182 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 6.2 m -54.39 -32.86 58.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 4.0 m-20 -81.39 -50.12 9.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.035 . . . . 0.0 109.545 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.665 ' CZ ' HG21 ' A' ' 2' ' ' THR . 0.0 OUTLIER -54.35 -39.79 67.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.22 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.618 ' OD1' ' N ' ' A' ' 15' ' ' VAL . 4.7 p-10 -75.54 -24.52 56.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 t -80.41 -25.49 11.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.601 0.715 . . . . 0.0 109.346 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -83.19 -25.55 31.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 110.025 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' THR . 28.1 ttt180 -92.45 6.33 47.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.597 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -63.12 -43.88 82.52 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -75.32 -72.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.54 1.284 . . . . 0.0 110.685 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.59 26.4 0.14 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 16' ' ' CYS . 9.5 m -83.04 142.0 44.04 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 121.125 -1.22 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -74.03 119.3 5.78 Favored 'Trans proline' 0 C--N 1.285 -2.782 0 O-C-N 124.616 1.851 . . . . 0.0 108.686 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.614 ' HB2' HD13 ' A' ' 34' ' ' ILE . 11.1 pt-20 -34.82 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -60.74 -43.6 97.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -73.63 -37.33 65.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 110.371 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 64.3 m -73.0 -20.03 61.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -98.39 -18.18 18.43 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.272 1.035 . . . . 0.0 109.511 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -83.83 -26.33 29.62 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.15 -43.83 9.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.519 0.676 . . . . 0.0 109.847 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.2 t -81.26 -10.52 59.57 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.426 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 103.07 -39.75 2.68 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.563 ' H ' HG23 ' A' ' 30' ' ' THR . 48.9 m -40.4 160.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.285 -1.126 . . . . 0.0 110.632 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' C ' HG13 ' A' ' 34' ' ' ILE . 7.4 pt -127.83 158.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.98 -1.075 . . . . 0.0 109.777 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 2' ' ' THR . 64.2 mt -137.22 139.72 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 110.72 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.74 137.08 12.25 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.51 66.33 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.925 1.487 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.06 -139.68 2.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.47 24.33 0.08 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.602 -0.94 . . . . 0.0 109.937 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.31 11.31 24.06 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.757 0.789 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.69 151.22 4.34 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.774 -0.579 . . . . 0.0 110.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.6 -172.21 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.993 1.523 . . . . 0.0 110.48 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.2 55.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' A' ' 44' ' ' TYR . 4.4 p30 -116.07 -20.23 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.819 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' OD2' ' A' ' 43' ' ' ASP . 19.5 m-85 -115.38 4.59 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.419 -0.801 . . . . 0.0 109.747 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.87 32.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.875 . . . . 0.0 110.175 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.092 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.843 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.711 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.962 HG23 HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -134.98 117.57 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.456 . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 134.48 55.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.904 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 24.1 m -105.18 152.03 39.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -73.06 -4.99 16.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 111.087 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.509 ' CA ' ' HB3' ' A' ' 46' ' ' ASN . 3.3 p -152.39 145.11 24.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -49.7 -39.22 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 109.214 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.33 -50.4 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.707 . . . . 0.0 109.776 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -51.25 -21.86 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.428 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -93.55 -36.27 12.49 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -47.42 81.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.278 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 25.0 p-10 -75.43 -36.09 60.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.906 ' CE1' HG21 ' A' ' 2' ' ' THR . 8.2 t80 -56.94 -42.92 80.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.409 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -75.86 -18.3 59.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.334 -0.853 . . . . 0.0 108.942 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -77.11 -23.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.467 0.651 . . . . 0.0 109.725 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.534 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.3 t -93.29 -21.51 19.54 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.523 -0.736 . . . . 0.0 110.52 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 6.3 ttt-85 -90.59 6.96 41.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.643 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -79.64 -41.78 1.5 Allowed Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.432 -0.792 . . . . 0.0 111.441 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -72.75 -18.07 25.35 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.379 1.199 . . . . 0.0 110.84 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.48 17.55 1.93 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.056 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 9.1 m -82.58 144.45 49.13 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.017 -1.284 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 40.3 Cg_endo -72.74 119.71 6.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 O-C-N 124.643 1.865 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' HD2' ' A' ' 17' ' ' ARG . 12.1 pt-20 -37.27 -25.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.104 0.478 . . . . 0.0 110.838 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -64.65 -43.2 94.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 109.924 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -76.63 -21.26 55.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.092 -1.005 . . . . 0.0 110.241 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 30' ' ' THR . 73.2 m -87.15 -11.96 48.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.31 -19.91 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.284 1.04 . . . . 0.0 109.12 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -91.07 -22.53 20.69 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.09 -27.65 14.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.206 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -99.98 -13.55 19.04 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.552 -0.718 . . . . 0.0 110.27 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.67 -37.86 3.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.991 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ALA . 6.2 t -46.96 176.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.636 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 44' ' ' TYR . 23.4 pt -138.39 154.88 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.943 -1.098 . . . . 0.0 110.455 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.962 HD13 HG23 ' A' ' 2' ' ' THR . 14.5 mm -102.82 168.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.017 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 34' ' ' ILE . 23.6 pt -158.24 144.23 12.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.347 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.6 -15.82 27.22 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.027 1.54 . . . . 0.0 110.029 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.72 -140.64 11.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -175.67 25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.397 -1.061 . . . . 0.0 110.839 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' O ' ' A' ' 40' ' ' CYS . 9.5 t -94.79 -15.87 23.45 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 39' ' ' THR . 54.3 m 53.13 122.99 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.676 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 42.7 Cg_endo -70.96 -170.72 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.518 1.273 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -13.16 64.81 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -97.76 -18.58 18.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -1.218 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 33' ' ' ILE . 9.6 m-85 -118.81 18.16 13.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -88.71 32.33 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.087 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' HB3' ' CA ' ' A' ' 6' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.12 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.844 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.406 HG23 ' CE2' ' A' ' 13' ' ' PHE . 4.4 m -126.99 131.21 51.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.882 ' SG ' HD11 ' A' ' 35' ' ' ILE . 10.9 m -119.02 123.69 45.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 84.1 m -136.3 150.94 72.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 43.0 Cg_endo -68.87 -8.53 23.74 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.694 1.365 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.498 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 3.1 m -174.58 160.27 3.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.013 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 7.7 mt -50.74 -42.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.611 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.7 t -56.13 -58.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 109.899 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -45.98 -47.81 16.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -68.43 -40.58 81.12 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.21 -52.63 34.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.758 . . . . 0.0 109.824 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.76 -56.54 20.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.19 -37.84 10.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.525 -0.735 . . . . 0.0 110.018 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -83.1 -22.13 33.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 11' ' ' SER . 1.2 t -87.76 -20.59 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.671 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.9 OUTLIER -85.46 -31.95 22.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.563 -0.711 . . . . 0.0 110.187 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 26.8 ttt-85 -88.73 7.37 34.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.164 -0.96 . . . . 0.0 109.279 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.609 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -63.65 -46.42 82.92 Favored Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.497 -0.752 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -73.87 -71.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.55 1.289 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.35 24.03 0.14 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.921 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.537 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 10.0 m -82.99 142.36 44.54 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 120.932 -1.334 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -73.87 118.38 5.41 Favored 'Trans proline' 0 C--N 1.286 -2.757 0 O-C-N 124.606 1.845 . . . . 0.0 108.542 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 18.6 pt-20 -36.37 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.039 0.447 . . . . 0.0 111.046 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.52 -42.53 99.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.028 -1.045 . . . . 0.0 109.67 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -73.18 -41.58 63.7 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.179 -0.951 . . . . 0.0 110.545 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.7 m -66.75 -24.24 66.19 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 111.061 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -97.74 -7.85 29.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.0 109.467 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.3 -24.74 19.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.9 t80 -95.52 -32.73 12.71 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 32' ' ' CYS . 0.8 OUTLIER -95.24 -10.48 30.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 110.179 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 100.34 -38.82 2.96 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.843 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 20.3 m -43.13 166.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.112 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.509 HG23 ' C ' ' A' ' 32' ' ' CYS . 2.1 pp -150.43 148.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.053 -1.029 . . . . 0.0 110.297 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -108.22 146.83 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 0.0 110.263 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.882 HD11 ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -130.81 174.83 4.21 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.258 -0.901 . . . . 0.0 110.114 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 35' ' ' ILE . 42.4 Cg_endo -70.93 -32.59 13.45 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.55 . . . . 0.0 110.525 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 140.53 134.28 3.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . 174.81 -80.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.612 -0.934 . . . . 0.0 109.735 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -174.32 18.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.61 -0.681 . . . . 0.0 111.315 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.3 m 56.14 166.05 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.439 -0.788 . . . . 0.0 109.363 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 45.8 Cg_endo -72.59 -158.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.933 1.491 . . . . 0.0 109.924 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.68 -29.76 3.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -81.57 -21.16 38.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.928 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 43' ' ' ASP . 2.8 m-85 -119.23 33.67 5.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.88 29.67 0.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.839 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 163.46 26.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.721 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 33' ' ' ILE . 5.9 p -158.24 144.18 17.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -125.9 147.88 60.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.287 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 46.9 Cg_endo -73.01 -0.61 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.008 1.531 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -156.22 157.11 35.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.093 -1.004 . . . . 0.0 110.413 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 mp -61.73 -33.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.926 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 5.3 t -70.01 -56.31 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.54 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -42.68 -36.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -81.61 -35.09 30.48 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -55.83 -42.27 75.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 109.565 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 15' ' ' VAL . 2.2 m-80 -73.83 -52.87 11.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 0.0 109.297 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -42.81 -36.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.47 -0.769 . . . . 0.0 109.453 179.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -73.42 -31.5 63.87 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.84 0.829 . . . . 0.0 109.182 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -71.52 -22.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.553 0.692 . . . . 0.0 109.338 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.935 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -80.74 -34.02 34.71 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.615 -0.678 . . . . 0.0 110.716 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -74.52 -6.38 48.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 2.1 mt -71.7 -57.67 4.06 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.471 -0.768 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -71.28 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.007 1.53 . . . . 0.0 110.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.93 23.08 0.24 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.935 HG21 ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -84.0 125.39 72.88 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.221 -1.164 . . . . 0.0 110.997 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 38.7 Cg_endo -70.82 121.87 8.3 Favored 'Trans proline' 0 C--N 1.288 -2.651 0 O-C-N 124.286 1.677 . . . . 0.0 108.801 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.3 pt-20 -34.23 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.413 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.4 -40.35 77.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.374 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -65.61 -43.78 88.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 110.645 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.568 ' O ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -85.63 -23.81 27.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.071 -1.018 . . . . 0.0 111.427 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 32' ' ' CYS . . . -71.86 -27.17 62.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.764 -1.21 . . . . 0.0 108.711 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -80.28 -32.76 38.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.247 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -94.01 -35.26 12.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.448 -0.782 . . . . 0.0 110.56 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 26' ' ' CYS . 1.0 OUTLIER -82.3 -11.73 58.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.552 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 19.13 23.27 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.573 ' C ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.5 -179.32 3.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -1.169 . . . . 0.0 110.005 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.6 HD11 ' SG ' ' A' ' 40' ' ' CYS . 45.1 pt -154.78 144.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.061 -1.024 . . . . 0.0 110.178 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.3 mp -95.97 142.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.444 -0.785 . . . . 0.0 110.114 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.697 HD12 ' HB3' ' A' ' 38' ' ' ALA . 8.5 pt -147.74 153.85 43.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.842 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.86 58.84 4.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.975 1.513 . . . . 0.0 110.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.763 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 76.66 132.36 0.47 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . 163.38 -28.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.818 -0.813 . . . . 0.0 109.668 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.692 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 69.69 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.716 0.769 . . . . 0.0 110.378 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 57.71 178.3 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 110.383 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 40' ' ' CYS . 45.5 Cg_endo -70.8 -168.1 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.99 1.521 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.6 2.43 87.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -103.96 -28.83 11.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -1.159 . . . . 0.0 109.653 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' O ' ' HB2' ' A' ' 3' ' ' CYS . 14.8 m-85 -103.45 1.8 32.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.5 -0.75 . . . . 0.0 110.038 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.11 29.76 0.47 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 0.0 110.718 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 5.0 m-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.075 -0.965 . . . . 0.0 109.982 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.842 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 1.07 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -86.59 156.82 19.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.798 . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 2' ' ' THR . 56.1 m -153.33 122.85 6.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 74.9 m -132.7 139.66 35.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.36 -2.6 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.883 1.465 . . . . 0.0 111.091 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -160.95 149.23 16.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.474 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 7' ' ' ILE . 49.1 mt -51.54 -32.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.727 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.542 HG12 HD21 ' A' ' 12' ' ' ASN . 50.5 t -69.71 -55.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.738 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -43.12 -36.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.846 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -82.5 -44.14 16.32 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.35 -0.844 . . . . 0.0 108.91 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -39.44 41.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.542 HD21 HG12 ' A' ' 8' ' ' VAL . 5.4 m-20 -68.58 -50.78 49.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 108.95 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 1.07 ' CE2' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -47.31 -42.31 20.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.58 -0.7 . . . . 0.0 109.407 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -78.0 -16.57 58.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.612 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -83.16 -25.4 8.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.591 -0.693 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.691 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.08 -26.97 22.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.545 -0.722 . . . . 0.0 110.386 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 21' ' ' THR . 4.4 ttt180 -91.02 9.97 28.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.326 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -73.11 -45.05 8.2 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.546 -0.721 . . . . 0.0 110.529 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.7 Cg_endo -75.81 -81.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.665 1.35 . . . . 0.0 110.776 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -150.86 36.43 0.9 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.996 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.691 HG21 ' SG ' ' A' ' 16' ' ' CYS . 12.0 m -106.46 134.44 19.8 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.921 -1.341 . . . . 0.0 110.403 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -71.18 119.86 6.59 Favored 'Trans proline' 0 C--N 1.286 -2.734 0 O-C-N 124.476 1.777 . . . . 0.0 109.051 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 10.3 mt-10 -28.91 -35.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.707 0.765 . . . . 0.0 111.116 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.7 -48.18 78.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.299 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -74.34 -19.39 60.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.014 . . . . 0.0 110.372 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 84.3 m -84.99 -19.31 32.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.248 -0.908 . . . . 0.0 110.742 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -96.47 -24.33 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.38 1.086 . . . . 0.0 109.208 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -85.3 -21.54 28.94 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.861 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -93.3 -30.95 14.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.619 -0.675 . . . . 0.0 109.639 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.1 t -95.43 -11.91 26.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 114.46 -39.36 2.83 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.367 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 66.2 m -48.24 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.333 -1.098 . . . . 0.0 111.028 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.492 ' CG2' ' C ' ' A' ' 32' ' ' CYS . 5.3 pt -151.68 157.58 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 24' ' ' ALA . 35.9 mt -135.32 142.36 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.478 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -138.79 163.92 43.27 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 46.6 Cg_endo -73.7 54.44 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.993 1.523 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 90.13 137.36 6.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 39' ' ' THR . . . 175.02 -28.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.959 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 73.64 -1.61 3.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.801 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' O ' ' A' ' 39' ' ' THR . 3.3 m 47.47 171.77 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.332 0.587 . . . . 0.0 111.915 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 44' ' ' TYR . 54.2 Cg_endo -75.04 -158.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.872 1.459 . . . . 0.0 110.098 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 7.65 59.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 -23.22 10.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 109.642 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.488 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 19.4 m-85 -110.48 9.17 23.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 110.066 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.95 30.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.847 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.844 HG21 ' CE1' ' A' ' 13' ' ' PHE . 86.0 m -135.65 131.9 36.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.463 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.3 m -132.13 99.68 4.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 109.883 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 37.2 m -97.06 159.98 30.13 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 42.1 Cg_endo -67.64 -9.19 24.62 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.97 1.511 . . . . 0.0 112.28 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 170.91 175.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.54 -1.35 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 11' ' ' SER . 27.0 mm -55.58 -40.16 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.483 -0.761 . . . . 0.0 109.797 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 11' ' ' SER . 78.9 t -54.44 -64.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.53 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -49.21 -65.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.206 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -44.48 -25.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.404 -0.81 . . . . 0.0 110.144 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 0.3 OUTLIER -69.04 -52.05 32.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.027 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.4 m-80 -70.45 -51.87 26.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.844 ' CE1' HG21 ' A' ' 2' ' ' THR . 38.1 t80 -42.31 -46.29 4.52 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.528 -0.733 . . . . 0.0 110.297 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -77.09 -20.57 55.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 109.622 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -81.24 -26.23 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 109.725 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -86.31 -22.82 26.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.173 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 21' ' ' THR . 16.2 tpt180 -89.28 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.742 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.642 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -68.34 -43.86 34.15 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.527 -0.733 . . . . 0.0 110.646 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -72.91 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.488 1.257 . . . . 0.0 110.857 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.64 28.75 0.18 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.696 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.4 m -96.2 142.27 24.32 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.2 Cg_endo -74.82 124.99 9.12 Favored 'Trans proline' 0 C--N 1.286 -2.741 0 O-C-N 124.622 1.854 . . . . 0.0 108.37 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 22' ' ' PRO . 81.6 mt-10 -33.29 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.125 0.488 . . . . 0.0 111.297 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.26 -49.55 76.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.021 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.61 -27.75 64.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.983 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -76.06 -32.82 59.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.446 -0.784 . . . . 0.0 110.572 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -94.13 -3.1 51.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 109.738 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -86.23 -36.81 19.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -88.21 -40.05 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.97 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.708 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.6 t -80.02 -16.95 54.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 110.239 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 101.6 -37.12 3.79 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.893 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 42.4 t -42.41 159.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -1.208 . . . . 0.0 110.195 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 3' ' ' CYS . 1.1 pp -137.05 145.61 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 1' ' ' THR . 4.0 mp -107.35 153.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.418 -0.801 . . . . 0.0 109.976 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.42 155.99 60.66 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.081 -1.012 . . . . 0.0 110.554 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.44 -1.27 11.1 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.083 1.57 . . . . 0.0 110.061 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.97 -141.83 3.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.96 47.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.986 . . . . 0.0 109.749 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.44 8.87 27.63 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.493 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 28.6 p -48.12 162.93 0.31 Allowed Pre-proline 0 C--N 1.291 -1.949 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.187 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 44.3 Cg_endo -69.78 162.18 43.06 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.839 1.442 . . . . 0.0 111.33 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 -8.33 78.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 10.8 m-20 -90.65 -21.33 21.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.239 . . . . 0.0 109.067 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' CD1' ' HG2' ' A' ' 41' ' ' PRO . 9.2 m-85 -119.61 10.58 11.79 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.519 0.676 . . . . 0.0 109.493 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.62 31.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 110.28 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.27 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.85 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.968 HG23 ' CE2' ' A' ' 13' ' ' PHE . 1.5 m -97.77 144.37 27.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 1.6 m -145.75 115.01 7.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.256 -0.903 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 1.7 m -106.28 158.46 32.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 48.3 Cg_endo -76.17 -21.89 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.193 1.628 . . . . 0.0 111.174 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 p -140.75 172.1 13.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.007 -1.058 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -69.92 -32.01 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.875 . . . . 0.0 110.019 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.627 HG12 HD21 ' A' ' 12' ' ' ASN . 88.2 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -64.3 -34.64 78.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -42.77 81.28 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -63.44 -45.77 89.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.753 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.627 HD21 HG12 ' A' ' 8' ' ' VAL . 6.3 m-20 -65.66 -53.18 44.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.968 ' CE2' HG23 ' A' ' 2' ' ' THR . 1.0 OUTLIER -44.65 -48.45 10.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.944 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.62 -14.43 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 0.0 109.637 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -84.58 -20.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 109.89 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.8 t -92.77 -22.41 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 0.0 110.567 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 5.0 mtp180 -85.38 0.6 51.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 109.597 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.62 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -67.82 -47.96 42.27 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 41.5 Cg_endo -69.45 -17.76 38.84 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.449 1.236 . . . . 0.0 110.836 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 19.99 3.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.568 HG21 ' SG ' ' A' ' 16' ' ' CYS . 6.3 m -77.27 145.85 73.4 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.361 -1.082 . . . . 0.0 110.295 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.0 Cg_endo -75.38 120.78 6.09 Favored 'Trans proline' 0 C--N 1.286 -2.744 0 O-C-N 124.593 1.839 . . . . 0.0 108.403 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.539 ' HG3' HG21 ' A' ' 34' ' ' ILE . 14.6 pm0 -35.68 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.973 0.416 . . . . 0.0 111.221 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.71 -52.13 66.82 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -42.94 97.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 109.759 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 27.8 m -70.22 -16.58 63.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -92.18 -7.19 49.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.241 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.0 -34.33 18.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -83.49 -39.69 20.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.429 -0.794 . . . . 0.0 109.632 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.473 HG21 ' CA ' ' A' ' 13' ' ' PHE 0.271 23.8 p -75.54 -26.62 58.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.45 -0.781 . . . . 0.0 110.429 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.23 14.26 64.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.498 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 33.2 m -93.86 -174.56 3.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -1.091 . . . . 0.0 110.389 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -144.62 151.86 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 27' ' ' ALA . 2.8 mp -111.2 138.89 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.398 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -125.36 171.77 7.11 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 44.5 Cg_endo -71.44 -26.35 20.39 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.99 1.521 . . . . 0.0 111.884 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.989 ' O ' HD13 ' A' ' 35' ' ' ILE . . . -151.28 -141.64 3.38 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.493 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.63 29.56 1.29 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.672 -0.899 . . . . 0.0 110.592 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.81 7.42 7.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 35' ' ' ILE . 55.7 m -51.15 151.13 5.09 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 121.587 -0.696 . . . . 0.0 110.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 50.1 Cg_endo -75.57 -159.66 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.883 1.465 . . . . 0.0 110.339 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 -13.04 25.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 3.9 m-20 -96.89 -16.15 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.922 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 15.4 m-85 -116.81 19.75 14.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 110.16 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.51 30.88 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.263 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.853 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.809 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.536 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 7.3 t -81.05 165.34 21.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 12.6 m -156.85 109.7 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 110.406 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.614 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -121.62 163.2 32.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 110.288 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.4 Cg_endo -72.04 -7.1 20.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.052 1.554 . . . . 0.0 111.063 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 5' ' ' PRO . 1.8 m -158.53 154.03 26.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.014 -1.054 . . . . 0.0 110.798 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 mt -61.75 -28.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.799 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 91.6 t -65.9 -48.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.614 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -58.83 -49.4 77.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.8 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -36.75 76.97 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.43 -39.89 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.672 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 5.4 m-20 -72.75 -51.57 18.62 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.026 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -44.2 -50.37 8.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.529 -0.732 . . . . 0.0 109.568 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.69 -39.9 95.46 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 1.2 t -58.02 -25.81 27.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.615 0.721 . . . . 0.0 109.06 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.4 OUTLIER -86.01 -16.04 39.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.768 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 21' ' ' THR . 14.1 tpt180 -84.43 -7.21 59.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 109.355 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -56.07 -50.94 84.48 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.364 -0.835 . . . . 0.0 111.142 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.72 -25.7 23.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.604 1.318 . . . . 0.0 110.713 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.46 17.69 2.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.589 HG21 ' SG ' ' A' ' 16' ' ' CYS . 6.3 m -68.09 144.17 96.71 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.186 -1.185 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.5 Cg_endo -74.1 122.13 7.39 Favored 'Trans proline' 0 C--N 1.283 -2.886 0 O-C-N 124.517 1.798 . . . . 0.0 108.757 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -32.04 -31.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.138 0.494 . . . . 0.0 111.054 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.01 -47.59 77.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.134 -0.978 . . . . 0.0 109.371 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -68.66 -41.44 79.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.405 -0.809 . . . . 0.0 110.414 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 16.3 m -70.38 -25.0 63.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.344 -0.848 . . . . 0.0 110.809 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.887 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -96.02 -2.06 47.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.064 . . . . 0.0 109.685 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -101.98 -22.92 14.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -93.47 -29.05 15.75 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 32' ' ' CYS . 0.6 OUTLIER -102.91 -21.23 14.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.838 -0.539 . . . . 0.0 110.13 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 109.67 -35.0 5.14 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.481 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.887 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.2 m -41.38 160.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.119 -1.224 . . . . 0.0 110.542 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.2 pt -133.24 145.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.883 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 1' ' ' THR . 2.7 mp -110.42 147.37 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 110.825 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.37 147.57 31.45 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.561 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.03 69.57 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.851 1.448 . . . . 0.0 110.292 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.92 145.95 4.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.42 25.38 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.98 . . . . 0.0 110.523 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -84.99 14.13 5.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 110.625 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.6 m -38.79 161.57 0.07 OUTLIER Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.989 -0.444 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.1 Cg_endo -70.69 -161.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.884 1.465 . . . . 0.0 110.902 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.61 -5.25 26.11 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 1.3 t0 -93.63 -31.4 14.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -1.232 . . . . 0.0 110.039 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.539 ' CE2' ' HB3' ' A' ' 43' ' ' ASP . 2.3 m-85 -114.49 23.13 13.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.634 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.91 32.12 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.85 . . . . 0.0 110.509 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.849 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.687 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.621 HG23 ' CE1' ' A' ' 13' ' ' PHE . 97.2 m -89.14 133.48 34.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.097 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.568 ' SG ' HD12 ' A' ' 35' ' ' ILE . 41.4 m -137.69 93.49 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 109.985 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 29.0 m -105.45 161.75 21.83 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.393 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.6 Cg_endo -70.08 -10.2 27.75 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.173 1.617 . . . . 0.0 111.605 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 172.57 -169.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.257 . . . . 0.0 111.005 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 11' ' ' SER . 11.2 mm -65.76 -33.4 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.106 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.7 t -53.7 -66.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.818 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -60.32 -58.6 7.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.888 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -40.54 -37.06 0.65 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.533 -0.729 . . . . 0.0 110.318 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 6.2 t -76.12 -36.22 58.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' CB ' ' OG1' ' A' ' 30' ' ' THR . 68.7 m-20 -69.13 -63.01 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.621 ' CE1' HG23 ' A' ' 2' ' ' THR . 0.7 OUTLIER -47.41 -34.62 7.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 13.3 m-20 -78.14 -14.3 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -96.66 -19.57 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.442 -0.786 . . . . 0.0 110.034 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -91.28 -23.69 20.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.412 -0.805 . . . . 0.0 110.868 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 21' ' ' THR . 26.4 tpt180 -88.95 -8.21 54.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.499 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.1 mt -60.8 -45.17 96.8 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.488 -0.757 . . . . 0.0 110.75 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.1 Cg_endo -73.65 -76.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.635 1.334 . . . . 0.0 110.895 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.11 25.91 0.11 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.65 HG21 ' SG ' ' A' ' 16' ' ' CYS . 4.1 m -91.34 141.33 26.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.134 -1.215 . . . . 0.0 110.261 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.91 122.96 8.08 Favored 'Trans proline' 0 C--N 1.285 -2.773 0 O-C-N 124.557 1.819 . . . . 0.0 108.5 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' OE1' HG21 ' A' ' 34' ' ' ILE . 1.8 pt-20 -34.74 -28.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.052 0.453 . . . . 0.0 110.986 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.26 -47.47 85.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.09 -1.006 . . . . 0.0 109.524 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -20.34 60.44 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.316 -0.865 . . . . 0.0 109.837 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -86.95 -24.94 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -100.17 -3.52 31.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.305 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -97.18 -29.02 13.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -90.04 -33.57 16.28 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.2 t -93.19 -19.74 21.15 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.353 -0.842 . . . . 0.0 110.354 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 108.87 -42.16 2.03 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.405 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.811 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 43.1 t -43.79 166.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.31 . . . . 0.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' HG3' ' A' ' 41' ' ' PRO . 1.4 pt -145.59 146.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 110.396 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.571 HG21 ' OE1' ' A' ' 23' ' ' GLU . 2.9 mp -108.21 156.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.418 -0.801 . . . . 0.0 109.562 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -142.03 145.2 35.06 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.145 -0.972 . . . . 0.0 110.282 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.35 62.01 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.11 1.584 . . . . 0.0 110.518 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.91 -139.36 2.78 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -148.21 12.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.976 . . . . 0.0 110.481 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 106.33 13.52 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.251 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 76.0 m -74.83 164.46 61.23 Favored Pre-proline 0 C--N 1.291 -1.956 0 O-C-N 121.859 -0.526 . . . . 0.0 109.66 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.624 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.0 Cg_endo -74.06 -165.44 0.26 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.944 1.497 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.69 -25.22 10.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.508 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 2.4 m-20 -85.62 -23.47 27.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -1.183 . . . . 0.0 109.666 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.508 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 2.8 m-85 -121.59 35.72 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.367 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -84.25 29.22 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.444 -0.785 . . . . 0.0 110.87 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.127 -0.983 . . . . 0.0 110.06 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.846 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.755 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.757 HG21 ' CD1' ' A' ' 13' ' ' PHE . 4.3 m -87.97 157.84 18.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -155.45 111.14 3.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 111.093 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.66 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -113.69 150.2 42.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 51.5 Cg_endo -78.63 30.86 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.75 1.395 . . . . 0.0 112.046 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.561 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 7.5 t -178.21 155.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 110.928 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.447 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 13.4 mt -65.53 -25.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.499 -0.751 . . . . 0.0 109.792 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 4.1 t -80.78 -54.03 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.803 . . . . 0.0 109.884 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.66 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -53.81 -48.13 70.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 109.495 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -68.51 -27.12 65.84 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.535 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.1 t -74.62 -45.23 46.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.152 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.54 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 9.9 m-20 -52.17 -48.67 64.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.464 -0.773 . . . . 0.0 108.967 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.757 ' CD1' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -52.96 -41.39 64.49 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.534 0.683 . . . . 0.0 109.629 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -75.04 -11.98 60.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.64 -23.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.587 -0.695 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.0 t -89.92 -17.11 28.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.64 0.99 55.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.899 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -55.41 -44.61 99.73 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.483 -0.76 . . . . 0.0 110.957 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.7 Cg_endo -76.62 -22.88 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.678 1.357 . . . . 0.0 110.852 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.58 15.2 2.23 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.583 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.3 m -65.3 145.16 99.11 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.975 -1.309 . . . . 0.0 110.293 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 42.3 Cg_endo -74.95 119.07 5.5 Favored 'Trans proline' 0 C--N 1.287 -2.685 0 O-C-N 124.613 1.849 . . . . 0.0 108.696 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 6.3 pt-20 -35.54 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.246 0.546 . . . . 0.0 110.528 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.18 -40.46 81.55 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.119 -0.988 . . . . 0.0 109.572 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -33.54 43.61 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 36.2 m -83.45 -17.88 40.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 111.155 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.82 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -100.85 -11.68 19.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 109.68 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.6 m -93.64 -25.47 17.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.85 -29.35 13.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.246 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -95.71 -16.59 21.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.439 -0.788 . . . . 0.0 110.36 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 110.95 -42.16 2.04 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.761 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.82 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 73.0 m -40.5 149.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.165 -1.197 . . . . 0.0 110.438 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 33' ' ' ILE . 18.2 pt -129.77 148.38 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.417 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.512 ' CD1' ' HG3' ' A' ' 23' ' ' GLU . 3.3 mp -113.29 151.34 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.764 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -145.79 162.69 34.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.8 Cg_endo -74.03 -3.82 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.83 1.437 . . . . 0.0 110.838 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.19 -142.65 12.54 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.94 7.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.469 -1.018 . . . . 0.0 111.233 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' CYS . 1.4 t -130.23 -2.63 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.798 -1.189 . . . . 0.0 111.101 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.609 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 9.0 p 37.64 -163.25 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 122.064 -0.398 . . . . 0.0 110.391 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.609 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 54.9 Cg_endo -79.24 176.98 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 122.84 0.916 . . . . 0.0 111.253 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.05 -2.34 66.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.41 -28.08 14.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 5.3 m-85 -114.36 23.69 12.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.31 -0.869 . . . . 0.0 109.544 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.493 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . -84.99 30.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.561 ' HB3' ' N ' ' A' ' 6' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.852 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.779 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.6 m -111.37 154.07 25.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -144.93 86.58 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.455 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 33.7 m -109.74 132.56 21.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.434 ' C ' ' OG ' ' A' ' 6' ' ' SER . 50.3 Cg_endo -76.18 47.57 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.862 1.454 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 179.47 121.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.084 -1.01 . . . . 0.0 109.903 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' OD1' ' A' ' 46' ' ' ASN . 43.6 mm -45.59 -32.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.007 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.745 HG12 HD21 ' A' ' 12' ' ' ASN . 31.0 t -79.3 -50.98 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.847 . . . . 0.0 109.951 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.421 ' CB ' ' OG ' ' A' ' 6' ' ' SER . . . -46.25 -31.1 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.901 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.35 -42.52 36.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.44 -0.787 . . . . 0.0 109.653 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.555 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -63.95 -53.85 43.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.388 -0.82 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.745 HD21 HG12 ' A' ' 8' ' ' VAL . 36.2 m-20 -50.54 -50.54 53.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 1.1 t80 -51.06 -37.67 46.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -76.57 -15.18 59.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -23.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.641 -0.662 . . . . 0.0 109.739 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.5 t -89.05 -18.71 26.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.403 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -90.51 -5.67 55.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.627 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -64.51 -42.24 64.32 Favored Pre-proline 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 111.003 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 44.9 Cg_endo -74.15 -26.63 12.53 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.456 1.24 . . . . 0.0 110.604 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.65 10.96 1.98 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.236 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 16' ' ' CYS . 8.6 m -70.39 143.99 91.31 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.019 -1.283 . . . . 0.0 110.352 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -74.94 120.03 5.91 Favored 'Trans proline' 0 C--N 1.285 -2.811 0 O-C-N 124.627 1.856 . . . . 0.0 108.989 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 1.012 ' OE1' HD13 ' A' ' 34' ' ' ILE . 1.7 pp20? -32.74 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.957 0.408 . . . . 0.0 111.413 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.48 -40.67 95.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 0.0 109.396 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -73.66 -37.39 65.31 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 23.8 m -75.28 -19.84 59.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.894 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -95.7 -6.64 39.41 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.076 0.941 . . . . 0.0 109.524 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -29.21 19.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.29 -35.23 17.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.676 -0.64 . . . . 0.0 109.489 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 27' ' ' ALA 0.261 16.8 p -80.35 -23.62 40.42 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.396 -0.815 . . . . 0.0 110.284 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 23.45 47.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.693 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -116.85 175.1 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -1.029 . . . . 0.0 109.937 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 pp -132.95 148.0 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.012 HD13 ' OE1' ' A' ' 23' ' ' GLU . 3.3 mp -105.68 161.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.247 -0.908 . . . . 0.0 110.114 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.478 HG23 ' C ' ' A' ' 34' ' ' ILE . 48.6 pt -148.72 163.39 26.11 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 110.436 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.7 Cg_endo -70.12 -38.03 7.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.014 1.534 . . . . 0.0 110.198 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.54 130.77 1.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 39' ' ' THR . . . -174.2 17.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.603 -0.94 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 66.86 4.29 3.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 110.89 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.516 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER 56.14 142.61 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.778 -0.576 . . . . 0.0 110.867 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.9 Cg_endo -74.6 173.68 13.92 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.631 1.332 . . . . 0.0 110.054 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.23 -4.11 88.79 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.425 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 37.3 m-20 -102.0 -26.11 13.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -1.201 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 4.8 m-85 -118.12 21.14 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.8 30.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.455 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.998 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.838 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.778 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 t -113.27 169.4 8.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.497 ' O ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -157.54 102.63 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.133 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.85 159.34 41.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.136 -0.978 . . . . 0.0 110.49 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 49.4 Cg_endo -77.83 6.51 4.5 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.178 1.62 . . . . 0.0 111.246 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 5' ' ' PRO . 8.7 m -170.56 168.35 7.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.086 . . . . 0.0 110.815 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.614 ' N ' HD13 ' A' ' 7' ' ' ILE . 4.0 mm -68.76 -30.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.513 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 9' ' ' ALA . 10.4 t -80.89 -48.46 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.313 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.529 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -44.18 -36.71 2.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.184 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -78.0 -39.28 42.75 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.407 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 4.4 p -55.62 -48.05 75.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.587 -0.696 . . . . 0.0 110.216 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 7.7 p30 -69.93 -33.29 71.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 1.0 OUTLIER -59.75 -41.33 90.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 108.741 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -79.54 -30.38 41.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.516 0.674 . . . . 0.0 109.422 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.699 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -64.97 -32.82 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.533 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -80.83 -27.83 36.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.503 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 21' ' ' THR . 2.0 ttt180 -94.3 6.39 48.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.299 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -74.16 -41.95 5.38 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.587 -0.695 . . . . 0.0 110.958 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -74.8 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.479 1.252 . . . . 0.0 110.941 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.19 24.84 0.2 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 7.6 m -94.95 141.42 23.25 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 120.995 -1.297 . . . . 0.0 110.255 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -73.7 119.74 6.07 Favored 'Trans proline' 0 C--N 1.285 -2.797 0 O-C-N 124.648 1.867 . . . . 0.0 108.793 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -35.13 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.225 0.536 . . . . 0.0 110.849 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.85 -45.58 93.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.848 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -70.85 -36.09 72.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 110.51 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.2 m -74.44 -23.46 58.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.689 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.667 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -96.0 -12.57 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.997 . . . . 0.0 109.761 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 1.1 m -95.13 -21.64 18.38 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -99.58 -20.46 16.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.497 ' HG1' ' CG ' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -111.55 -7.28 14.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.56 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 104.18 -34.48 5.75 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.686 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.667 ' C ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -46.15 174.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.027 -1.278 . . . . 0.0 110.42 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 32' ' ' CYS . 28.3 pt -158.32 145.74 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.772 ' O ' HG23 ' A' ' 35' ' ' ILE . 4.8 mp -106.41 140.48 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 110.138 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.024 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.2 pp -160.98 134.1 4.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 110.186 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.98 70.81 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.918 1.483 . . . . 0.0 110.448 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' HD13 ' A' ' 35' ' ' ILE . . . 168.87 138.27 2.44 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.48 15.35 5.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -81.9 10.29 6.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.524 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -40.57 163.53 0.09 OUTLIER Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.874 -0.516 . . . . 0.0 110.264 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 42.7 Cg_endo -69.8 169.28 19.34 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.068 1.562 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.69 61.83 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 43.4 p-10 -112.0 -19.86 12.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.03 -1.276 . . . . 0.0 109.519 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 16.2 m-85 -123.27 17.94 9.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.614 -0.678 . . . . 0.0 109.444 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.4 32.55 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.489 -0.757 . . . . 0.0 110.338 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 4' ' ' CYS . 17.7 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.337 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.84 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.929 HG21 ' CE1' ' A' ' 13' ' ' PHE . 94.2 m -127.58 160.71 30.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.5 m -148.05 156.98 43.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 85.9 m -147.53 130.52 7.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' ' CB ' ' A' ' 6' ' ' SER . 49.6 Cg_endo -77.74 25.26 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.977 1.514 . . . . 0.0 112.79 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER 174.25 164.95 0.21 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.254 -1.528 . . . . 0.0 111.059 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 11' ' ' SER . 56.4 mt -65.46 -30.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.508 -0.745 . . . . 0.0 109.328 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 64.8 t -66.74 -50.79 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.925 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -55.24 -66.15 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -51.75 -22.52 3.63 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.593 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 2.1 t -80.24 -63.33 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.565 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 10.3 p30 -61.65 -37.04 82.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.929 ' CE1' HG21 ' A' ' 2' ' ' THR . 0.2 OUTLIER -59.87 -44.92 93.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.942 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 1.5 p30 -69.46 -27.83 65.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.186 -0.946 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -23.25 28.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.664 ' SG ' HG21 ' A' ' 21' ' ' THR . 5.3 t -92.78 -22.93 19.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.697 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -91.1 5.23 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.556 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -65.89 -46.47 65.05 Favored Pre-proline 0 C--N 1.306 -1.29 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.4 Cg_endo -74.8 -71.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.614 1.323 . . . . 0.0 110.581 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.1 27.31 0.09 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.664 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.7 m -84.23 141.35 39.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.064 -1.256 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.6 Cg_endo -74.17 124.73 9.25 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 O-C-N 124.546 1.814 . . . . 0.0 108.242 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.821 ' OE2' HG23 ' A' ' 2' ' ' THR . 0.0 OUTLIER -39.98 -23.37 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.8 -0.563 . . . . 0.0 110.209 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.19 -51.23 68.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.089 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -29.09 66.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 110.576 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.676 ' O ' HG22 ' A' ' 30' ' ' THR . 27.8 m -78.63 -44.92 22.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.039 -1.038 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.889 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -68.89 -13.29 62.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.927 -1.108 . . . . 0.0 109.648 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.561 HG22 ' N ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -77.84 -47.03 19.8 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.537 0.684 . . . . 0.0 109.663 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' N ' HG22 ' A' ' 28' ' ' THR . 4.6 t80 -94.89 -41.03 9.4 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.616 0.722 . . . . 0.0 110.064 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -68.25 -31.87 71.65 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.438 -0.789 . . . . 0.0 110.357 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 124.26 -47.41 1.02 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.561 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.889 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 66.5 m -44.17 169.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.041 -1.27 . . . . 0.0 110.193 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.9 148.8 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.136 -0.977 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 24' ' ' ALA . 1.9 mp -80.39 138.38 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.587 HD13 ' SG ' ' A' ' 40' ' ' CYS . 1.1 pp -134.97 133.16 20.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.79 6.66 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.95 1.5 . . . . 0.0 110.388 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.23 -138.9 5.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.9 -48.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.995 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -102.65 2.06 35.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.012 . . . . 0.0 110.42 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.587 ' SG ' HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER 47.48 177.73 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.862 -0.524 . . . . 0.0 111.168 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.16 -157.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.032 1.543 . . . . 0.0 110.188 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.76 -8.54 54.23 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -19.33 14.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.246 . . . . 0.0 110.145 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 16.6 m-85 -114.25 10.27 17.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -89.11 31.38 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.429 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.9 t30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.838 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.757 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 t -92.82 171.32 9.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 33' ' ' ILE . 1.1 m -147.16 106.07 3.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.045 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 10' ' ' ARG . 1.2 m -99.58 144.07 27.63 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.917 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 44.8 Cg_endo -70.86 -3.35 12.56 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.951 1.5 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.483 ' N ' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER 172.43 175.09 0.1 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.803 -1.186 . . . . 0.0 110.559 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 7' ' ' ILE . 30.9 mm -57.7 -36.08 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -0.845 . . . . 0.0 110.05 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.49 -62.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -61.63 -54.24 45.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.944 . . . . 0.0 108.992 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.69 -52.63 4.84 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.302 -0.874 . . . . 0.0 109.555 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -64.45 -32.73 74.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.064 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.565 ' HB2' ' HA ' ' A' ' 9' ' ' ALA . 1.2 m-20 -59.85 -71.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.683 0.754 . . . . 0.0 109.83 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.649 ' CE2' ' CB ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -47.62 -33.64 6.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.562 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -70.35 -26.11 63.59 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.827 0.822 . . . . 0.0 109.165 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -70.95 -25.02 25.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.68 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.52 -22.64 26.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -74.05 -10.1 59.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.554 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.6 mt -72.4 -55.73 4.53 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.11 -34.14 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.732 1.385 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.6 7.9 1.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.259 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.68 HG21 ' SG ' ' A' ' 16' ' ' CYS . 32.9 m -65.26 131.61 95.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 120.91 -1.347 . . . . 0.0 110.363 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 40.3 Cg_endo -72.23 116.99 4.92 Favored 'Trans proline' 0 C--N 1.288 -2.647 0 O-C-N 124.431 1.753 . . . . 0.0 108.738 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 26.4 pt-20 -33.03 -31.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.433 0.635 . . . . 0.0 110.896 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.53 -43.08 99.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 110.734 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -72.15 -45.29 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.905 -1.122 . . . . 0.0 111.368 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -84.37 -15.45 46.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 0.0 111.763 -178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -75.99 -39.12 56.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.465 -1.397 . . . . 0.0 108.631 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.41 -30.18 63.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.182 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 1.7 t80 -90.89 -48.36 7.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.805 . . . . 0.0 110.357 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 26' ' ' CYS . 1.2 t -66.67 -12.83 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.569 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.95 -43.95 1.61 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.447 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' GLY . 1.5 t -46.77 175.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -1.203 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.471 HD11 ' SG ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER -140.39 156.72 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.112 -0.992 . . . . 0.0 109.808 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 27' ' ' ALA . 73.5 mt -137.25 141.26 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.815 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.692 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -147.52 156.3 45.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 0.0 109.804 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.82 68.85 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.815 1.429 . . . . 0.0 110.046 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 149.11 4.97 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.37 32.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -1.006 . . . . 0.0 110.419 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' CYS . 1.5 t -84.06 14.35 4.26 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 110.768 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' THR . 62.4 m -36.19 154.75 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 122.095 -0.378 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 49.0 Cg_endo -73.97 -176.72 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.943 1.496 . . . . 0.0 110.33 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.23 4.87 82.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.96 -22.5 12.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -1.201 . . . . 0.0 109.872 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -117.87 14.93 14.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 109.838 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.12 29.21 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.824 . . . . 0.0 110.551 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' HB3' ' N ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.127 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.843 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.806 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 1.3 m -124.61 161.1 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -152.56 145.24 24.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.633 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -134.12 161.08 65.9 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.3 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 46.7 Cg_endo -73.59 -0.98 10.06 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.112 1.585 . . . . 0.0 111.607 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -176.17 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.669 -1.27 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -75.07 -31.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 109.968 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.2 t -65.61 -44.48 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -62.74 -70.22 0.22 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 109.049 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -42.84 -26.87 0.15 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.1 m -72.37 -61.78 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.356 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.621 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 36.3 p30 -58.14 -21.18 45.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.998 -1.064 . . . . 0.0 109.802 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.806 ' CZ ' HG21 ' A' ' 2' ' ' THR . 2.2 t80 -72.47 -45.13 60.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.662 0.744 . . . . 0.0 109.101 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -73.56 -20.13 60.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.79 . . . . 0.0 109.048 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.24 -25.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.452 0.644 . . . . 0.0 109.653 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -84.57 -25.88 28.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.783 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 15.5 ttt180 -88.32 7.32 32.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.758 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.593 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -61.07 -43.69 91.67 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.454 -0.778 . . . . 0.0 110.829 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -76.98 -21.41 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.611 1.322 . . . . 0.0 110.834 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.49 12.99 1.93 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.222 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.548 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 11.7 m -65.63 144.8 99.01 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.063 -1.257 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.1 Cg_endo -73.96 118.82 5.57 Favored 'Trans proline' 0 C--N 1.287 -2.693 0 O-C-N 124.614 1.849 . . . . 0.0 108.859 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 22' ' ' PRO . 75.2 mt-10 -36.34 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.145 0.498 . . . . 0.0 110.562 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.69 -38.85 89.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.195 -0.94 . . . . 0.0 109.953 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -30.88 32.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.049 -1.032 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.547 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 69.4 m -80.05 -14.44 58.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.05 . . . . 0.0 110.361 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.648 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -99.85 -27.47 13.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.371 1.081 . . . . 0.0 109.555 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -78.74 -23.58 45.33 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.798 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.8 t80 -102.28 -32.21 10.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.283 -0.885 . . . . 0.0 109.792 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.621 ' HG1' ' CG ' ' A' ' 12' ' ' ASN . 0.6 OUTLIER -91.09 -5.11 55.62 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.03 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 105.64 -38.75 3.14 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.728 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.648 ' C ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -50.01 -177.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.969 -1.312 . . . . 0.0 110.196 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.563 HG23 ' C ' ' A' ' 32' ' ' CYS . 1.2 pp -156.82 163.22 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.871 -1.143 . . . . 0.0 110.499 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' ILE . 7.4 mm -100.79 165.92 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.078 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.926 HG23 ' O ' ' A' ' 34' ' ' ILE . 1.3 pt -171.56 170.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 109.646 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 42.5 Cg_endo -69.75 -16.84 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.865 1.455 . . . . 0.0 110.139 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.746 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 105.03 141.04 10.6 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 74.6 -6.84 1.83 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.686 -0.891 . . . . 0.0 111.323 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' THR . 0.6 OUTLIER -96.78 10.87 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' SG ' HD11 ' A' ' 35' ' ' ILE . 52.0 m -62.32 130.1 92.87 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 110.112 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 43.7 Cg_endo -70.38 -165.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.817 1.43 . . . . 0.0 110.717 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.98 -14.01 55.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.492 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 37.2 p-10 -98.18 -20.22 17.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -1.208 . . . . 0.0 109.498 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 11.9 m-85 -119.49 23.34 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.804 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -88.93 21.64 3.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 4.8 m120 . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.274 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.836 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.682 HG21 ' HE1' ' A' ' 13' ' ' PHE . 9.4 t -138.75 173.93 11.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 1.1 m -152.38 110.83 3.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.889 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.499 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 19.4 m -99.46 162.94 19.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.0 Cg_endo -71.41 -7.84 22.11 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.531 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 9.0 t 175.14 -171.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.8 -1.187 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.2 mm -70.72 -33.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.1 t -55.54 -61.41 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.589 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -56.99 -66.46 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.64 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.499 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -41.99 -37.7 1.42 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.368 -0.833 . . . . 0.0 110.386 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 t -66.81 -49.71 64.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 0.0 109.949 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.481 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 12.2 m-20 -57.14 -59.34 5.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.682 ' HE1' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -50.09 -38.88 40.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.39 -0.819 . . . . 0.0 109.573 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 3.3 m-20 -68.4 -32.79 73.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.905 0.859 . . . . 0.0 108.866 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.49 -18.33 23.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.803 0.811 . . . . 0.0 108.966 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.874 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.89 -26.93 22.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.779 -0.575 . . . . 0.0 110.723 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.32 -9.17 58.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.532 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.2 mt -73.19 -56.55 3.23 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.606 -0.684 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.0 Cg_endo -70.26 -85.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.959 1.505 . . . . 0.0 110.825 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.58 27.32 0.22 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.874 HG21 ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -89.8 127.71 53.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.294 -1.121 . . . . 0.0 110.843 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.6 Cg_endo -71.86 121.29 7.49 Favored 'Trans proline' 0 C--N 1.286 -2.715 0 O-C-N 124.302 1.685 . . . . 0.0 108.78 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.627 ' CB ' ' CE2' ' A' ' 13' ' ' PHE . 8.5 pt-20 -34.03 -28.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.158 0.504 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.18 -43.5 74.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.01 -1.056 . . . . 0.0 110.887 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -69.61 -35.51 75.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 111.661 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -92.74 -14.59 27.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.658 -1.276 . . . . 0.0 111.196 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -82.02 -32.17 30.65 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.692 1.234 . . . . 0.0 107.925 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -79.19 -28.83 42.68 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.917 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -88.0 -33.69 18.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.468 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 26' ' ' CYS . 2.1 t -86.97 -12.15 48.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.085 . . . . 0.0 110.761 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 113.66 -46.26 1.2 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' ALA . 16.6 t -45.93 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -1.206 . . . . 0.0 110.036 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.74 153.18 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.901 ' O ' HG23 ' A' ' 35' ' ' ILE . 5.7 mm -90.28 163.68 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.256 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.901 HG23 ' O ' ' A' ' 34' ' ' ILE . 2.1 pt -167.7 156.82 8.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.44 -0.787 . . . . 0.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.16 -28.75 8.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.14 1.6 . . . . 0.0 109.918 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.32 -141.74 4.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.47 33.26 3.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -1.087 . . . . 0.0 110.033 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -79.45 9.03 5.24 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.676 -0.64 . . . . 0.0 111.133 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -43.45 165.87 0.11 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.4 -0.813 . . . . 0.0 109.69 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.629 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.3 Cg_endo -70.04 179.56 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.911 1.479 . . . . 0.0 111.187 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.61 -10.91 85.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 2.1 t0 -95.54 -19.93 19.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.672 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.563 ' CD2' ' CG ' ' A' ' 41' ' ' PRO . 11.3 m-85 -117.78 11.99 13.75 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.525 -0.734 . . . . 0.0 109.933 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.89 30.8 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.2 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.848 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 3' ' ' CYS . 47.3 m -79.37 169.43 18.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.088 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.48 ' N ' HG22 ' A' ' 2' ' ' THR . 88.1 m -147.67 128.39 14.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 110.648 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 89.8 m -126.52 141.26 39.6 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 109.923 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 45.8 Cg_endo -72.0 -6.69 19.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.99 1.521 . . . . 0.0 111.488 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 10.9 p 176.41 161.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 34.3 mt -45.88 -29.88 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.892 . . . . 0.0 109.456 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.7 t -52.19 -62.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.9 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -67.03 -53.35 32.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.153 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -43.63 -33.37 1.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 33.0 t -70.8 -49.44 46.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.311 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.495 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 7.3 m-20 -63.82 -56.86 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 1.1 t80 -40.95 -42.06 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 109.8 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -83.82 -24.26 31.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 109.919 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -72.25 -31.41 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.802 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.707 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.84 -27.14 23.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -86.5 -2.08 58.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.274 -0.892 . . . . 0.0 109.757 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.4 mt -77.1 -45.19 2.81 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.343 -0.848 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -71.75 -81.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.523 1.275 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.93 29.09 0.59 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.39 -1.386 . . . . 0.0 109.984 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.707 HG21 ' SG ' ' A' ' 16' ' ' CYS . 1.9 m -101.01 142.61 24.97 Favored Pre-proline 0 C--N 1.305 -1.36 0 O-C-N 120.921 -1.341 . . . . 0.0 110.444 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.5 Cg_endo -74.93 126.1 9.79 Favored 'Trans proline' 0 C--N 1.286 -2.73 0 O-C-N 124.622 1.854 . . . . 0.0 108.555 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -34.23 -27.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.947 0.403 . . . . 0.0 111.532 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.56 -48.31 82.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.912 -1.117 . . . . 0.0 109.925 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -70.17 -39.1 75.48 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.176 -0.953 . . . . 0.0 110.203 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 59.0 m -61.22 -30.48 70.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.625 -0.672 . . . . 0.0 111.826 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.895 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -95.89 -11.3 26.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -26.79 30.76 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -89.64 -42.68 11.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.393 0.616 . . . . 0.0 109.95 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.572 HG22 ' HA ' ' A' ' 27' ' ' ALA . 2.4 t -85.51 -13.74 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 0.0 110.949 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 109.11 -42.01 2.07 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.084 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.9 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 74.9 m -41.31 154.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.267 -1.137 . . . . 0.0 110.198 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.2 pt -142.61 147.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.016 -1.053 . . . . 0.0 110.627 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 HG12 ' OE2' ' A' ' 23' ' ' GLU . 3.0 mt -101.49 139.05 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.422 -0.799 . . . . 0.0 109.949 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -130.15 171.07 9.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.501 -179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 50.1 Cg_endo -76.79 6.25 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.079 1.568 . . . . 0.0 110.875 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.04 -142.97 13.61 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.11 16.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -1.043 . . . . 0.0 111.705 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -130.81 5.32 4.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' THR . 68.2 m 53.07 165.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.84 0 O-C-N 121.753 -0.592 . . . . 0.0 110.531 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.963 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 49.5 Cg_endo -74.51 -158.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.873 1.46 . . . . 0.0 110.187 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.11 -18.42 24.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 44' ' ' TYR . 21.5 p30 -96.04 -21.76 17.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.131 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.54 ' CG ' ' OD1' ' A' ' 43' ' ' ASP . 2.4 m-85 -121.9 26.6 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.963 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.75 30.74 0.63 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.4 -0.812 . . . . 0.0 110.595 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.09 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.849 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.544 HG21 ' CE1' ' A' ' 13' ' ' PHE . 97.7 m -111.38 149.69 30.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 m -155.16 105.83 2.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 35.0 m -99.05 150.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.123 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 44.5 Cg_endo -69.36 -3.11 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 111.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.49 175.93 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.23 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.469 HG13 ' OD1' ' A' ' 46' ' ' ASN . 1.8 mp -67.09 -35.2 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.84 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.792 HG12 HD21 ' A' ' 12' ' ' ASN . 3.2 t -68.32 -47.92 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.509 -0.744 . . . . 0.0 109.855 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.95 69.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -77.57 -42.91 33.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.478 -0.764 . . . . 0.0 109.196 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.54 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 21.5 p -57.93 -49.89 75.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.767 . . . . 0.0 109.907 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.792 HD21 HG12 ' A' ' 8' ' ' VAL . 6.8 m-20 -66.66 -53.6 32.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.6 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 20.8 t80 -41.49 -45.9 3.35 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.519 0.676 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.68 -28.47 55.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -74.14 -26.3 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -82.51 -25.27 33.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.891 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 21' ' ' THR . 8.0 tpt180 -85.09 -1.91 57.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -0.878 . . . . 0.0 109.295 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.641 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -70.67 -49.11 15.51 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.491 -0.756 . . . . 0.0 110.473 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 39.7 Cg_endo -69.12 -81.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.663 1.349 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.73 32.17 0.38 Allowed Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.729 HG21 ' SG ' ' A' ' 16' ' ' CYS . 3.6 m -101.1 137.22 19.65 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 121.147 -1.208 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.3 Cg_endo -73.08 124.62 9.7 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.481 1.779 . . . . 0.0 108.279 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 22' ' ' PRO . 71.0 mt-10 -31.84 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.269 0.557 . . . . 0.0 111.141 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -55.81 -52.1 65.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 110.062 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.2 OUTLIER -71.43 -26.71 62.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.609 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.6 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 61.6 m -71.54 -25.25 62.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -99.86 -17.39 17.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.082 -1.012 . . . . 0.0 109.357 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 m -81.24 -28.96 34.59 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -93.34 -37.18 12.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.379 -0.825 . . . . 0.0 109.904 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 27' ' ' ALA . 1.2 t -88.23 -9.49 52.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 103.99 -40.46 2.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.861 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 41.9 t -42.58 159.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -1.201 . . . . 0.0 110.218 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 3' ' ' CYS . 2.5 pp -143.28 144.46 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 110.944 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.0 142.17 17.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.55 -0.719 . . . . 0.0 109.59 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.05 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -145.94 136.56 12.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.74 62.45 7.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.967 1.509 . . . . 0.0 110.044 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 35' ' ' ILE . . . -176.63 137.41 3.58 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 15.01 4.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.596 -0.943 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -84.85 12.27 7.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.301 -0.874 . . . . 0.0 110.62 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.2 m -35.48 140.77 0.32 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 122.096 -0.377 . . . . 0.0 110.648 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' CG ' ' CD1' ' A' ' 44' ' ' TYR . 47.2 Cg_endo -72.27 -171.54 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.539 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.65 -0.56 69.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -108.09 -8.9 15.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' CD1' ' CG ' ' A' ' 41' ' ' PRO . 23.1 m-30 -119.7 5.44 11.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.58 30.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.437 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.832 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.549 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -136.61 176.98 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.195 . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 40.4 m -154.19 144.56 22.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.569 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 11.4 m -144.97 141.82 17.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.82 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 40.5 Cg_endo -65.43 -8.61 19.47 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.098 1.578 . . . . 0.0 112.533 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.496 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 2.7 p 173.0 -170.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.446 -1.408 . . . . 0.0 111.098 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 11' ' ' SER . 29.6 mm -65.38 -40.93 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.816 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 74.9 t -53.26 -56.9 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.415 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.911 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -62.36 -66.6 0.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.285 -0.884 . . . . 0.0 109.005 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' CD ' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -40.76 -48.77 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.541 -0.725 . . . . 0.0 110.344 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 15' ' ' VAL . 47.7 t -49.99 -60.6 2.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.963 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 42.3 m-20 -51.73 -62.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.651 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.71 -41.94 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.248 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -76.48 -19.66 57.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 109.329 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -83.31 -27.97 7.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.536 -0.728 . . . . 0.0 109.343 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.697 ' SG ' HG21 ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.02 -19.81 36.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -5.83 59.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.593 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -63.91 -48.95 77.56 Favored Pre-proline 0 C--N 1.305 -1.362 0 O-C-N 121.48 -0.763 . . . . 0.0 111.03 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -71.63 -25.79 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.602 1.317 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.66 11.18 2.73 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.076 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.697 HG21 ' SG ' ' A' ' 16' ' ' CYS . 3.7 m -70.32 145.81 93.68 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.094 -1.239 . . . . 0.0 110.125 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 41.9 Cg_endo -75.32 122.91 7.34 Favored 'Trans proline' 0 C--N 1.286 -2.754 0 O-C-N 124.556 1.819 . . . . 0.0 108.559 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 22' ' ' PRO . 11.2 pt-20 -35.32 -26.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.044 0.45 . . . . 0.0 111.279 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.42 -50.32 74.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.957 -1.089 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -18.98 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.061 -1.025 . . . . 0.0 110.131 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 48.3 m -80.89 -29.53 35.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.549 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.634 ' HB1' ' C ' ' A' ' 32' ' ' CYS . . . -91.6 -12.37 34.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.71 -33.88 30.9 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -42.47 19.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.53 -0.731 . . . . 0.0 110.024 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 32' ' ' CYS . 4.1 t -84.21 -5.25 59.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.796 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 96.72 -30.29 9.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.911 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 23.3 m -48.47 177.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.251 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 pt -141.63 168.17 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 110.498 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 35' ' ' ILE . 7.4 mm -102.21 178.23 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.008 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.553 HG23 ' CB ' ' A' ' 1' ' ' THR . 0.9 OUTLIER -170.31 135.98 1.21 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.123 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.92 -28.16 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.942 1.496 . . . . 0.0 110.648 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -124.92 -141.34 5.65 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.23 25.82 4.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.995 . . . . 0.0 110.328 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -78.48 7.21 7.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.504 -0.748 . . . . 0.0 110.879 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' THR . 0.5 OUTLIER -41.87 163.33 0.12 Allowed Pre-proline 0 C--N 1.293 -1.871 0 O-C-N 121.627 -0.671 . . . . 0.0 110.183 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.1 Cg_endo -73.03 -164.7 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.805 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.11 -8.05 34.45 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.9 OUTLIER -95.4 -19.5 19.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.698 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.426 ' CD2' ' C ' ' A' ' 43' ' ' ASP . 10.5 m-85 -119.12 17.86 13.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.512 -0.743 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.87 28.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.121 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' O ' ' CD ' ' A' ' 10' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.142 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.849 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.463 ' OG1' HG13 ' A' ' 34' ' ' ILE . 7.2 t -126.77 167.22 16.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.853 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -157.68 112.02 2.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.638 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 16.8 m -94.75 164.09 20.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.88 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 45.3 Cg_endo -70.63 -4.87 15.48 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.018 1.536 . . . . 0.0 111.333 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 11.5 p -178.24 171.67 1.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.964 -1.085 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.459 HG12 ' OD1' ' A' ' 46' ' ' ASN . 41.3 mm -64.16 -34.49 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.413 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 87.1 t -68.14 -50.81 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' A' ' 5' ' ' PRO . . . -52.21 -34.32 44.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -79.98 -32.02 39.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.13 -46.15 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.585 -0.697 . . . . 0.0 109.682 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 4.0 m-20 -71.16 -47.34 58.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.308 -0.87 . . . . 0.0 109.085 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -51.57 -31.64 25.38 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.734 0.778 . . . . 0.0 109.507 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -81.84 -22.29 37.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -32.66 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.742 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.52 -28.08 28.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.522 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -88.03 5.13 42.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.445 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -75.45 -48.22 4.1 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.468 -0.77 . . . . 0.0 110.517 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -73.67 -84.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.732 1.385 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.44 29.66 0.63 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.742 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.1 m -91.32 142.01 26.69 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 120.729 -1.454 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.7 Cg_endo -72.56 125.63 10.79 Favored 'Trans proline' 0 C--N 1.283 -2.882 0 O-C-N 124.547 1.814 . . . . 0.0 108.594 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mt-10 -32.87 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.173 0.511 . . . . 0.0 111.259 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -61.15 -51.25 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.11 -32.72 74.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.016 . . . . 0.0 110.102 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 33.5 m -72.56 -36.72 68.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.948 . . . . 0.0 110.206 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.032 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -89.67 4.5 49.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.743 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -91.74 -40.17 11.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -86.18 -28.5 23.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.704 HG23 ' H ' ' A' ' 32' ' ' CYS . 2.1 t -93.23 -21.12 19.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.99 . . . . 0.0 110.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 104.49 -37.93 3.53 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.196 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 1.032 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 39.3 t -41.52 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -1.163 . . . . 0.0 110.466 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.36 148.18 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -0.939 . . . . 0.0 110.394 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.7 mp -108.69 161.2 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.511 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 19.3 pt -151.15 167.32 13.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.947 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 41.5 Cg_endo -68.78 -20.88 39.18 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.771 1.406 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' ' CG2' ' A' ' 1' ' ' THR . . . 119.51 128.45 3.73 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.662 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.57 -89.57 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.885 -0.774 . . . . 0.0 109.366 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -156.42 2.51 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.024 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 39' ' ' THR . 71.2 m 53.05 160.04 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 110.901 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 51.4 Cg_endo -80.0 -157.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.62 1.326 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.26 -10.58 27.39 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 44' ' ' TYR . 19.0 p30 -104.74 -17.57 14.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -1.159 . . . . 0.0 109.96 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 10.4 m-85 -116.58 16.89 15.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -85.68 30.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 110.508 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.459 ' OD1' HG12 ' A' ' 7' ' ' ILE . 1.7 t-20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.835 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.816 HG23 HG12 ' A' ' 34' ' ' ILE . 3.3 m -94.41 160.69 14.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 2' ' ' THR . 66.1 m -151.71 111.99 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.558 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 88.0 m -111.01 144.42 30.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.728 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -74.42 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.044 1.549 . . . . 0.0 111.271 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -159.44 165.74 32.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.851 -1.156 . . . . 0.0 110.725 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -31.62 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 11.3 t -73.74 -53.79 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.932 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -42.35 -37.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.237 -0.914 . . . . 0.0 110.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -83.69 -37.85 22.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.411 -0.806 . . . . 0.0 109.182 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 6.2 m -54.39 -32.86 58.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 4.0 m-20 -81.39 -50.12 9.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.035 . . . . 0.0 109.545 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.665 ' CZ ' HG21 ' A' ' 2' ' ' THR . 0.0 OUTLIER -54.35 -39.79 67.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.22 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.618 ' OD1' ' N ' ' A' ' 15' ' ' VAL . 4.7 p-10 -75.54 -24.52 56.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 t -80.41 -25.49 11.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.601 0.715 . . . . 0.0 109.346 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -83.19 -25.55 31.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 110.025 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' THR . 28.1 ttt180 -92.45 6.33 47.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.597 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -63.12 -43.88 82.52 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.8 Cg_endo -75.32 -72.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.54 1.284 . . . . 0.0 110.685 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.59 26.4 0.14 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 16' ' ' CYS . 9.5 m -83.04 142.0 44.04 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 121.125 -1.22 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 42.0 Cg_endo -74.03 119.3 5.78 Favored 'Trans proline' 0 C--N 1.285 -2.782 0 O-C-N 124.616 1.851 . . . . 0.0 108.686 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.614 ' HB2' HD13 ' A' ' 34' ' ' ILE . 11.1 pt-20 -34.82 -28.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -60.74 -43.6 97.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -73.63 -37.33 65.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 110.371 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 64.3 m -73.0 -20.03 61.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -98.39 -18.18 18.43 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.272 1.035 . . . . 0.0 109.511 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -83.83 -26.33 29.62 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.15 -43.83 9.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.519 0.676 . . . . 0.0 109.847 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.2 t -81.26 -10.52 59.57 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.426 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 103.07 -39.75 2.68 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.563 ' H ' HG23 ' A' ' 30' ' ' THR . 48.9 m -40.4 160.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.285 -1.126 . . . . 0.0 110.632 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' C ' HG13 ' A' ' 34' ' ' ILE . 7.4 pt -127.83 158.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.98 -1.075 . . . . 0.0 109.777 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 2' ' ' THR . 64.2 mt -137.22 139.72 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 110.72 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.74 137.08 12.25 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.51 66.33 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.925 1.487 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.06 -139.68 2.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.47 24.33 0.08 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.602 -0.94 . . . . 0.0 109.937 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.31 11.31 24.06 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.757 0.789 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.69 151.22 4.34 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.774 -0.579 . . . . 0.0 110.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.6 -172.21 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.993 1.523 . . . . 0.0 110.48 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.2 55.95 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' A' ' 44' ' ' TYR . 4.4 p30 -116.07 -20.23 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.819 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' OD2' ' A' ' 43' ' ' ASP . 19.5 m-85 -115.38 4.59 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.419 -0.801 . . . . 0.0 109.747 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.87 32.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.875 . . . . 0.0 110.175 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.092 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.843 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.711 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.962 HG23 HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -134.98 117.57 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.456 . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 134.48 55.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 109.904 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 24.1 m -105.18 152.03 39.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 48.1 Cg_endo -73.06 -4.99 16.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 111.087 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.509 ' CA ' ' HB3' ' A' ' 46' ' ' ASN . 3.3 p -152.39 145.11 24.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -49.7 -39.22 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 109.214 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.33 -50.4 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.707 . . . . 0.0 109.776 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -51.25 -21.86 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.428 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -93.55 -36.27 12.49 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -47.42 81.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.278 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 25.0 p-10 -75.43 -36.09 60.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.906 ' CE1' HG21 ' A' ' 2' ' ' THR . 8.2 t80 -56.94 -42.92 80.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.409 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -75.86 -18.3 59.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.334 -0.853 . . . . 0.0 108.942 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -77.11 -23.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.467 0.651 . . . . 0.0 109.725 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.534 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.3 t -93.29 -21.51 19.54 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.523 -0.736 . . . . 0.0 110.52 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 6.3 ttt-85 -90.59 6.96 41.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.643 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -79.64 -41.78 1.5 Allowed Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.432 -0.792 . . . . 0.0 111.441 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.2 Cg_endo -72.75 -18.07 25.35 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.379 1.199 . . . . 0.0 110.84 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.48 17.55 1.93 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.056 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 9.1 m -82.58 144.45 49.13 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.017 -1.284 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 40.3 Cg_endo -72.74 119.71 6.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 O-C-N 124.643 1.865 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' HD2' ' A' ' 17' ' ' ARG . 12.1 pt-20 -37.27 -25.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.104 0.478 . . . . 0.0 110.838 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -64.65 -43.2 94.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 109.924 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -76.63 -21.26 55.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.092 -1.005 . . . . 0.0 110.241 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 30' ' ' THR . 73.2 m -87.15 -11.96 48.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . -99.31 -19.91 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.284 1.04 . . . . 0.0 109.12 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -91.07 -22.53 20.69 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -97.09 -27.65 14.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.206 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -99.98 -13.55 19.04 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.552 -0.718 . . . . 0.0 110.27 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 111.67 -37.86 3.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.991 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ALA . 6.2 t -46.96 176.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.636 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 44' ' ' TYR . 23.4 pt -138.39 154.88 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.943 -1.098 . . . . 0.0 110.455 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.962 HD13 HG23 ' A' ' 2' ' ' THR . 14.5 mm -102.82 168.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.017 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 34' ' ' ILE . 23.6 pt -158.24 144.23 12.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.347 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.6 -15.82 27.22 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.027 1.54 . . . . 0.0 110.029 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.72 -140.64 11.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -175.67 25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.397 -1.061 . . . . 0.0 110.839 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' O ' ' A' ' 40' ' ' CYS . 9.5 t -94.79 -15.87 23.45 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 39' ' ' THR . 54.3 m 53.13 122.99 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.676 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 42.7 Cg_endo -70.96 -170.72 0.5 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.518 1.273 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -13.16 64.81 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -97.76 -18.58 18.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -1.218 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 33' ' ' ILE . 9.6 m-85 -118.81 18.16 13.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -88.71 32.33 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.087 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' HB3' ' CA ' ' A' ' 6' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.12 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.844 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.406 HG23 ' CE2' ' A' ' 13' ' ' PHE . 4.4 m -126.99 131.21 51.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.882 ' SG ' HD11 ' A' ' 35' ' ' ILE . 10.9 m -119.02 123.69 45.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 84.1 m -136.3 150.94 72.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 109.742 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 43.0 Cg_endo -68.87 -8.53 23.74 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.694 1.365 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.498 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 3.1 m -174.58 160.27 3.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.013 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 7.7 mt -50.74 -42.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -0.863 . . . . 0.0 109.611 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.7 t -56.13 -58.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 109.899 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -45.98 -47.81 16.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -68.43 -40.58 81.12 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.21 -52.63 34.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.758 . . . . 0.0 109.824 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.76 -56.54 20.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.19 -37.84 10.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.525 -0.735 . . . . 0.0 110.018 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -83.1 -22.13 33.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 11' ' ' SER . 1.2 t -87.76 -20.59 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.671 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.9 OUTLIER -85.46 -31.95 22.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.563 -0.711 . . . . 0.0 110.187 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 26.8 ttt-85 -88.73 7.37 34.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.164 -0.96 . . . . 0.0 109.279 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.609 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -63.65 -46.42 82.92 Favored Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.497 -0.752 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -73.87 -71.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.55 1.289 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.35 24.03 0.14 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.921 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.537 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 10.0 m -82.99 142.36 44.54 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 120.932 -1.334 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -73.87 118.38 5.41 Favored 'Trans proline' 0 C--N 1.286 -2.757 0 O-C-N 124.606 1.845 . . . . 0.0 108.542 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 18.6 pt-20 -36.37 -26.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.039 0.447 . . . . 0.0 111.046 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -62.52 -42.53 99.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.028 -1.045 . . . . 0.0 109.67 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -73.18 -41.58 63.7 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.179 -0.951 . . . . 0.0 110.545 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 68.7 m -66.75 -24.24 66.19 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 111.061 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -97.74 -7.85 29.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.0 109.467 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.3 -24.74 19.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 2.9 t80 -95.52 -32.73 12.71 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.566 -0.709 . . . . 0.0 109.581 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 32' ' ' CYS . 0.8 OUTLIER -95.24 -10.48 30.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 110.179 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 100.34 -38.82 2.96 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.843 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 20.3 m -43.13 166.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.112 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.509 HG23 ' C ' ' A' ' 32' ' ' CYS . 2.1 pp -150.43 148.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.053 -1.029 . . . . 0.0 110.297 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -108.22 146.83 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 0.0 110.263 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.882 HD11 ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -130.81 174.83 4.21 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.258 -0.901 . . . . 0.0 110.114 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 35' ' ' ILE . 42.4 Cg_endo -70.93 -32.59 13.45 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.55 . . . . 0.0 110.525 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 140.53 134.28 3.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . 174.81 -80.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.612 -0.934 . . . . 0.0 109.735 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -174.32 18.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.61 -0.681 . . . . 0.0 111.315 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.3 m 56.14 166.05 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.439 -0.788 . . . . 0.0 109.363 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 45.8 Cg_endo -72.59 -158.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.933 1.491 . . . . 0.0 109.924 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.68 -29.76 3.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -81.57 -21.16 38.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.928 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 43' ' ' ASP . 2.8 m-85 -119.23 33.67 5.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.88 29.67 0.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.839 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 163.46 26.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.721 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 33' ' ' ILE . 5.9 p -158.24 144.18 17.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -125.9 147.88 60.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.287 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 46.9 Cg_endo -73.01 -0.61 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.008 1.531 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -156.22 157.11 35.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.093 -1.004 . . . . 0.0 110.413 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 mp -61.73 -33.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.926 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 5.3 t -70.01 -56.31 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.54 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -42.68 -36.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -81.61 -35.09 30.48 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -55.83 -42.27 75.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 109.565 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 15' ' ' VAL . 2.2 m-80 -73.83 -52.87 11.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 0.0 109.297 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -42.81 -36.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.47 -0.769 . . . . 0.0 109.453 179.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -73.42 -31.5 63.87 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.84 0.829 . . . . 0.0 109.182 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' ASN . 1.1 t -71.52 -22.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.553 0.692 . . . . 0.0 109.338 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.935 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -80.74 -34.02 34.71 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.615 -0.678 . . . . 0.0 110.716 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -74.52 -6.38 48.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 2.1 mt -71.7 -57.67 4.06 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.471 -0.768 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 42.5 Cg_endo -71.28 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.007 1.53 . . . . 0.0 110.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.93 23.08 0.24 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.935 HG21 ' SG ' ' A' ' 16' ' ' CYS . 11.1 m -84.0 125.39 72.88 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.221 -1.164 . . . . 0.0 110.997 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 24' ' ' ALA . 38.7 Cg_endo -70.82 121.87 8.3 Favored 'Trans proline' 0 C--N 1.288 -2.651 0 O-C-N 124.286 1.677 . . . . 0.0 108.801 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.3 pt-20 -34.23 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.413 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -69.4 -40.35 77.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.374 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -65.61 -43.78 88.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 110.645 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.568 ' O ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -85.63 -23.81 27.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.071 -1.018 . . . . 0.0 111.427 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 32' ' ' CYS . . . -71.86 -27.17 62.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.764 -1.21 . . . . 0.0 108.711 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -80.28 -32.76 38.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.247 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -94.01 -35.26 12.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.448 -0.782 . . . . 0.0 110.56 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 26' ' ' CYS . 1.0 OUTLIER -82.3 -11.73 58.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.552 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 19.13 23.27 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.573 ' C ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.5 -179.32 3.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -1.169 . . . . 0.0 110.005 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.6 HD11 ' SG ' ' A' ' 40' ' ' CYS . 45.1 pt -154.78 144.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.061 -1.024 . . . . 0.0 110.178 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.3 mp -95.97 142.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.444 -0.785 . . . . 0.0 110.114 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.697 HD12 ' HB3' ' A' ' 38' ' ' ALA . 8.5 pt -147.74 153.85 43.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.842 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.86 58.84 4.16 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.975 1.513 . . . . 0.0 110.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.763 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 76.66 132.36 0.47 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 37' ' ' GLY . . . 163.38 -28.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.818 -0.813 . . . . 0.0 109.668 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.692 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 69.69 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.716 0.769 . . . . 0.0 110.378 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 57.71 178.3 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.685 . . . . 0.0 110.383 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 40' ' ' CYS . 45.5 Cg_endo -70.8 -168.1 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.99 1.521 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.6 2.43 87.32 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -103.96 -28.83 11.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -1.159 . . . . 0.0 109.653 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' O ' ' HB2' ' A' ' 3' ' ' CYS . 14.8 m-85 -103.45 1.8 32.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.5 -0.75 . . . . 0.0 110.038 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.11 29.76 0.47 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 0.0 110.718 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 5.0 m-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.075 -0.965 . . . . 0.0 109.982 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.842 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 1.07 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -86.59 156.82 19.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.798 . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 2' ' ' THR . 56.1 m -153.33 122.85 6.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 74.9 m -132.7 139.66 35.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.36 -2.6 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.883 1.465 . . . . 0.0 111.091 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -160.95 149.23 16.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.474 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 7' ' ' ILE . 49.1 mt -51.54 -32.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 109.727 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.542 HG12 HD21 ' A' ' 12' ' ' ASN . 50.5 t -69.71 -55.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.738 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . . . -43.12 -36.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.846 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -82.5 -44.14 16.32 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.35 -0.844 . . . . 0.0 108.91 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -39.44 41.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.542 HD21 HG12 ' A' ' 8' ' ' VAL . 5.4 m-20 -68.58 -50.78 49.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 108.95 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 1.07 ' CE2' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -47.31 -42.31 20.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.58 -0.7 . . . . 0.0 109.407 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -78.0 -16.57 58.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.612 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -83.16 -25.4 8.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.591 -0.693 . . . . 0.0 109.726 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.691 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.08 -26.97 22.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.545 -0.722 . . . . 0.0 110.386 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 21' ' ' THR . 4.4 ttt180 -91.02 9.97 28.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.326 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -73.11 -45.05 8.2 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.546 -0.721 . . . . 0.0 110.529 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.7 Cg_endo -75.81 -81.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.665 1.35 . . . . 0.0 110.776 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -150.86 36.43 0.9 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.996 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.691 HG21 ' SG ' ' A' ' 16' ' ' CYS . 12.0 m -106.46 134.44 19.8 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.921 -1.341 . . . . 0.0 110.403 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.9 Cg_endo -71.18 119.86 6.59 Favored 'Trans proline' 0 C--N 1.286 -2.734 0 O-C-N 124.476 1.777 . . . . 0.0 109.051 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 10.3 mt-10 -28.91 -35.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.707 0.765 . . . . 0.0 111.116 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.7 -48.18 78.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.299 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -74.34 -19.39 60.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.014 . . . . 0.0 110.372 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 84.3 m -84.99 -19.31 32.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.248 -0.908 . . . . 0.0 110.742 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -96.47 -24.33 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.38 1.086 . . . . 0.0 109.208 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -85.3 -21.54 28.94 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.861 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -93.3 -30.95 14.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.619 -0.675 . . . . 0.0 109.639 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 12' ' ' ASN . 1.1 t -95.43 -11.91 26.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' CYS . . . 114.46 -39.36 2.83 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.367 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 66.2 m -48.24 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.333 -1.098 . . . . 0.0 111.028 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.492 ' CG2' ' C ' ' A' ' 32' ' ' CYS . 5.3 pt -151.68 157.58 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 24' ' ' ALA . 35.9 mt -135.32 142.36 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.478 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -138.79 163.92 43.27 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 46.6 Cg_endo -73.7 54.44 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.993 1.523 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . 90.13 137.36 6.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 39' ' ' THR . . . 175.02 -28.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.57 -0.959 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 73.64 -1.61 3.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.801 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' O ' ' A' ' 39' ' ' THR . 3.3 m 47.47 171.77 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 CA-C-O 121.332 0.587 . . . . 0.0 111.915 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 44' ' ' TYR . 54.2 Cg_endo -75.04 -158.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.872 1.459 . . . . 0.0 110.098 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 7.65 59.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 -23.22 10.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -1.123 . . . . 0.0 109.642 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.488 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 19.4 m-85 -110.48 9.17 23.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 110.066 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.95 30.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 110.26 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.847 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.844 HG21 ' CE1' ' A' ' 13' ' ' PHE . 86.0 m -135.65 131.9 36.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.463 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.3 m -132.13 99.68 4.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 109.883 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 37.2 m -97.06 159.98 30.13 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 42.1 Cg_endo -67.64 -9.19 24.62 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.97 1.511 . . . . 0.0 112.28 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 170.91 175.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.54 -1.35 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 11' ' ' SER . 27.0 mm -55.58 -40.16 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.483 -0.761 . . . . 0.0 109.797 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 11' ' ' SER . 78.9 t -54.44 -64.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.53 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . . . -49.21 -65.35 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.206 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -44.48 -25.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.404 -0.81 . . . . 0.0 110.144 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 0.3 OUTLIER -69.04 -52.05 32.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.027 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.4 m-80 -70.45 -51.87 26.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.844 ' CE1' HG21 ' A' ' 2' ' ' THR . 38.1 t80 -42.31 -46.29 4.52 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.528 -0.733 . . . . 0.0 110.297 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -77.09 -20.57 55.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 109.622 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -81.24 -26.23 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 109.725 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -86.31 -22.82 26.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.173 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 21' ' ' THR . 16.2 tpt180 -89.28 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.742 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.642 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -68.34 -43.86 34.15 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.527 -0.733 . . . . 0.0 110.646 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 42.3 Cg_endo -72.91 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.488 1.257 . . . . 0.0 110.857 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -166.64 28.75 0.18 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.696 HG21 ' SG ' ' A' ' 16' ' ' CYS . 2.4 m -96.2 142.27 24.32 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.2 Cg_endo -74.82 124.99 9.12 Favored 'Trans proline' 0 C--N 1.286 -2.741 0 O-C-N 124.622 1.854 . . . . 0.0 108.37 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 22' ' ' PRO . 81.6 mt-10 -33.29 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.125 0.488 . . . . 0.0 111.297 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -58.26 -49.55 76.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.021 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.61 -27.75 64.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 109.983 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 33.9 m -76.06 -32.82 59.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.446 -0.784 . . . . 0.0 110.572 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -94.13 -3.1 51.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 109.738 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -86.23 -36.81 19.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -88.21 -40.05 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.97 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.708 HG23 ' H ' ' A' ' 32' ' ' CYS . 1.6 t -80.02 -16.95 54.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 110.239 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 101.6 -37.12 3.79 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.893 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 42.4 t -42.41 159.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -1.208 . . . . 0.0 110.195 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 3' ' ' CYS . 1.1 pp -137.05 145.61 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 1' ' ' THR . 4.0 mp -107.35 153.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.418 -0.801 . . . . 0.0 109.976 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.42 155.99 60.66 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.081 -1.012 . . . . 0.0 110.554 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.44 -1.27 11.1 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.083 1.57 . . . . 0.0 110.061 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.97 -141.83 3.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.96 47.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.986 . . . . 0.0 109.749 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.44 8.87 27.63 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.493 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 28.6 p -48.12 162.93 0.31 Allowed Pre-proline 0 C--N 1.291 -1.949 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.187 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 44.3 Cg_endo -69.78 162.18 43.06 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.839 1.442 . . . . 0.0 111.33 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 -8.33 78.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' C ' ' CD2' ' A' ' 44' ' ' TYR . 10.8 m-20 -90.65 -21.33 21.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.239 . . . . 0.0 109.067 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' CD1' ' HG2' ' A' ' 41' ' ' PRO . 9.2 m-85 -119.61 10.58 11.79 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.519 0.676 . . . . 0.0 109.493 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.62 31.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 110.28 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.27 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.85 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.968 HG23 ' CE2' ' A' ' 13' ' ' PHE . 1.5 m -97.77 144.37 27.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 1.6 m -145.75 115.01 7.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.256 -0.903 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 1.7 m -106.28 158.46 32.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 48.3 Cg_endo -76.17 -21.89 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.193 1.628 . . . . 0.0 111.174 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 p -140.75 172.1 13.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.007 -1.058 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -69.92 -32.01 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.875 . . . . 0.0 110.019 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.627 HG12 HD21 ' A' ' 12' ' ' ASN . 88.2 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' SG ' ' A' ' 32' ' ' CYS . . . -64.3 -34.64 78.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -42.77 81.28 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -63.44 -45.77 89.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.753 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.627 HD21 HG12 ' A' ' 8' ' ' VAL . 6.3 m-20 -65.66 -53.18 44.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.968 ' CE2' HG23 ' A' ' 2' ' ' THR . 1.0 OUTLIER -44.65 -48.45 10.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.944 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.62 -14.43 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 0.0 109.637 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -84.58 -20.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 109.89 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' A' ' 21' ' ' THR . 2.8 t -92.77 -22.41 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 0.0 110.567 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 5.0 mtp180 -85.38 0.6 51.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 109.597 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.62 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -67.82 -47.96 42.27 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 41.5 Cg_endo -69.45 -17.76 38.84 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.449 1.236 . . . . 0.0 110.836 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 19.99 3.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.568 HG21 ' SG ' ' A' ' 16' ' ' CYS . 6.3 m -77.27 145.85 73.4 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.361 -1.082 . . . . 0.0 110.295 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.0 Cg_endo -75.38 120.78 6.09 Favored 'Trans proline' 0 C--N 1.286 -2.744 0 O-C-N 124.593 1.839 . . . . 0.0 108.403 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.539 ' HG3' HG21 ' A' ' 34' ' ' ILE . 14.6 pm0 -35.68 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.973 0.416 . . . . 0.0 111.221 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -59.71 -52.13 66.82 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -42.94 97.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 109.759 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 27.8 m -70.22 -16.58 63.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -92.18 -7.19 49.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.241 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.0 -34.33 18.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -83.49 -39.69 20.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.429 -0.794 . . . . 0.0 109.632 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.473 HG21 ' CA ' ' A' ' 13' ' ' PHE 0.271 23.8 p -75.54 -26.62 58.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.45 -0.781 . . . . 0.0 110.429 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.23 14.26 64.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.498 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 33.2 m -93.86 -174.56 3.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -1.091 . . . . 0.0 110.389 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -144.62 151.86 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 27' ' ' ALA . 2.8 mp -111.2 138.89 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.398 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -125.36 171.77 7.11 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 44.5 Cg_endo -71.44 -26.35 20.39 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.99 1.521 . . . . 0.0 111.884 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.989 ' O ' HD13 ' A' ' 35' ' ' ILE . . . -151.28 -141.64 3.38 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.493 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.63 29.56 1.29 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.672 -0.899 . . . . 0.0 110.592 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.81 7.42 7.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 35' ' ' ILE . 55.7 m -51.15 151.13 5.09 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 121.587 -0.696 . . . . 0.0 110.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 50.1 Cg_endo -75.57 -159.66 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.883 1.465 . . . . 0.0 110.339 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 -13.04 25.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 3.9 m-20 -96.89 -16.15 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.922 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 15.4 m-85 -116.81 19.75 14.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 110.16 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.51 30.88 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.808 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.263 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.853 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.809 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.536 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 7.3 t -81.05 165.34 21.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 2' ' ' THR . 12.6 m -156.85 109.7 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 110.406 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.614 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -121.62 163.2 32.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 110.288 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.4 Cg_endo -72.04 -7.1 20.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.052 1.554 . . . . 0.0 111.063 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 5' ' ' PRO . 1.8 m -158.53 154.03 26.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.014 -1.054 . . . . 0.0 110.798 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 mt -61.75 -28.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.799 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 91.6 t -65.9 -48.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.614 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -58.83 -49.4 77.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.8 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -36.75 76.97 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.43 -39.89 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.672 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 5.4 m-20 -72.75 -51.57 18.62 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.026 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -44.2 -50.37 8.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.529 -0.732 . . . . 0.0 109.568 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.69 -39.9 95.46 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 12' ' ' ASN . 1.2 t -58.02 -25.81 27.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.615 0.721 . . . . 0.0 109.06 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.4 OUTLIER -86.01 -16.04 39.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.768 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 21' ' ' THR . 14.1 tpt180 -84.43 -7.21 59.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 109.355 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -56.07 -50.94 84.48 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.364 -0.835 . . . . 0.0 111.142 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.6 Cg_endo -70.72 -25.7 23.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.604 1.318 . . . . 0.0 110.713 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.46 17.69 2.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.589 HG21 ' SG ' ' A' ' 16' ' ' CYS . 6.3 m -68.09 144.17 96.71 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.186 -1.185 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 24' ' ' ALA . 41.5 Cg_endo -74.1 122.13 7.39 Favored 'Trans proline' 0 C--N 1.283 -2.886 0 O-C-N 124.517 1.798 . . . . 0.0 108.757 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -32.04 -31.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.138 0.494 . . . . 0.0 111.054 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . -56.01 -47.59 77.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.134 -0.978 . . . . 0.0 109.371 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -68.66 -41.44 79.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.405 -0.809 . . . . 0.0 110.414 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 16.3 m -70.38 -25.0 63.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.344 -0.848 . . . . 0.0 110.809 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.887 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -96.02 -2.06 47.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.064 . . . . 0.0 109.685 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -101.98 -22.92 14.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -93.47 -29.05 15.75 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 32' ' ' CYS . 0.6 OUTLIER -102.91 -21.23 14.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.838 -0.539 . . . . 0.0 110.13 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 32' ' ' CYS . . . 109.67 -35.0 5.14 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.481 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.887 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.2 m -41.38 160.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.119 -1.224 . . . . 0.0 110.542 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.2 pt -133.24 145.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.883 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 1' ' ' THR . 2.7 mp -110.42 147.37 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 110.825 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -146.37 147.57 31.45 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.561 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.03 69.57 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.851 1.448 . . . . 0.0 110.292 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.92 145.95 4.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.42 25.38 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.98 . . . . 0.0 110.523 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -84.99 14.13 5.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.533 -0.729 . . . . 0.0 110.625 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' THR . 1.6 m -38.79 161.57 0.07 OUTLIER Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.989 -0.444 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.1 Cg_endo -70.69 -161.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.884 1.465 . . . . 0.0 110.902 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.61 -5.25 26.11 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 1.3 t0 -93.63 -31.4 14.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -1.232 . . . . 0.0 110.039 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.539 ' CE2' ' HB3' ' A' ' 43' ' ' ASP . 2.3 m-85 -114.49 23.13 13.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.634 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -87.91 32.12 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.85 . . . . 0.0 110.509 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.773 . . . . . . . . 1 1 . 1 stop_ save_